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Abstract
Antibiotic overuse has driven the development of antimicrobial resistance (AMR), whilst a dwin-
dling antibiotic development pipeline has led to the emergence of resistance to ”last resort”
antibiotics, such as carbapenem. Antimicrobial peptides (AMPs) are emerging as a promising
means of treating multidrug resistant bacterial infections, with reduced risk of AMR develop-
ment due to the AMP efficacy and rapid bactericidal effects. Clinical translation of AMPs is
hindered by peptide susceptibility to proteolytic degradation, low biostability and unknown po-
tential for systemic toxicity. Stimuli-responsive AMP delivery systems offer a promising means
of circumventing these shortcomings with spatial and temporal control over drug delivery in-
creasing drug pharmacodynamics, thus permitting the use of lower drug doses. Furthermore,
the encapsulation of an AMPs inside a delivery vehicle can improve biostability and protect the
cargo from proteolytic degradation.
This thesis discusses the development of a prototype poly(ethylene glycol) (PEG) hydrogel
wound dressing that contains phospholipid coated gold nanorods (AuNRs) and liposomes loaded
with the AMP IRIKIRIK-CONH2 (IK8). Using facile lipid film hydration techniques, liposomes
were fabricated to encapsulate lethal doses of IK8 and protect the internalised peptides from
protease degradation. The liposomes exhibit negligible leakage until heated to the gel-fluid
phase transition temperature in the presence of bacteria. The bulk temperature of the gel can
be controlled by varying the intensity of applied continuous wave irradiation that mediates
the AuNR photothermal heating profile. Irradiation at 2.1 W cm−2 for 10 mins (heating the
sample to 55◦C) demonstrated triggered delivery of IK8, eliciting bactericidal activity against
Staphylococcus aureus and Pseudonomas aeruginosa. Irradiation at 2.4 W cm−2 (heating the
sample to 60◦C for 10 mins) demonstrated thermal bacteria killing alone, and an additive
antibacterial effect in conjunction with the AMP. Through controlling the concentration of IK8-
liposomes and the laser irradiation time a single gel can provide bactericidal activity against
multiple batches of bacteria.
Additionally, by mixing maleimide-functionalised phospholipid stabilised AuNRs with IK8-
loaded liposomes containing the thiolated lipid DPPE-Ptd, AuNR conjugated IK8-liposome
(ANCIL) complexes were fabricated that enabled the triggered release of AMPs under pulsed
laser irradiation (450 µJ cm−2 for 10 mins) without bulk heating. The ANCIL complexes
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and C) DPPG. Reproduced with permission.220 Copyright 2017, Elsevier. . . . . 43
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Adapted with permission.294. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 54
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1.1 Overview and thesis outline
Antibiotic remedies have been used for millennia to treat bacterial infections, however chemical
treatments, or chemotherapeutics, were not discovered until physician Paul Ehrlich isolated ar-
sphenamine as a treatment for syphilis in the late 19th century.1 Chemotherapeutic antibiotics
have since revolutionised medicine, with their high treatment efficiency and ease of manufacture
leading to wide spread usage. However, overuse has driven the development of antimicrobial
resistance (AMR) in bacteria, dramatically decreasing antibiotic efficacy and in turn increased
the risks of infection related mortalities.2 Furthermore, a dwindling development pipeline of
novel antibiotics has led to bacteria evolving resistance to “last resort” antibiotics such as car-
bapenem, leaving critically few options for treatment.3–5 As such, antibiotic alternatives are
viewed as a promising means of overcoming resistance. Antimicrobial peptides (AMPs) in
particular exhibit potential as antibacterial chemotherapeutics, displaying rapid and high an-
tibacterial efficacy that decreases the likelihood of bacteria acquiring resistance. The path to
the clinical translation of AMPs is blocked by their susceptibility to proteolytic degradation, low
biostability, and potential to induce systemic toxicity. This thesis discusses the loading of AMPs
into stimuli-responsive delivery systems that will protect the encapsulated cargo from protease
degradation and ensure peptide stability until the drug is released in response to an exogenous
stimulus. Spatial and temporal control allows direct delivery at the infection site increasing
the drug pharmacodynamic profile, meaning lower concentrations are required for treatment
which in turn decreases the risk of toxicity. Payload release can be triggered upon exposure
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to chemical (e.g. changes in pH and ionic strength), physical (e.g. thermal or magnetic) or
biological (e.g. proteolytic enzyme) stress. Recent studies on murine models have shown that
increasing the localised temperature of an infected wound to 50-60◦C effectively kills pathogenic
bacteria without detriment to the reepithelialisation process.6–10 As such, this thesis will em-
ploy a thermal release mechanism that will investigate not only AMP efficacy upon delivery
to planktonic bacteria but whether thermal bacteria killing can be utilised in conjunction with
AMPs. The prevailing mechanisms of drug delivery vehicle heating from external stimuli con-
vert light irradiation or electromagnetic fields into thermal energy through photothermal and
magnetothermal mechanisms, respectively. Metallic nanoparticles (e.g. gold, silver, copper) are
commonly used as photothermal agents due to the presence of delocalised electrons that can
be driven into coherent oscillation by incident radiation, creating a localised surface plasmon
resonance (LSPR) condition at specific frequencies of light. Using anisotropic particles, such
as gold nanorods (AuNRs), a longitudinal plasmon with a tunable absorbance peak is created,
providing enhanced absorbance efficiency compared to the transverse plasmon peak of isotropic
particles. The energy absorbed is then dissipated as heat through electron-phonon collisions
with the particle lattice. Nanoparticles are also prevalent in magnetothermal heating, requir-
ing superparamagnetic iron oxide nanoparticles (SPIONs). The application of an alternating
magnetic field produces a phase lag between the applied field and the SPION magnetization
creating a hysteresis loop. The excess energy of the hysteresis is thermally emitted through
changes in spin state and through the induced rotation causing friction between the particle
and the surrounding fluid, mechanisms known as Néel and Brownian relaxations, respectively.
Photothermal heating is significantly more efficient than magnetothermal heating11,12, as such
this thesis will utilise light-responsive triggering mechanisms to enable AMP release. The main
limitation of photothermal heating is the low tissue penetration of light irradiation, however
this is less of an issue with regard to the treatment of bacterial infections, as lesions in the skin
are the most frequent locations of such infections. This means that incident radiation does not
have to penetrate through much, if any, tissue to reach the treatment site.
Phospholipids are amphiphilic molecules containing a hydrophilic head group and hydrophobic
hydrocarbon tails that enable self assembly into micelle or vesicles formed of a lipid bilayer,
otherwise known as liposomes, in aqueous environments. Drug molecules can be loaded into
phospholipid structures by simply including the therapeutic in the solution during liposome/mi-
celle fabrication. Phospholipids possess a fundamental gel-fluid phase transition temperature
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(Tm), above which the lipid molecules are highly mobile within a bilayer creating a flexible
structure, whereas below the Tm the alkyl chains are rigid, reducing lipid mobility creating a
thicker and more brittle bilayer. The conformational changes in a liposome enable release of
small molecule payloads encapsulated within the lumen. The thermo-responsive nature, as well
as the biocompatibility of many phospholipids, mean that liposomes are ideal drug delivery
vehicles that release their cargoes only when the Tm is reached. Furthermore, by restricting
protease access to encapsulated AMPs, phospholipid structures demonstrate a protective effect
against proteolytic degradation.13,14 Liposomes will therefore be adopted as the AMP encapsu-
lating vehicle that will be used in conjunction with photothermal agents that will enable the
localised heating to initiate AMP delivery.
In summary, this thesis discusses the synthesis of AuNR mediated light-responsive delivery sys-
tems to provide triggered release from AMP-loaded liposomes, and the potential for combination
AMP-photothermal bacteria treatment. IRIKIRIK-CONH2 (IK8) will be used throughout this
thesis as the model AMP. IK8 is a broad-spectrum short AMP that forms a β-sheet secondary
structure upon interaction with a bacteria membrane to elicit both antimicrobial and antibiofilm
properties,15,16 and is an ideal model drug to demonstrate triggered delivery; it displays high
antimicrobial efficacy, its small size should ensure ease of encapsulation, enables demonstration
of the protective properties of soft matter delivery systems. This thesis will also explore the
incorporation of such systems into a prototype hydrogel wound dressing to aid topical bacterial
infection management.
1.2 Aims and objectives
The primary aim of this thesis is to develop light-responsive systems that provide the triggered
delivery of AMPs, overcoming the shortcomings hindering AMP clinical translation. The main
issues surrounding AMPs are its susceptibility to proteolytic degradation, instability in vivo
leading to poor biodistribution, and systemic toxicity. Spatial and temporal control over drug
delivery delivery increases the pharmacodynamic profile of a drug, meaning lower concentrations
are required for treatment, reducing the risk of systemic toxicity. Loading the AMP into a
delivery vehicle should also protect the drug until it is released, providing increased stability
and restricting protease access. As such, the AMP delivery systems desribed in this thesis must
fit the following criteria:
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• Exhibit the encapsulation of lethal doses of AMPs and restrict premature leakage that
could both reduce treatment efficacy and increase the likelihood of bacterial resistance.
• Protect internalised cargo from protease degradation.
• Provide controllable photothermal heating profiles.
• Demonstrate an adequate release profile in response to light irradiation, delivering lethal
AMP doses.
• Ensure encapsulated AMP stability in biologically relevant media (i.e. broth or cell media)
to maintain its antimicrobial efficacy.
• Guarantee no toxicity to host cells.
• Maintain colloidal stability both in suspension and in a hydrogel network, over a prolonged
period of time.
Thermal treatments of infected wounds on murine models have previously been shown to ef-
fectively reduce bacteria concentrations whilst not being of detriment to the wound healing
process.6–10 As such, this thesis aims to investigate the potential of combined photothermal and
AMP treatments.
1.3 Overview of results chapters
This thesis contains four distinct results chapters. The first results chapter (Chapter 4) dis-
cusses the synthesis of AuNRs, investigating how the ratio of the surfactants cetrimonnium bro-
mide (CTAB) and sodium oleate (NaOL) affected the morphology and optical properties of the
resultant rod shaped gold crystals. CTAB exhibits an innate toxicity against both mammalian
and bacterial cell types, affecting the respiratory pathways and membrane protein functionali-
ties. As such, the surface replacement of this co-surfactant bilayer with phospholipids was also
investigated to improve stability, biocompatibility, and reduced cytotoxicity before determining
the photothermal properties of these particles under continuous wave laser irradiation.
The second results chapter (Chapter 5) is focused on development of IK8-loaded liposomes
that triggered cargo release upon light mediated photothermal heating. Initially, the liposome
fabrication process was investigated to create homogeneous vesicles that can encapsulate IK8 at
several times the minimum inhibitory concentration (MIC) against Staphylococcus aureus and
Pseudonomas aeruginosa. The effects of the liposome composition were then explored to obtain
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vesicles that did not exhibit passive leakage but demonstrate an adequate release profile upon
heating to the vesicle’s gel-fluid phase transition temperature. Finally, the efficacy of the AMP-
liposomes to treat planktonic S. aureus was assessed when used in combination with AuNRs
under laser irradiation. Furthermore, the bacteria killing effects of photothermal heating were
evaluated to determine whether it can enhance the antimicrobial properties of the IK8.
The third results chapter (Chapter 6) discusses the development of a poly(ethylene glycol)
(PEG) hydrogel that incorporated both AMP-loaded liposomes and AuNRs to form the basis
of a prototype wound dressing. Hydrogels are widely used as dressings due to their oxygen per-
meability17 and high water content (generally>90%) that accelerates the angiogenesis process,18
prevents cell dehydration19 and provides a soothing texture that increases patient compliance
with the treatment.20 The first stage of testing was the optimisation of the gelation process
through controlling the weight percentage of gel within the network and buffering conditions
to control the rate of reaction, before loading the construct with AuNRs and liposomes. The
mechanical properties, swelling ratios and retention rates of the particle loaded gels was then
characterised. The antimicrobial efficacy of the system was assessed against both Gram-positive
and Gram-negative bacteria, before fine tuning the system to determine whether it was possible
for a single gel complex to provide treatment against multiple batches of fresh bacteria.
The final results chapter (Chapter 7) provides proof of concept for the liposomal delivery
of AMPs using a pulsed laser system, to trigger release without generating any bulk heating.
Initial developments entailed attempts to synthesise a gold coating on the liposomes before
demonstrating the potential for binding phospholipid coated AuNRs onto the liposome surface.
The release efficacy of the liposome-AuNR complexes was evaluated by varying the pulse fluence
and irradiation time. This ascertained whether the system could provide AMP triggered release




Some of the content within this chapter can be found within the following the following publica-
tions: S. C. T. Moorcroft et al. 2018. ‘Stimuli-Responsive Release of Antimicrobials Using Hy-
brid Inorganic Nanoparticle-Associated Drug-Delivery Systems’ in Macromolecular Bioscience
18.12:1800207
2.1 Pathogenic bacteria and antibiotic resistance
Bacteria are single cellular microorganisms have have adapted and evolved over hundreds of
millions of years to thrive in almost every environment on Earth. Classed as prokaryotes,
bacterial cells do not have a nucleus but have deoxyribonucleic acid (DNA, molecules that govern
cell growth, function, and reproduction) free floating in the cytoplasm in a tangled nucleoid or
forming a plasmid ring structure. Alongside the DNA, ribosomes synthesise functional proteins
through the assembly of amino acids. The cytoplasm is encapsulated within a cell membrane, of
which there are two distinct variations that are categorised using the crystal violet Gram stain.
Gram-positive bacteria have a plasma membrane with a thick peptidoglycan pericellular layer,
see Figure 2.1, onto which the Gram stain will bind causing a pink/violet colouration under
a microscope. Gram-negative bacteria have a thinner peptidoglycan layer and an additional
membrane on the outside of the peptidoglycan, however the overall structure is thinner than
that of the Gram-positive bacteria. The peptidoglycan layer in the cell wall has a mesh-like
structure, allowing molecules smaller than 50 kDa to freely diffuse through the cell wall directly
to the plasma membrane. Bacteria cell membranes primarily consist of phosphatidylglycerol
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(PG), phosphatidylethanolamine (PE) and cardiolipin complemented with small amounts of
phosphatidylcholine (PC), and phosphatidylinositol (PI).21 PG, cardiolipin and PI all exhibit
a negative charge at physiological pH, in addition to this Gram-positive and Gram-negative
membranes have negative Lipoteichoic acids and lipopolysaccharides respectively, providing
the bacterial membrane with a strong anionic charge. Bacteria cells may also have external
structures such as flagella which enable directional motion or pili that anchor the bacterium to













Gram-positive cell wall Gram-negative cell wall 
Figure 2.1: The cell walls of Gram-positive and -negative bacteria.
Bacteria are an integral part of the human microbiome providing a vast array of functionalities
from aiding digestion to the production of vitamins.22 These commensal bacteria only cause
harm when the host becomes immunocompromised or there is an abnormality in the bacteria’s
environment, whereas pathogenic bacteria utilise the host’s resources, circumventing the im-
mune system and potentially causing trauma. Pathogenic bacteria such as Staphyloccoci and
Streptococci are present in our every day lives without causing any issues, it is only when the
immune system is weakened (e.g. through a lesion in the skin) that the opportunistic bacteria
pose a threat. In order to effectively survive within a host the bacteria must: 1) make the initial
colonisation in the correct in vivo environment that provides adequate nutrients, 2) be able to
circumvent the immune system, 3) be able to reproduce, 4) be able to relocate to a new host.
This induces a high selective pressure on the bacteria meaning only the most resilient species
may survive.
Many of the symptoms associated with bacterial infections are in fact physiological responses
of the immune system in order to fight of the invading pathogen. Prime examples of this are
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the inflammation of an infected wound, due to immune cells attacking the pathogenic bacteria,
and fevers that increase the host temperature above the optimal reproductive temperature of
the pathogen, stunting the progression of the infection. To elicit immunogenic responses the
bacteria have to impair some functionality or harm host cells. This can simply occur through
the presence of bacteria, an imbalance between host and bacteria cells in an open lesion can
be detrimental to the reepithelialisation process regardless of the contaminant activity, leading
to inflammation and slower healing.23 The physiological response can also be so intense that
it is itself toxic. The response to bacteria such as Mycobacterium tuberculosis and Mycobac-
terium leprae (bacteria commonly associated with tuberculosis and leprosy) can induce the
production of toxic biomolecules by lymphocytes, macrophages, and polymorphonuclear neu-
trophils host defense cells that can destroy tissues, providing an ideal proliferation environment
for resistant bacteria.24 The harmful activity of many pathogens can substantially exacerbate
these issues. Certain bacteria invade host cells, providing a nutrient-rich environment in or-
der to grow and reproduce whilst offering protection against extracellular immune responses.
Rickettsia for example, are only able to reproduce within the cytosol of eukaryotes, killing the
cell in the process.25 Pathogenic bacteria also produce an array of virulence factors to support
their proliferation. These molecules perform a variety of functions; 1) adhesion and colonisation
factors initiate the formation of a colony within a host, 2) invasion factors that facilitate the
internalisation of the pathogen inside host eukaryotes, 3) capsules and surface components to
protect the bacteria from phagocytosis, 4) endotoxins are released upon bacterial lysis inducing
toxicity and a large amount of physiological responses.26
2.1.1 Biofilms
In nature infectious bacteria rarely survive for long periods of time in isolation, as such many
bacteria will form colonies and biofilms that will increase their chances of survival. Biofilms are
a collective community of microorganisms enclosed within a matrix of extracellular polymeric
substances (EPS), formed by the excretion of a polymeric conglomeration of polysaccharrides,
lipids, DNA and protein producing a slime containing a high density of cells. The formation of
a biofilm creates nutrient and oxygen gradients within the EPS matrix causing cells to switch
from a planktonic to biofilm mode of growth. In this state bacteria exhibit decreased metabolic
activity and higher doubling rates that can result in a series of phenotypic, metabolic and
physiological changes.27–29 This switch can actuate mechanisms that result in antimicrobial
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resistance (AMR), increased virulence and persistence.30 In combination with EPS restricting
of antibiotic availability to sub-lethal doses, these effects can result in significant increases in
AMR, potentially increasing the dosage required for treatment by several orders of magnitude.30
Furthermore, the concentration of persister cells in a biofilm is greatly increased compared to
planktonic bacteria, up to 1% in biofilms and approximately 1 in 106 in bacterial suspensions.31
Persister cells are metabolically inactive, spore-like cells that are potentially the main reason
for AMR in certain biofilms such as P. aeruginosa.32
Bacterial biofilms pose the largest burden to infection treatment with 65%33 to 80%34 of all
microbial and chronic infections attributed to bacterial biofilms. Biofilm formation within an
open wound can cause prolonged inflammation that produces excess levels of metalloproteases
that degrade the extracellular matrix, a vital component in tissue regeneration. Ultimately this
can lead to the development of chronic wounds, particularly in immunocompromised individuals,
a common example being diabetic foot ulcers.35,36 Biofilms also occur within the digestive and
respiratory systems, due to the presence of bacteria in food and air respectively, and can produce
long lasting diseases such pneumonia in cystic fibrosis suffers, causing a substantial decrease in
a patient’s quality of life.37 In addition, biofilm formation on medical implants and catheters is
the main cause of nosocomial infection.38
Figure 2.2: Schematic representation of the formation of a biofilm, from the initial adhesion of
planktonic bacteria through biofilm maturation to dispersion to form new colonies. Accompa-
nying scanning electron micrographs of the different stages of growth of a P. aeruginosa biofilm.
Reproduced with permission.39 Copyright 2018, Elsevier.
9
Chapter 2. Background and Theory Section 2.1
Prior to biofilm formation, bacteria will be in a planktonic state, free in a liquid suspen-
sion. When under flow a bacterium will approach a surface at which point it can become
constrained by both hydrodynamic and physiochemical (electrostatic, Van der Waals and hy-
drophobic forces) effects.40 These effects are weak and short lasting (i.e. demonstrate adhesion
timescales of minutes), as such the bacterium will then irreversibly bind itself to a surface by
enhancing the Van der Waals forces between the surface and the hydrophobic regions of the
cell membrane whilst augmenting the binding strength with cell adhesion structures such as
pili and lipopolysaccharides.41 As depicted in Figure 2.2, bacteria will only bind to a surface
provided the environment is optimal for its survival (i.e. a rich source of nutrients, moist, the
correct temperature and adequate oxygen levels if the bacteria is aerobic), leading to higher
cell densities in specific regions. At this point the bacteria will start to excrete a mixture of
DNA and lipids to form the basis of the EPS, and initiating microcolonisation. The bacterial
cells begin to communicate through the production and detection of extracellular signalling
molecules, known as quorum sensing. Quorum sensing allows synchronisation between cells to
regulate phenotype expressions to govern the behaviour of the colony as a whole.42,43 At this
point the bacteria in the colony will begin to produce polysaccharides that form the bulk of the
EPS.44 As the bacteria switch to their biofilm mode of growth the cell doubling rate increases
causing rapid biofilm growth, until a mature 3D biofilm is formed. The mature biofilm will then
start to disperse, releasing cells into the surrounding medium such that they initiate the biofilm
formation elsewhere.
2.1.2 Mechanisms of action of antibiotics
Antibiotics primarily target the synthesis pathways of the cell wall, nucleic acids, and proteins,
Figure 2.3, to kill the bacteria directly (bactericidal) or inhibit proliferation (bacteriostatic).45
Many antibiotics have concentration dependent antibacterial action, providing bacteriostatic
activity at low concentrations and bactericidal effects at high concentrations.
Cell wall targeting antibiotics primarily disrupt peptidoglycan synthesis, leading to bacteria
lysis. The peptidoglycan layer is formed of glycan saccharides cross-linked via glycine residues
of the D-alanyl D-alanine portion of side chain peptides, that is facilitated by penicillin binding
proteins (PBPs).46 β-lactam antibiotics (penicillins, cephalosporins, monobactams, carbapen-
ems and carbacephems)47 mimic D-alanyl D-alanine causing the PBP to bind to the antibiotics,
inhibiting cell wall synthesis.45 Conversely, glycopeptides (e.g. vancomycin and teicoplanin)
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bind to the D-alanyl D-alanine portion of the saccharide bridging peptides, impeding PBPs and
hindering cell wall synthesis.48
Quinolone antibiotics prevent bacterial DNA replication that leads to both bacteriostatic and
bactericidal effects. Fluoroquinolones (e.g. ciprofloxacin, delafloxacin, gemifloxacin, levofloxacin,
moxifloxacin, norfloxacin, and ofloxacin) are the most commonly prescribed quinolone, that pro-
vide broad-spectrum antimicrobial activity through the inhibition of bacteria DNA gyrase.49
Gyrase enzymes catalyse the ATP-dependent negative super-coiling that terminates the DNA
double coil.50 Fluoroquinolones bind to the gyrase sub unit relating to the nicking of the DNA,
interfering with the DNA cutting and sealing.
Antibiotics that inhibit protein biosynthesis by targeting the 30S and 50S ribonucleoprotein
subunits of the bacterial 70S ribosome. Simply put, protein synthesis occurs through the bind-
ing of messenger RNA (mRNA) to the 30S ribosome subunit, the 50S subunit then promotes
the addition of amino acids to form a protein chain before release factors activate the pep-
tidyltransferase function of the ribosome, releasing the complete protein.51 Aminoglycosides
(e.g. streptomycin, kanamycin, and gentamicin) and tetracyclines (e.g. chlortetracycline, doxy-
cycline, and minocycline) both target the 16S subunit of the 30S ribosome RNA (r-RNA)
that binds to the Shine-Dalgarno sequence of the mRNA initiating the protein synthesis.52,53
Aminoglycoside binding to the 16S subunit causes the misreading and premature termination
of translation of mRNA, whereas tetracyclines inhibit binding of transfer RNA to the ribosome
stopping the initiation of protein synthesis. Macrolides (e.g. erythromycin, azithromycin, and
clarithromycin) and oxazolidinones (e.g. Linezolid, and tedizolid) target the 23S r-RNA of the
50S ribosome subunit, that is associated with the peptidyl transferase which form the amine
bonds between the amino acids.54–56 The antibiotic molecules binding to the 23S r-RNA results
in prematurely releasing incomplete peptide chains from the ribosome.
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Figure 2.3: Common mechanisms of action of antibiotics and the mechanisms of resistance to
combat them. Reproduced with permission.57 Copyright 2009, CMAJ Group.
2.1.3 Mechanisms of antimicrobial resistance
There are four major biochemical mechanisms of antibiotic resistance; enzymatic interaction/-
modification of the drug molecule, altering the target site, utilising efflux pumps to remove
internalised drugs, and altering the cell membrane composition to decrease drug permeability.
The antibiotic targets within a bacterial cell and the AMR mechanisms that protect the bacteria
are depicted in Figure 2.3.
Firstly, resistant bacteria can produce enzymes that will alter or degrade an antibiotic disabling
its antimicrobial activity. One of the most well studied examples is the resistance against β-
lactam antibiotics. β-lactams bind to the D-Ala-D-Ala substrates responsible for crosslinking
the peptidoglycan components within the cell wall, disrupting the cell wall integrity which
ultimately leads to cell lysis.58 As such bacteria have evolved to excrete β-lactamase enzymes
that cleave the β-lactam rings rending the molecule inactive.59
Another cause of resistance is through alterations in the primary site of action for the antibiotic,
meaning the drug will no longer have affinity to the binding site and as such it cannot perform
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its activity. Possibly the most commonly known of drug resistant bacteria methicillin-resistant
Staphylococcus aureus (MRSA), contains the mecA gene that facilitates the the synthesis of an
altered penicillin-binding protein (PBP2a) that inhibits the binding of all β-lactam antibiotics.60
This effect has also been observed in initially β-lactam susceptible Streptococcus pneumoniae,
that gain resistance through alterations in peptidoglycan synthesising enzymes, thus lowering
the affinity to the penicillin molecule.61,62
The final two resistance mechanisms restrict access of the antibiotic molecule to its action site.
Efflux pumps are membrane spanning proteins that remove potentially toxic molecules from the
cytoplasm and expel them from the cell. It’s believed these proteins were initially devised as a
mechanisms to remove disruptive amphiphilic compounds from the cell, as such these proteins
evolved to remove a wide range of harmful products, it should therefore be of no surprise that
efflux pumps evolved to remove harmful antibotics.63 There are five main bacterial antibiotic
specific super-families of efflux pump associated with antibiotic resistance; Small multidrug
resistance (remove lipophilic and multicationic subtrates), ATP-binding cassette (removes am-
phiphilic, neutral, cationic, and anionic substrates), Multi-antimicrobial extrusion protein fam-
ily (remove organic and cationic substrates), Resistance nodulation division (remove amphiphilic
and charged substrates), and Major facilitator superfamily (amphiphilic and mono- or dicationic
substrates).63–66 Each protein family utilises a different molecule expulsion mechanism allowing
targeting of a variety of molecular properties, as such this efflux pumps have been observed
to increase resistance against a wide range of antibiotics. Access to the antibiotic binding site
is also blocked by mutations in the outer cell membrane to decrease antibiotic permeability.
Hydrophilic compounds, such as β-lactams, gain access into the cell through pore-forming pro-
teins (porins) that regulate molecule internalisation,67 whereas hydrophobic antibiotics, such as
macrolides, diffuse into the lipid bilayer of the membrane.68 By changing the membrane lipid
and protein composition the antibiotic permeability can be severely restricted.68,69 Furthermore,
alterations in membrane permeability can be coupled with other mechanisms, such as antibiotic
degrading enzyme secretion, to significantly increase multidrug resistance.70
Horizontal gene transfer is the primary means of passing along antimicrobial resistance. Mu-
tations in the DNA of one bacterium that increase the chance of survival against an antibiotic
may be passed to other bacteria leading to the rapid spread of resistance. This DNA transfer is
achieved in three ways; plasmid conjugation, natural transformation by extracellular DNA, and
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transduction by bacteriophages.71 Plasmid conjugation is performed through the direct transfer
of a small portion of the donor cell genome to the recipient via a sexual pilus that requires
cell-to-cell contact.72 Natural transformation occurs through the excretion of plasmids contain-
ing the resistant DNA, which is internalised by alternate bacteria under environmental stress.73
The third means of resistance transfer requires the use of bacteriophages, viruses that target
bacteria cells in order to reproduce. A bacteriophage will bind to a bacteria membrane before
injecting their genome into the cell, commandeering the metabolic pathways and utilising the
cell’s energy for DNA replication and production of capsid proteins that encase the DNA.74
Upon assembly of the new phages, the cell nucleoids and plasmids are broken apart creating
DNA debris before the the bacterium lyses releasing the new virus particles. Antibiotic resis-
tance is transferred when DNA debris that encodes the resistance mechanism is accidentally
encapsidated, subsequently transferring the DNA when that virus infects another bacterium.75
2.2 Antimicrobial peptides
Antimicrobial peptides (AMPs), otherwise known as host defence peptides (HDPS), are short
chains of amino acids, generally 5-50 residues in length, that are an integral part of the immune
system in all life forms, performing a wide breadth of functions as depicted by Figure 2.4.76–78
Taking AMPs alone, such is the diversity of the structures that they demonstrate activity
against bacteria, parasites, yeast, fungi, and viruses, with a range of techniques to disarm each
pathogen. AMPs are mostly comprised of a mixture of cationic and hydrophobic residues that
provide attraction to the anionic membrane of bacteria (-130 to -150 mV) and enable structural
organisation into secondary structures that enhance efficacy.15,79–81 The plasma membrane of
eukaryotic cells mainly consist of zwitterionic (neutral) phospholipids meaning mammalian cells
are less negatively charged (-90 to -110 mV) and as such are targeted less.80,82
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Figure 2.4: The wide array of functions host defence peptides play, with antimicrobial peptides
only one branch of the versatile biomolecules. Reproduced with permission under a CC-BY
license.76
AMPs have been touted as a key weapon in the antimicrobial arsenal to combat the ever-growing
issue of multidrug resistance. The primary antibacterial mechanism of AMPs is through mem-
brane disruption, which in turn promotes cytoplasmic leakage. This brute approach provides a
decreased chance of resistance development, and offers broad-spectrum activity. As discussed in
section 2.1.3, resistance to traditional antibiotics can be acquired through the uptake of foreign
DNA through horizontal gene transfer83 or through a variety of genetic mutations, altering a
range of functions or properties of the cell.84 Such resistant mechanisms are possible due to the
low metabolic cost of mutation, whereas the brute membrane disruption of many AMPs is be-
lieved to reduce the risk of drug resistance due to the higher metabolic cost of membrane repair
than the rate at which the damage is inflicted.15 Despite the significant decrease in the chances
of bacterial resistance development to AMPs, resistant mechanisms have been identified against
natural HDPs. The most common means of acquiring resistance that have been observed in vivo
are the modification of the cell surface structures and the usage of efflux transporters.85 Bacteria
cell membrane modification occurs by altering the anionic lipopolysaccharide and lipoteichoic
acids of Gram-negative and Gram-positive cell membranes respectively, and through acylation
of phosphatidylglycerol headgroups, to reduce the anionic charge of the membrane suppressing
the electrostatic attraction of the cationic AMPs.86 Efflux pumps are transmembrane proteins
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used to expel toxic substances from the bacteria cytoplasm, and are a leading cause of antibi-
otic resistance.65 AMP resistance through the secretion of additional proteases has also been
observed in a small number of studies.85 Frighteningly, AMP resistance development has the
potential to further decrease bacterial susceptibility to classic antibiotics,87 however the risk of
AMP resistance is significantly lower than that of antibiotics and there is also evidence that
using synthetic AMPs minimizes the risk further.88
2.2.1 AMP membrane disruptive mechanisms of action
Despite studying the properties of AMPs for three decades the complexity of interactions means
that the specific antimicrobial mechanisms are still not fully understood.89 There are currently
four prevailing theories as to how cationic peptides interact with the bacterial membrane; the
Barrel-stave model, the Toroidal pore model, the Carpet model, and the Detergent model. The
simplest models for the AMP antimicrobial activity, the Barrel-stave and Toroidal pore mod-
els, describe the formation of a transmembrane pore. In the barrel-stave model, peptides lie
in within polar headgroups of the lipids within the upper leaflet of the bilayer before rotating
such that they are perpendicular to the bilayer. This encourages lateral peptide interactions,
causing the formation of a peptide-stabilised pore, Figure 2.5A. This model requires the for-
mation of secondary structures (α-helices or β-sheets), that match their hydrophobic regions
to the hydrophobic core of the bilayer creating a hydrophilic lumen through which diffusion of
polar solvents can flow.90,91 Similarly to the Barrel-stave model the Toroidal pore model causes
pore formation, however in the toroidal model the pores are not stabilised but are transient and
dynamic. The AMP will directly insert itself perpendicularly to the membrane disrupting the
lipid arrangement. This in turn rearranges the lipid molecule orientation, making it energeti-
cally favourable to form a radius of curvature between the bilayer leaflets, such that the lipid
headgroups aid the hydrophilic regions of the AMP combine forming a pore lumen, see Figure
2.5B. It is entirely possible that upon degeneration of the pore the AMP is translocated across
the cell membrane allowing targeting of the cytoplasmic materials.92
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B) Toroidal pore model 
D) Detergent model 
A) Barrel-stave model 
C) Carpet model 
Figure 2.5: Schematic representations of the four most accepted models describing the inter-
actions between antimicrobial peptides and a lipid bilayer. A) The barrel-stave model, AMPs
form secondary α-helix or β-sheet structures producing a transmembrane pore. B) The Toroidal
pore model, AMPs insert themselves into the bilayer with little order, causing transient and
dynamic pore formation. C) The carpet model, AMPs lie within the membrane outer leaflet
causing lipid packing disruption and allowing leakage. D) The detergent model, at high con-
centrations AMPs cause mass disruption leading to membrane disintegration. Adapted with
permission under a CC-BY license.93
AMPs are also able to interact with a membrane without pore formation. In the carpet model
AMPS are adsorbed onto the outer leaflet parallel to the membrane, Figure 2.5C. Upon reaching
a critical concentration, the peptides ”carpet” the membrane causing unfavourable interactions
with the lipids, compromising the membrane integrity. Since the carpet model requires no
peptide-peptide interactions or peptide insertion into the bilayer a large proportion of AMPs
are expected to interact with membranes in this way.94,95 The detergent, or aggregation, model
become relevant upon further increasing the AMP concentration such that the membrane dis-
ruption is substantial enough that the bilayer will disintegrate with the lipids forming micelle,
Figure 2.5D. It is probable that an individual AMP is likely to act through several mechanisms
due to the wide range of parameters that will affect the AMP-lipid interactions (i.e. the struc-
tural properties of the membrane, the lipid:AMP ratio, the topology, and AMP aggregation).96
As such the Shai–Matsuzaki–Huang (SMH) model was developed as a way of describing the
mechanism of most membrane active AMPs and integrates three of the fundamental mecha-
nisms.82,97,98 Initially the AMP will be adsorbed onto the surface of the lipid bilayer through
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electrostatic attraction between the cationic residues of the AMP and the anionic cardiolipin
and phosphatidylglycerol lipids within the membrane, as described by the carpet model (Fig-
ure 2.6A). The AMP will then insert itself into the upper leaflet of the bilayer (Figure 2.6B),
pushing the lipids apart and increasing the total surface area of the leaflet. This in turn causes
the layer to become thinner and imparts a strain force throughout the membrane. Upon sub-
stantial membrane disruption, rather than having the alkyl-tails of the lipids exposed to the
aqueous environment the hydrophobic forces impose a radius of curvature between the leaflets
of the bilayers causing the formation of toroidal pores (Figure 2.6C). The transient nature of
these pores means that the bilayer will reform, however some of the AMP will be translocated
onto the bottom leaflet (Figure 2.6D). At this point the AMPS on both sides of the bilayer can
cause the formation of micelle, leading to disintegration of the membrane as described by the




C) Toroidal Pore      
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Figure 2.6: Schematic representations of the Shai-Matsuzaki-Huang (SMH) model of the mech-
anism of action of antimicrobial peptides (AMPs). A) Through electrostatic attraction AMPs
adsorb onto outer leaflet of a lipid membrane, causing initial disruption of the bilayer as de-
scribed by the carpet model. B) The AMP inserts itself into the bilayer causing thinning of
the outer leaflet. The surface area of the outer leaflet is then increased causing a stain force
within the bilayer, denoted with jagged arrows). C) It becomes energetically favourable to
form a radius of curvature within the bilayer causing the formation of transient toroidal pores.
D) AMPs are translocated across the membrane, at which point either E) the lipid will form
micelle leading to membrane disintegration (the detergent model), or F) AMPs will diffuse into
the cytoplasm. Adapted with permission.82 Copyright 2002, Nature.
These models are general descriptions of how a large proportion of AMPs will interact with a
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bacterial membrane, however many AMPs interact through more unique mechanisms. Nisin for
example, anchors itself to Lipid II, a peptidoglycan precursor in the cell wall, before inserting
into the membrane.99,100 The limited mobility of the Lipid II-nisin complexes causes aggregation
and eventually vesiculation. Similar effects have been observed in plant defensins, however they
tend to target phospholipids and fungus-specific sphingolipids.101 As such, the wide scope of
AMPs acting through a variety of specific and non-specific mechanisms means that there is still
a great deal about the antimicrobial activities of AMPs that is still unknown.
2.2.2 The challenges facing AMP clinical translation
Despite the significant benefits of AMPs as a treatment for multi-drug resistant microorgan-
isms, few have made it to clinical trails and even fewer have demonstrated efficacy in human
patients. The largest challenges facing the clinical translation of AMPs is that of instability in
vivo and low bioavailability.102 Preclinical studies often overstate the therapeutic potential of
AMPs due to the in vitro test being performed in ionic conditions that are not representative of
physiological conditions and potentially more importantly tests are generally performed in the
absence of proteolyic enzymes.103 The fundamental susceptibility of AMPs to proteases, such as
trypsin and peptin, have restricted the means of application to topical uses only as the peptide
half-life is too short to demonstrate efficacy with systemic delivery through oral or parenteral
means.104 Systemic delivery of AMPs is also hindered by the rapid removal of peptides through
the renal system and the lack of understanding of the AMP biodistribution requires cytotoxic
dosages to provide treatment of an infection.105 A frequently used means of alleviating these
issues is through chemical modification, of which the most common approaches are; cyclization
to improve metabolic stability or bind bioactive groups, replacement of non-integral residues
with amino acids known to increase stability, and N-/C-terminus modifications to avoid target-
ing by proteases.102,106 One such modification is the inclusion of poly(ethylene) glycol (PEG)
in the AMP structure, or PEGylation, which does not affect the antimicrobial efficacy but in-
creases both the half-life in blood and the cytocompatibility, whilst reducing non-specific cellular
uptake.107,108
Another critical issue of AMP clinical translation is that of systemic toxicity. AMPs have been
shown to demonstrate hemolytic activity and cause long term toxic side effects.109,110 In order
to reduce the cytotoxic effects many novel AMPs are being synthesised with an emphasis on
decreasing the number of residues. Synthetic short chain analogues of natural AMPs have shown
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toxicity levels over 300 times lower than their endogenous counterparts.111,112 Using shorter
chain AMPs also reduces both material costs and synthesis time, whilst providing the added
benefit of minimising the likelihood of immunogenicity.15 Reducing the peptide chain length
whilst maintaining antimicrobial efficacy is difficult, however it can be achieved by altering
the residue sequencing to change the stereochemistry, creating secondary α-helical or β-sheet
structures that augment the bactericidal properties.15,16,113,114
2.2.3 Conventional drug delivery systems for controlled release treatment of
pathogenic bacteria
To overcome the therapeutic challenges facing AMP clinical translation, AMPs may be loaded
into biocompatible delivery vehicles that will improve the pharmacokinetics and pharmacody-
namics by increasing stability and protecting encapsulated peptides from proteolytic degrada-
tion.
2.2.3.1 Liposomes and lipid nanostructures
Liposomes are artificial vesicles consisting of a lipid bilayer that encloses an aqueous com-
partment. The lipid bilayers self-assemble into an energetically favourable structure with the
hydrophilic headgroups exposed to the aqueous environment, sandwiching a bilayer of hydropho-
bic acyl chains, which offer a favourable environment for the encapsulation of hydrophobic
molecules. Liposomes are the most widely researched nanoscale antimicrobial delivery sys-
tem,115–117 primarily due to their ability to increase the biocompatibility, bioavailability, and
safety profiles of encapsulated antimicrobial materials.118
With regard to AMPs, Ron-Doitch et al. demonstrated an increase in the cytocompatibil-
ity by encapsulating cathelicidin LL-37 (100 µM) within liposomes (DSPC/DSPE-mPEG-
2k/cholesterol, molar ratio 20:1:10) and inoculating keratinocyte HaCaT cells with the AMP-
loaded vesicles.119 After 24 hours the cells were adversely affected by free LL-37 (100 µM) with
an >80% viability decrease, however the liposomal formulation containing the equivalent AMP
concentration only resulted in a 20% reduction in viability. As such the isolation of drugs inside
delivery vehicles can restrict interaction with peripheral tissues reducing toxic effects.
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Figure 2.7: Schematic representation of Apep10 loaded liposomes coated in chitosan, that pro-
vide release of peptides upon pore formation from bacterial toxins. Scanning electron mi-
crographs display the Apep10 degradation of planktonic Listeria monocytogene membranes
(indicated with red arrows) and LIVE/DEAD staining of a L. monocytogene biofilm demon-
strates a change from a mature viable (green) biofilm before treatment to a dead biofilm (red).
Reproduced with permission.120 Copyright 2016, Royal Society of Chemistry.
The bioavailability of AMPs may also be increased through liposomal encapsulation. Using an
in vivo pharmacokinetic study Li et al. demonstrated the encapsulation of the cyclic lipopeptide
daptomycin (DAP) within liposomes (soy phosphatidylcholine/sodium cholate, 17:1 mol ratio)
enabled DAP to accumulated at bacteriostatic concentrations even after permeating through
5 layers of dermal and subcutaneous tissues.121 The liposomes provided controlled release of
the DAP with maximum concentrations observed in each tissue within 2.5 hours and ensured
bacteriostatic concentrations in all 5 soft tissues 24 hours after administration to the dermis.
By altering the liposomal lipid composition the release of encapsulated AMPs may be con-
trolled to produce antimicrobial activity over several days. For example, Imran et al. demon-
strated the controlled release of nisin from liposomes (1,2-dioleoyl-sn-glycero-3-phosphocholine
[DOPC]) that induced progressively larger reductions in the Listeria monocytogenes bacterial
load over the course of 72 hours.122 Conversely, the liposome composition may be altered to
encourage more rapid delivery. Many bacteria secrete pore forming toxins that target lipid
bilayers, causing eukaryotic cell death. Pu et al. harnessed this by loading APep10 into chi-
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tosan coated liposomes (1,2-dipalmitoyl-sn-glycero-3-phosphocholine [DPPC]/1,2-dimyristoyl-
sn-glycero-3-phosphoglycerol [DMPG]/cholesterol, molar ratio 2:1:1) that release over 60% of
their payload in the presence of L. monocytogenes in 5 hours, and nearly 100% after 24 hours,
whereas the liposomes exhibit negligible release in phosphate buffered saline (PBS) in the same
time frame.120 Furthermore, 30 mg ml−1 of the liposome formulation produced eradication of
both planktonic and biofilm L. monocytogenes in 10 and 24 hours respectively (see Figure
2.7). The liposomal encapsulation of AMPs has also been shown to increase the drug efficacy.
Through the encapsulation of nisin into Phospholipon 90G/phytosphingosin (molar ratio 5:1) li-
posomes there was a four-fold reduction in drug concentration required to inhibit glucan-biofilm
synthesis by Streptococcus mutans compared to free nisin;123 resulting in complete inhibition of
biofilm growth after 6 h using the liposome formulation, as opposed to free nisin at equivalent
concentrations that lost inhibitory activity in the same time period. An increase in treatment
efficacy has also been demonstrated in vivo. Polymyxin B (PB) encapsulated within DPPC and
cholesterol liposomes showed a decrease in bacterial load of multidrug resistant P. aeruginosa
in a lung tissue model compared to free PB, 3.9- and 8.0-log colony forming units (CFUs) g−1
respectively, and prolonged the survival rates of murine models by ∼14% (an additional 8 hours)
compared to a PB solution.124
Alternative lipid based delivery systems such as solid lipid nanoparticles (SLNs) and nanostruc-
tured lipid carriers (NLCs) have also been used to provide controlled release of AMPs.125–127
SLNs are composed of a matrix of solid lipids encased in a surfactant, whereas NLCs are droplets
of fluid lipids and a surfactant coating. Moreno-sastre et al. demonstrated that colistin loaded
NLCs exhibit excellent stability with no decrease in antimicrobial efficacy after a year in storage,
whereas colistin-loaded SLNs lost their antimicrobial activity after only 3 months.127 The NLC
encapsulation of colistin sulfate also demonstrates increased antibiofilm activity compared to the
free drug, when used to treat P. aeruginosa biofilms obtained from cystic fibrosis patients.125
Furthermore, the antimicrobial efficacy of an AMP-NLC complex may be augmented through
co-loading the AMP with antibiotics. This effect was explored by Lewies et al. who loaded
nisin Z and melittin into NLCs with a variety of antibiotics in order to determine the fractional
inhibitory concentrations when treating E. coli.126 The most potent combination was found to
be nisin Z used in combination with novobiocin, interestingly the bactericidal activity of nisin
Z was also complimented using the non-antibiotic chelating agent ethylenediaminetetraacetic
acid (EDTA). In 2018 Groo et al. developed a unique NLC containing AP138-loaded reverse
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micelle to demonstrate protection against protease degradation and provide controlled release
to treat Gram-positive and Gram-negative bacteria.13 Upon incubating both the AP138-NLC
complex and free AP138 with the proteolytic enzyme trypsin it took over double the amount
of time to degrade 90% of the encapsulated AMP compared to the peptide in solution, >120
mins and 60 mins respectively. The same construct provided complete bacteria eradication of
both S. aureus and MRSA within 18 hours of incubation with each bacterial suspension.
E) Reference F) AP114 G) DPK-060 
H) Reference cubosomes I) Cubosomes+AP114 J) Cubosomes+DPK-060 
A) Reference B) AP114 C) DPK-060 D) LL-37 
Figure 2.8: Transmission electron micrographs of (A) blank cubosomes, and cubosomes loaded
with (B) AP114, (C) DPK-060 and (D) LL-37 AMPs. Scale bars equal 100 nm. Scanning
electron micrographs of MRSA incubated for 10 hours with free AMPs (E-G) and AMP-loaded
cubosomes (H-J). Scale bar equals 1 µm. Adapted with permission.128 Copyright 2017, Elsevier.
Lipid stabilised liquid crystalline nanoparticles, are gaining attention as AMP delivery vehi-
cles due to their high stability that allows protection and delivery of AMPs in enzyme-rich
environments such as the mouth.14 Boge et al. have investigated the incorporation of three
different AMPs (AP114, DPK-060, and LL-37) in to cubosomes (Figures 2.8A-D) and hexo-
somes (cubic and hexagonal 3D structures) achieving encapsulation efficiencies between 40-90%
and 94-98% respectively.129 Hexosomes of glycerol monooleate (GMO)/oleic acid were found
to be too stable, demonstrating no change in morphology upon internalisation of AMPs and
23
Chapter 2. Background and Theory Section 2.2
little AMP release, substantially increasing the MIC against S. aureus and MRSA. AMP in-
corporation into cubosomes (GMO alone) induced a slight radius of curvature that increased
with peptide hydrophobicity. The use of cubosome vehicles was observed to increase the AMP
efficacy against S. aureus, Escherichia coli and MRSA.128 Scanning electron micrographs of the
MRSA cells show that the AMP-loaded cubosomes (Figures 2.8I,J) produced a greater degree
of membrane disruption than the free peptide (Figures 2.8F,G), and that the non-functionalised
cubosomes did not affect the bacteria (Figure 2.8H). The cubosome formulation protected all 3
AMPs from Pseudomonas elastase (PE) and human neutrophil elastase.130
2.2.3.2 Hydrogels and polymer systems
Hydrogels are water-swollen three-dimensional networks exhibiting viscoelastic properties gov-
erned by the characteristics of the subunits and the means and degree to which the subunits are
bound.131 The high water content of hydrogels means that they are ideal vehicles for hydrophilic
drugs that allow control of the molecular diffusion and release by altering the solute size com-
pared to the pore size between polymer chains, the polymer chain mobility, and the electrostatic
interactions between the solute and the polymer chain.132 The controlled release of molecules
from a polymeric hydrogel is often not just controlled by the diffusive motion of a molecule but is
affected by erosion, swelling and dissolution of the network.133 Rajan et al. fabricated gels com-
prised of 8arm-PEG-thiol crosslinked with 4arm-PEG-NHS that demonstrated a biphasic release
of the relatively hydrophobic cyclic peptide subtilosin; for 12 hours gels of 4 and 6 wt% released
the AMP at 3.96 and 4.04 µg h−1 respectively, before dropping to 0.28 and 0.24 µg h−1 for the
next 108 h.134 The release was deemed to be non-Fickian (i.e. the characteristic solute diffusion
time was comparable to the polymer relaxation time), and as such was governed by both the
AMP diffusion through the network and the polymer relaxation. Furthermore, the AMP-loaded
gel only exhibited antimicrobial activity against the pathogenic Gardnerella vaginalis, with only
a small increase in the MIC compared to the free drug (7.2 to 12 µg ml−1), without imparting
any adverse effects upon 4 types of lactobacilli (L. acidophilus, L.gasseri, L. plantarum, and L.
vaginalis) that play a key part in the vaginal microflora. The release kinetics from a gel can
also be affected by the polymer charge and the ionic strength of the environment. Anionic mi-
crogels made from poly(ethyl acrylate/methacrylic acid (MAA)/1,4-butandiol diacrylate) with
electrostatically adsorbed cationic AMPs LL-37 and DPK-060, exhibit high retention at 10 mM
NaCl concentrations (∼10-20% release of both AMPs), whereas at higher NaCl concentrations
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(150 mM) the ionic buffering reduces the polymer-AMP electrostatic attraction increasing the
release profiles, ∼30-40% and ∼60-70% for LL-37 and DPK-060 respectively.135 This system was
also used to demonstrate how the gel charge density affects its protective properties. The gel
containing a higher proportion of anionic MAA, 60% rather than 26.5%, exhibited significantly
higher protection of LL-37 against PE degradation than both the low MAA content microgel
and the free peptide.
AMPs can also be immobilised within/onto hydrogels through chemical modification of AMPs,
by binding to functional groups within a polymer.136,137 Cleophas et al. first demonstrated
as such by synthesising a series of AMP HHC10 analogues containing thiol groups to anchor
to poly(ethylene glycol)diacrylate-based hydrogels using thiol-ene chemistry.136 The thiol func-
tionalised HHC10 analogue with the highest antimicrobial efficacy (inverso-CysHHC10) was
subsequently conjugated to the network which demonstrated complete bacteria killing against
S. aureus, S. epidermis and E. coli. Through polymer conjugation AMPs can have prolonged
efficacy, increased stability and can be modified to provide multi-functionality.138
An interesting property of hydrogels is that they can form interpenetrating networks with
apolar polymers currently used to fabricate plastics in medical devices. Klein et al. developed
a novel hybrid catheter material comprised of an interpenetrating network of silicone elastomer
(polydimethylsiloxane) host polymer accompanied by poly(2-hydroxyethyl methacrylate)-co-
poly(ethylene glycol) methyl ether acrylate hydrogel as a guest polymer, onto which the plectasin
derivate NZ2114 adsorbed.139 This novel catheter system demonstrated effective inhibition of
MRSA biofilm growth within a continuous flow system used to emulate blood flow (Figure 2.9).
The plectasin NZ2114 retention was high enough that a 2-log MRSA CFU reduction was still
observed even after 6 days of continuous flow of PBS prior to testing.
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Figure 2.9: Microscopy images of MRSA biofilms grown on a catheter made from an interpen-
etrating network of a silicone elastomer (polydimethylsiloxane) and the a poly(2-hydroxyethyl
methacrylate)-co-poly(ethylene glycol) methyl ether acrylate hydrogel loaded without (A) and
with (B) the AMP, plectasin NZ2114. Biofilms were imaged using a LIVE/DEAD BacLight
bacterial viability kit producing green and red fluorescence depending on whether the bacteria
were alive or dead respectively. Adapted with permission.139
Polymers may also used to fabricate micro- or nanogel particles, that can be loaded with AMPs.
Polymeric nanoparticles offer most of the same benefits as macroscopic hydrogel delivery vehicles
(i.e. controlled release, protection against degradation, prolonged activity, and increased bio-
compatibility)140–142 whilst allowing parenteral or oral administration. For example, Casciaro et
al. fabricated poly(vinyl alcohol) stabilised poly(lactide-co-glycolide) nanoparticles for use as an
aerosol to treat lung infections of cystic fibrosis sufferers.143 The nanoparticles encapsulating the
AMPs Esc(1-21) or its diastereomer Esc(1-21)-1c were administered to murine models infected
with P. aeruginosa through intratracheal inoculation, demonstrating a statistically significant
decrease in the CFUs observed in the bronchoalveolar lavage, compared to treatment with the
free peptides. Interestingly, the total number of inflammatory cells (including macrophages,
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neutrophils, and lymphocytes) in the bronchoalveolar lavage was also observed to increase upon
treatment with ESC(1-21)-NPs, whereas this was not seen using the particles or AMP alone.
Electrospun nanofibres have also been utilised to produce controlled release of AMPs. Electro-
spinning is a technique whereby a charged polymer solution is drawn out into a fibril through
attraction to a surface with an opposing charge, this results in a highly porous mesh with a
large fibre surface area.144 The innate polymer charge required to produce electrospun fibres
can be adopted to electrostatically adsorb cationic AMPs to the fibre surface. This has been
demonstrated by Amariei et al. to adhere ε-polylysine to anionic fibres of poly(vinyl alcohol)-
poly(acrylic acid). These fibres were used to create a mesh dressing that demonstrated inhibition
of bacterial fouling after 14 days of incubation in S. aureus, S. epidermis and E. coli broths (Fig-
ure 2.10).145 Nanofibres have also been utilised by the food industry with nisin-loaded amaranth
protein isolate-pullulan nanofibres displaying pH dependent controlled release of the AMP.146
After 12 hours at a neutral pH the nanofibres release ∼40% of the loaded-nisin, whereas in an
acidic environment (pH 3.4) the fibres released ∼80% of the AMP. This produced total eradica-
tion of Salmonella Typhimurium, L. monocytogenes and Leuconostoc mesenteroides after 20-100
h in acidic apple juice whereas total bacteria killing required 120-170 h on the neutral surface
of Panela cheese.
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Figure 2.10: Scanning electron micrographs of (A) non-functionalised and (B) ε-polylysine
loaded poly(vinyl alcohol)-poly(acrylic acid) nanofiber dressings after a 14 day incubation with
S. aureus (A1, B1), S. epidermis (A2, B2) and E. coli (A3, B3). Scale bars are 5 µm. Repro-
duced with permission.144
2.3 Optical properties of gold nanoparticles
2.3.1 The Drude model and skin depth of penetrating light
Before broaching the subject of plasmonics it is important to discuss the behaviour of electrons
within metals. The high electric and thermal conductivities, as well as many optical effects of
metals may be attributed to the high density of delocalised, or ’free’ electrons, that can propa-
gate through a metallic lattice with little resistance. The high density of electrons means that
the spacing between the electron energy levels is very small compared to the the thermal excita-
tion, KBT, at room temperature.
147 As such, the interactions of electrons with electromagnetic
forces may be modelled by Maxwell’s equations, and ignore many of the quantum mechanical
phenomena of nanoscale structures with low electron densities, such as semiconductors. This
allows the application of Drude’s model as an approximation to the propagation of electrons
through a material. Based on Lorentz’ oscillating dipole theory; electron motion acts as if it
were attached by a spring to an atomic nucleus and undergoing oscillatory motion driven by
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an applied electromagnetic field.148–150 Drude’s model is a classical representation of a damped,
driven harmonic oscillator in which electrons are driven to oscillate by an external electric field
(e.g. light). The lack of a restoring force means there is no natural resonant frequency. Using
this model the dielectric function of the free electron gas as a function of an applied electric





where τ is the relaxation time for a free electron gas (∼10−14 s at room temperature) and ωp





where n is the free electron density, e is the charge of an electron and m∗ is the effective mass
of an electron. The real and complex components of the dielectric function, ε(ω) = ε1(ω) +








This model predicts that the metals are reflective when the frequency of incident radiation
is lower than the plasma frequency (ω < ωp), as ε1(ω) is ∼1 meaning no light can propagate
through the material. Conversely, when the frequency of the incident radiation is greater than
the the plasma frequency (ω > ωp) then ε1(ω) tends to zero, meaning the light is not retarded
and the material is transparent. Irradiation at low frequencies, when ωτ  1 and ε2  ε1,
the refractive index (n) and the extinction coefficient (k) are approximately equal, allowing
the complex refraction index, ε1/2 = n+ ik, to be rearranged and substituted directly into the
equation for the absorption coefficient,













Using the Beer-Lambert law of absorbance, I = I0e
−xα/2,151 the intensity of the light can be seen
to decrease exponentially with the penetration depth, providing a material with a characteristic
retardation length scale known as the skin depth, that is the inverse of the absorption coefficient.
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The electromagnetic excitation of electrons in conductive materials is therefore restricted to a
thin layer at the surface, shielding the electrons in the bulk material from the incident radiation.
This result means that when radiation is applied the conductive structures of equivalent size
to the skin depth, the light can drive the coherent oscillation of all delocalised electrons. This
forms a longitudinal charge density wave, known as a polariton, that drives an electromagnetic
wave that propagates along the nanoparticle surface. This resultant wave is called a localised
surface plasmon (LSP).152
2.3.2 Localised surface plasmons - Mie theory
A plasmon is a quasiparticle (a collective excitation that can be modelled as an individual
particle) that is formed when coherently oscillating electrons are driven at their resonance
frequency. Plasmons are driven by the E-field component of incident light, which has a skin
depth of up to ∼50 nm in gold meaning that all electrons within a nanoparticle may be excited
creating a localised surface plasmon. As shown in Figure 2.11 excited electrons coordinate to
oppose the applied electrical field forming an oscillating dipole that is dampened by electron








Figure 2.11: A schematic representation of the oscillations of the free electrons within the
nanoparticle structures and the resulting electric field it induces. For spherical particles this can
be seen in only the transverse axis, whereas asymmetric nanoparticles, such as gold nanorods,
produce E-fields along both the transverse and longitudinal axes. Reproduced with permis-
sion.153 Copyright 2013, The Royal Society.
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The absorption and scattering of the E-field upon interaction with a metallic nanoparticle can
be modelled by solving Maxwells equations for a singular sphere being acted upon by a plane
wave in a homogenous medium, known as Mie theory.154 The scattering properties are defined














The functions πn and τn are angle dependent functions related to first degree Legendre polyno-
mials.
2.3.3 Localised surface plasmons - Gans’ Solution
In 1912 Gans published a solution to augment Mie theory by including scattering from oblate or
prolate ellipsoids, rather than just a sphere.155 This solution models the splitting of the localised
surface plasmons into two distinct modes that vary as a function of the ellipsoid aspect ratio.156
Whilst this model is designed for ellipsoids the solutions are in agreement with the absorption
profiles of cylindrical hemi-spherically capped gold nanorods (AuNRs).157 The Gans solution








εm + Px,y,x(εp − εm)
(2.6)
Where εp and εm represent the real components of the permittivity of the particle and medium
respectively, ax is the length of the major axis and ay,z is the length of the minor axes, Figure
2.12A, and Px,y,z denotes the shape factor along each axis in relation to the eccentricity of the























This produces two distinct plasmonic absorption peaks for the ellipsoidal particles, the trans-
verse plasmonic peak at ∼550 nm and a longitudinal plasmonic peak at longer wavelengths as
seen in Figure 2.12B. The transverse absorption peak is a result of plasmon propagation along
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the ellipsoid circumference, and as the aspect ratio of the ellipsoid increases the peak decreases
in intensity and is slightly blue shifted. Conversely, upon increasing the ellipsoid aspect ra-
tio the longitudinal peak, the plasmon propagation along the major axis, is seen to increase
in intensity and is substantially red shifted. This indicates that the absorption spectra of an
ellipsoidal nanoparticle, or nanorod, may be tuned to provide a resonance peak in the visible





Figure 2.12: A) An ellipsoid in a cartesian coordinate system. B) The simulated spectra of
gold ellipsoids of increasing aspect ratio (R) calculated using Gans solution. Inset: the relation
between the peak absorption wavelength and the aspect ratio. Reproduced with permission.158
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Q(r, t) = ⟨j(r, t) · E(r, t)⟩
Figure 2.13: The photothermal effect occurs when energy is absorbed from incident light with
little scattering. Of the energy absorbed, approximately 99% is thermally radiated with the
excess energy lost through photoluminescence. The thermal energy dissipated from Au NP,
Q(r,t), may be calculated by taking the time dependent average of the current density, j(r,t),
by the electric field from the applied light source, E(r,t).
Photothermal heating is the phenomena by which electromagnetic energy applied to a pho-
tothermal agent is absorbed and the energy is reemitted as thermal radiation. In the case of
metallic nanoparticles, when exposed to light of a resonant wavelength, governed by the particle
size and anisotropy, the incident photons can couple with the electrons within the metal lattice
driving the formation of a plasmon. This energy can then be dissipated through either scatter-
ing or absorbance, it can be assumed that nearly all of the absorbed energy is transferred into
thermal radiation. The generation of heat occurs in a three step process; (1) the absorption
of the photon by free electrons takes approximately ∼100 fs, (2) heat is generated within the
nanoparticle through electron-phonon scattering with the crystal lattice (> 85%) or through
electron-electron scattering (< 15%), taking approximately 0.1-10 ps, (3) thermalisation occurs
between the nanoparticles and the surrounding medium through phonon-phonon scattering tak-
ing up to 1 ns.159–161 To reach a quasi-stationary temperature profile within a particle of ∼10
nm in diameter, takes approximately 2 ps and upon irradiation timescales above several ns it
can be assumed that that there is a continuous heat flow radially away from the particle surface.
The heating of a particle can be assumed to be uniform throughout the lattice and is described
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I(t)σabsSp − jSp (2.8)
where ρp, cp, Vp and Sp, are the particle’s density, specific heat capacity, volume and surface
area, t is time, T is temperature, I(t) is the irradiation density, σabs is the absorption coefficient
and j is the energy flux density away from the particle surface. When the timescale of irradiation
is greater than the the thermal dissipation time, tT ∼ r2p/4αp, where rp and αp are the particle
radius and thermal diffusivity, the quasi-stationary temperature at a distance r in a spherical
coordinate system originating at the centre of the particle is












where a is a constant and assuming a temperature-dependent media thermal conductivity, k, is
k = k∞(T/T∞)
a where k∞ and T∞ are the thermal conductivity of the liquid and the tempera-
ture at an infinite radius, respectively.162 This equation is useful to model the temperature due
to an individual nanoparticle however it does not describe the thermal output of a bulk AuNP
suspension. The thermal power output of a solution of AuNPs, otherwise known as the specific
absorption rate (SAR, W m−3), is the sum of the power output from each particle individually,
SAR = N × σabs × I = µnp × I (2.10)
where N is the number of AuNPs per m3, σabs is the AuNP absorbance cross-section, I is the
laser fluence and µnp is the absorption coefficient of the AuNP solution. This shows that the
only information required to identify the thermal power output are the solution absorbance and
the laser fluence. To obtain the temperature increase within an isolated AuNP solution the





In a non-isolated system the temperature increase is also hindered by heat diffusion into the sur-
roundings and potentially melting/morphological changes in the AuNP altering the absorbance
cross-section.
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2.4.1 Localised heating through pulsed-laser irradiation
Light deposition into photothermal agents on timescales equivalent or less than the thermalisa-
tion rate can lead to localised temperature increases of several hundred degrees. The tempera-
ture of a nanoparticle during a heating pulse is




where B is B = 3k∞/ρpcpr
2
p. Neglecting the loss of heat during irradiation and expanding the
exponential function gives the maximum temperature at the end of the pulse duration,




where tp is the pulse width. Subsequently, the temperature of a particle is cooling after the
pulse is:





This equation again demonstrates that at the end of the pulse width (t=tp) the exponential
equals one and as such the particle temperature is at it’s maximum. The exponential decrease in
temperature after the pulse width (t> tp), means that even at fast repetition rates in the range of
kHz there is a long duration of time, relative to tp, in which the particle is at thermal equilibrium
with the surrounding medium (Tp=T∞) meaning there is no bulk heating. It is worth noting
that the thermalisation time after the pulse is approximately equal for all nanoparticles that
have absorbed equal quantities of energy independent of the pulse width, see Figure 2.14. This
figure also depicts the significance of the pulse duration, simply by depositing the equivalent
amount of energy at one hundredth the pulse width the particle is heated by an additional
∼ 700◦C.
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Figure 2.14: The simulated temperature of gold nanoparticles under irradiation from a pulse
laser when maintaining an equal energy absorption but varying the pulse width. Reporduced
with permission.161 Copyright 2009, Taylor & Francis.
2.4.2 Photothermal heating effects on AuNPs and its medical applications
Figure 2.15: The phase diagrams of water and gold and the corresponding thermophysical
effects of gold nanoparticles upon photothermal heating as the laser power is increased from
left to right. The equilibrium thermodynamic states of water and gold are displayed as solid
lines, with each thermodynamic state, solid (S), liquid (L) and vapour (V) displayed for both
materials. The non-equilibrium spinodal curve of water is depicted by the blue dashed line. The
blue slope indicates the rise in pressure surrounding the gold nanoparticle as the laser intensity
is increased. Reproduced with permission.163 Copyright 2011, Royal Society of Chemistry.
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The laser irradiation of metallic nanoparticles and the subsequent thermal heating have been
shown to produce a wide array of effects, see Figure 2.15. Through control of the energy de-
posited into the AuNP structure the photothermal heating can achieve temperatures greater
than 1000◦C on the femtosecond timescale. To provide macroscopic bulk heating of temper-
atures below 100◦C a continuous wave laser may be used to deposit energy into the system
such that the system can reach a quasi-stationary temperature, balancing the constant thermal
output of the particles with the thermal diffusivity away from the material. Within medical
research, bulk photothermal heating has primarily been used for anti-cancer therapies, the fine
temperature control afforded by photothermal therapy can elevate the temperature within a
tumour to 42-43◦C to incite cell necrosis.164 The high absorption cross-section of AuNRs has
made them particularly desirable as photothermal agents in this field, lowering the laser in-
tensities and nanoparticle concentrations to achieve thermal ablation, and have demonstrated
anti-tumour photothermal effects in vivo.165–170166 To achieve temperatures significantly higher
than 100◦C, nano- or femto-second pulsed-lasers must be used to deposit large amounts of
energy. Neodymium-doped yttrium aluminum garnet (Nd:YAG) lasers are the most common
pulsed laser used in medical research and are capable of delivering ∼100 mJ typically over 2-
10 ns with repetition rates of 10-30 Hz. Using lasers with a pulse width, the duration of an
individual pulse, of ≤ nanosecond timescales means that the excitation rate is greater than
the thermalization rate of the absorbing material; as such the energy can be dissipated fast
enough such that the lattice cannot approach a thermal equilibrium to provide a constant ther-
mal output.171,172 This means that gold nanoparticles are able generate temperatures of over
1000◦C very locally without inducing any bulk heating within the sample. The high thermal
gradients can induce interesting effects, such as the creation of photoacoustic pulses and nano-
or microbubble generation and cavitation. At temperatures above 100◦C AuNPs begin to ex-
pand and contract creating stress that is dissipated into the surroundings as a pressure wave.173
This effect has been utilised as a medical imaging technology whereby the acoustic wave gen-
erated by the AuNP propagates through the soft tissues before detection using an ultrasound
transducer.174 When the surface temperature of an AuNP is above the spinodal limit of water
the liquid in the immediate vicinity to the AuNP is vapourised, creating a thin layer of gas at
the AuNP surface.175–177 This layer forms the nucleus of a nanobubble as further evaporation
occurs causing the formation of a transient vapour cavity, the size of which is determined by
both the AuNP diameter and the laser fleunce.178,179 Upon collapse of the bubble a stress wave
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is released into the surroundings, the effects of which have been shown to increase the perme-
ability of phospholipid vesicles and mammalian cells.180,181 As shown by Figure 2.15, through
photothermal heating the temperature within an AuNP can exceed the melting temperature
of bulk gold, however melting effects of AuNPs have been observed at significantly lower tem-
peratures. This is due to the thermal energy within the lattice surpassing the binding energy
between the surface Au atoms allowing migration of said atoms from areas of high curvature to
surfaces that are more energetically favourable.182,183 The high curvature of the hemi-spherical
tips of AuNRs are particularly susceptible to such migration effects,159,184–187 with thermal re-
shaping of AuNRs observed at temperatures as low as 50◦C, however the rate of melting is seen
to increase with temperature.188,189 The melting effects of AuNPs are not just dependent upon
the morphology but are also affected by the particle size, larger particles reshape more readily
than smaller particles, and the surface coating.189–191
2.5 Incorporation of NPs into delivery vehicles
To date, the soft matter drug-delivery systems that have been combined with inorganic NPs
for the stimuli-responsive release of cargoes include the liposomes, polymersomes, hydrogels,
and hybrids of these systems. This section will describe the methods of NP incorporation into
liposomal and hydrogel drug-delivery systems, the factors affecting NP-loading efficiencies, and
how the incorporation of NPs within the drug carriers could affect the overall stability and
drug release from the delivery systems. Despite the large body of research performed utilising
NP-polymersome complexes192–195 this section will focus on nanoparticle incorporation into
liposomes and hydrogel structures due to their prevalence as AMP delivery vehicles compared
to polymer vesicles. Each method of production described in this section has been used to
demonstrate NP-stimulated release of antibiotics or dyes (Table 2.1).
2.5.1 Liposomes
The use of NPs with liposomes is the one of the most widely investigated among the various
antimicrobial delivery systems.117 As seen in Figure 2.16, the four primary means of NP as-
sociation with liposomes include: (A) the entrapment of NPs within the lipid bilayer, (B) NP
encapsulation within the aqueous core of the liposomes, (C) the adsorption of the NPs onto the
lipid bilayer, and (D) the addition of free NPs to liposomes.
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Figure 2.16: The four primary means of inorganic nanoparticle (NP) association with liposomes
for the stimuli-responsive release of antibiotics. Inorganic NPs with the indicated surface func-
tionalizations can be incorporated (A) within the lipid bilayer through hydrophobic interactions,
(B) within the aqueous core by hydrogen bonding, (C) adhered to the surface of the lipid bilayer
through electrostatic attractions, or (D) mixed freely with liposomes.
2.5.1.1 Nanoparticle encapsulation within the lipid bilayer
The lipophilic property of the lipid bilayer core has been utilised to produce liposomes with
lipid bilayers containing a variety of hydrophobic NPs, Figure 2.16A.196,197 The conventional
thin-film hydration method is commonly used for the encapsulation of hydrophobic NPs within
a lipid bilayer. In this method, a mixture of lipids and hydrophobic NPs is dispersed in an
organic solvent, which is evaporated to form a dry lipid film. Subsequently, an aqueous solu-
tion is added to the film, causing the spontaneous formation of lipid bilayers. These bilayers
often stack to form multilamellar vesicles that can be converted to monodispersed unilamellar
vesicles using mechanical agitation involving sonication or extrusion of the mixture through
a membrane of predetermined pore size. Another popular route for the encapsulation of hy-
drophobic NPs within lipid bilayers is the reverse phase evaporation (RPE) process.198 RPE is
performed through the addition of water to an organic solvent containing dissolved lipids and
the NPs, before gradually evaporating away the organic solvent to produce lipid vesicles with
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the hydrophobic NPs incorporated within the lipid bilayers.199
The insertion of a NP within a lipid bilayer has been found to affect the properties of the mem-
brane, which could affect the stability of the drug-loaded liposomes during preparation and
storage. The inclusion of hydrophobic NPs within a lipid bilayer could alter the permeability
of the membrane depending on whether the temperature is above or below the fluid-gel phase
transition temperature (Tm) of the lipids.
200–202 Park et al. showed that at a temperature
below the Tm (41
◦C for 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC)), an increase in
the concentration of 3-4 nm hexanethiol-capped Ag NPs added to the lipids (from 0 to 400
ppm), increased the fluidity of the lipid bilayers in the liposomes produced.200 This was iden-
tified through an increase in fluorescence anisotropy values from 0.08 to 0.09 monitored using
the fluorescent probe diphenylhexatriene. Above the Tm, however, a decrease in fluorescence
anisotropy from 0.106 to 0.097 was observed, suggesting a decrease in the bilayer fluidity. In
a subsequent study, the authors incorporated increasing amounts of 3-4 nm Au NPs within
DPPC lipid bilayers and observed a consistent trend.201 A decrease in anisotropy indicates that
the bilayer membrane is becoming more disordered and is thus exhibiting more fluid behaviour.
The inclusion of both Ag and Au NPs therefore appears to stabilise lipid bilayers at above the
Tm and decrease the stability below the Tm.
2.5.1.2 Nanoparticle encapsulation within the aqueous core of the liposome
Hydrophilic NPs are typically incorporated within the aqueous core of liposomes via the thin-
film hydration method, which involves the re-hydration of a lipid film with an aqueous solution
containing the NPs to induce liposome formation.203,204 This method of bulk liposome pro-
duction suffers from high polydispersity and low encapsulation efficiencies, and as such new
techniques have been developed to overcome these issues. The RPE method for instance, can
produce liposomes with aqueous volume to lipid ratios that are 30 times higher than those pro-
duced through lipid film hydration and sonication,205 and has therefore been used to maximise
NP encapsulation within the aqueous compartments of liposomes.206 As the aqueous core of the
liposome offers a large volume for the encapsulation of NPs, a wide variety of NP morpholo-
gies can be held within the liposome. Lajunen et al. demonstrated this through encapsulating
both Au nanostars (60 nm in diameter) and nanorods (25 nm by 60 nm) within DPPC/1,2-
distearoyl-sn-glycero-3-phosphocholine (DSPC) and DPPC/1-stearoyl-2-hydroxy-sn-glycero-3-
phosphocholine (LysoPC)/1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polye thy-
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lene glycol)-2000] (DSPE-mPEG2k) liposomes.206 However, the encapsulation efficiency of the
NPs was not quantified in this study, with changes in the UV-vis spectra provided as the only
evidence for successful NP encapsulation. The application of near infrared (NIR) radiation to
the thermosensitive liposomes initiated a photothermal response, causing a temperature increase
that led to the phase transition of the lipid bilayer to a leaky liquid crystalline phase inducing
leakage of the fluorescent reporter molecule calcein. The indiscriminate nature of encapsulation
allows for a wide range of NPs with distinct properties to be chosen for specific applications.
For example, in the light-stimulated release of therapeutics, the liposomal encapsulation of
anisotropic Au NPs such as Au nanorods, Au nanostars, and Au nanoprisms with strong ab-
sorbance in the NIR region, where tissues and biological fluids minimally absorb, allows for
deeper light penetration through human tissues.207–209 However, further technique development
is required to provide confidence in the encapsulation of anisotropic NPs, as there is little direct
evidence, through TEM imaging, to indicate that large scale uniform incorporation of the NPs
into the liposomes has been achieved.
The encapsulation efficiency of NPs within the aqueous cores of liposomes has been found to
be greatly dependent on several factors such as the total amount of lipids used and the initial
amount of NPs added to prepare the liposomes.203,204 Wijaya and Hamad-Schifferli systemat-
ically varied the amount of lipids and NPs used in the preparation of liposomes via the RPE
method to investigate lipid-NP phase behaviours.203 When the DPPC lipid concentration was
fixed between 23-27 mg ml−1, a step-wise decrease in the concentration of 12 nm Fe3O4 NPs
(from 105 to 12 mg ml−1) resulted in morphological changes from a mixture of perforated
bilayer/NP-loaded vesicles to empty/NP-loaded vesicles, before finally yielding spherical high
density NP-loaded vesicles. In a subsequent study by Bealle et al., it was demonstrated that
by using an even lower lipid concentration of 2.5 mg ml−1 (DPPC/DSPC 90/10 mol%), the
addition of increasing amounts of γ-Fe2O3 NPs (from 3 to 313 mg ml
−1 in iron content) pro-
gressively led to the formation of more spherical liposomes that were more densely packed with
magnetic NPs as seen under the transmission electron microscope (TEM).204 This study also
stated that the NP size affects the packing density within the liposome, as ascertained using
the magnetophoretic mobilities of individual liposomes. The volume fractions of encapsulated 7
and 9 nm diameter NPs were 33±3% and 24±4%, respectively. However, the initial concentra-
tion of NPs added during liposome formation was not provided. Taken together, these studies
demonstrate that the concentrations of both the lipid and NP used in the formulation of the
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liposomes must be optimised to give efficient NP encapsulation.
2.5.1.3 NPs adsorbed onto the liposome bilayers
Another route for NP-liposome association is the adsorption of hydrophilic NPs onto the inner
or outer lipid bilayer-aqueous interface of the liposomal structure, Figure 2.16C. This process
has been achieved through the electrostatic interactions that occur between oppositely charged
lipid bilayers and NPs as well as through the direct synthesis of NPs on the bilayer surface.210–214
The adsorption of charged NPs on the outer surface of liposomes provides an additional benefit
of increasing liposomal stability due to electrostatic repulsions between NP-decorated liposomes
of the same charge, which prevents liposomal fusion.215–218 Phosphatidylcholines, which possess
a zwitterionic headgroup containing a negatively charged phosphate and a positively charged
choline, are the most commonly used lipids used to form liposomes. Despite the net neutrality
of the headgroup, there is a dipole, allowing the electrostatic attraction of charged nanopar-
ticles.215,219 The positive charge at the terminus of the phosphatidylcholine lipid headgroup
results in anionic NPs being more greatly attracted to zwitterionic lipid bilayers than cationic
NPs. For the stabilisation of liposomes, however, it has been suggested that the weakly binding
cationic NPs are preferable due to the reduced likelihood of NPs forming strong bridges between
adjacent liposomes, hence reducing the clustering and fusion of the liposomes. This has been
examined through the use of single particle diffusion to observe the motion of 1,2-dilauroyl-sn-
glycero-3-phosphocholine (DLPC) liposomes stabilised with cationic and anionic polystyrene
NPs.216 It was found that liposomes stabilised with anionic NPs on the outer surface tended to
form large dense lipid clusters in which the individual liposomes were unable to move, whereas
liposomes stabilised with the same ratio of cationic NPs retained their diffusivity, hence indicat-
ing enhanced colloidal stability. However, as the zeta-potentials of the NPs were not provided,
the difference in binding strengths may have been due to the difference in NP charge densities.
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Figure 2.17: Liposome-NP colloid formed via electrostatic interactions between oppositely
charged lipids and Au NPs at the aqueous–bilayer interface within a multilamellar structure
(inset). The lipid structures presented are A) DPPC, B) DPTAP, and C) DPPG. Reproduced
with permission.220 Copyright 2017, Elsevier.
Dichello et al. also explored the use of electrostatic interactions between oppositely charged
NPs and lipids within a liposomal formulation to incorporate Au NPs at the bilayer-aqueous
interfaces on the inside of the liposomes, Figure 2.17.220 Briefly, the liposomes were formed us-
ing the RPE process where an aqueous dispersion of the NPs is added to the lipids dissolved in
an organic solvent, which is evaporated before sonication and extrusion of the mixture to form
homogenous unilamellar vesicles with NPs adsorbed to the inner surface of the liposome. In-
terestingly, the encapsulation efficiency of cationic 2-dimethylaminoethanthiol (DMET) coated
Au NPs in anionic liposomes (DPPC: DPPG; molar ratio 6.1:0.7) determined using microwave-
plasma atomic emission spectroscopy was found to be significantly higher compared to the
encapsulation of anionic 2-mercaptoethanesulfonate (MES) coated Au NPs within cationic li-
posomes [DPPC: 1,2-dipalmitoyl-3-trimethylammonium-propane (DPTAP); molar ratio 6.1:0.8]
with encapsulation of 7.3±2.6% vs. 3.1±1.5% of the initial gold added, respectively. In another
approach by Volodkin et al., the addition of pre-aggregated Au NPs to positively charged
carboxyfluorescein-loaded liposomes was used to form liposome-NP complexes with strong NIR
absorbance.221 After laser irradiation, an increase in the fluorescent signal was observed un-
der the confocal laser scanning microscopy, which indicates lysis of the liposomes and release
of the fluorescent dye. In contrast, the liposome-NP complexes formed from the addition of
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single non-aggregated AuNPs to dye-loaded liposomes did not give any dye release upon laser
irradiation due to the poor absorbance of the single AuNPs in the NIR region.
The surface decoration of liposomes with NPs may also be achieved through the selective reduc-
tion and deposition of metal atoms at the liposome surface.213,214,222–225 Rengan et al. utilised
DSPC/cholesterol (8:2 molar ratio) liposomes as a template for the deposition of a layer of
gold via the reduction of Au3+ ions by ascorbic acid.213 Following irradiation with a 750 nm
diode laser (650 mW) for 15 mins, the Au-coated calcein-loaded liposomes released 85% of the
encapsulated dye, as opposed to 10% release without the Au NP coating. Irradiation for 30
mins showed complete liposome degradation producing 5 nm Au NPs, which can be excreted
by the kidneys by virtue of its size. A similar approach was also employed in another study,
where the liposomes were coated in a layer of poly-L-histidine which is capable of chelating
metal ions, before the addition of the Au salt and the reducing agent hydroxylamine.222 This
produced complete Au coverage over the liposome forming a nanocontainer. The structural in-
tegrity of the nanocontainer was enhanced by the gold shell as observed by negligible leakage of
encapsulated carboxyfluorescein after 24 days. The nanocontainers appeared stable under laser
irradiation at 4 mJ cm−2 independent of the laser wavelength used. However, at laser powers
greater than 4 mJ cm−2, the nanocontainers degraded; with maximum dye released observed
upon irradiation using a 20 mJ cm−2 laser.
2.5.1.4 Free nanoparticles added to liposome dispersions
Lastly, the co-administration of free NPs with drug-loaded liposomes represents the simplest
means of utilising NPs for stimuli-responsive drug delivery as this can be achieved simply
through the mixing of preformed liposomes and NPs.180,226 Liposomes can also be designed to
further augment their cargo release efficiency in response to an external stimulus. In the study by
Guo et al., the thermoresponsive poly(N-isopropylacrylamide-co-butylmethacrylate) (PNIPAM-
BMA) copolymer was adsorbed onto the surface of calcein-loaded DPPC liposomes and mixed
with Au NPs to provide ‘on-demand’ release of the cargo through a thermally induced two stage
mechanism.226 Under NIR irradiation, the heat generated by the Au NPs first causes contraction
of the adsorbed PNIPAM-BMA polymers to give the first stage of membrane disruption and dye
release below the Tm DPPC (41
◦C). As the temperature increases above Tm, the permeability
of the phospholipid bilayer is enhanced as it undergoes solid gel-to-liquid crystal transition,
thereby giving rise to the second stage of dye release.
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Whilst the addition of free NPs to liposomal dispersions has shown promise for the light acti-
vated release of cargoes, the proximity of the NPs to the drug carrier has been found to greatly
influence release efficiency. Wu et al. investigated the use of hollow Au nanoshells (HGNs) that
were encapsulated within, tethered to, or freely dispersed in the liquid medium with DPPC
liposomes for the triggered release of encapsulated carboxyfluorescein via transient microbubble
cavitation-induced membrane disruption following irradiation with femtosecond pulses of NIR
light.180 When the HGNs are irradiated with a pulsed laser, a temperature gradient is formed
around the HGNs which induces the formation of microbubbles that grows and collapses to
provide transient mechanical disruption of lipid membranes. For the most efficient membrane
permeabilization by light-induced microbubble cavitation, the HGNs must be at an optimal
distance from the lipid membrane. It was found that the HGNs directly tethered to the li-
posomes via a thiol-PEG-lipid linker provided the most efficient release of carboxyfluorescein
(93%), followed by the encapsulated HGNs (71%), and lastly the free HGNs (35%) after pulsed
laser irradiation.
2.5.2 Hydrogels incorporating NPs
NP-incorporated hydrogels are commonly prepared either by the direct addition of an aque-
ous NP dispersion to the polymer mixture before gel formation, or through the re-hydration
of a preformed dehydrated gel using a NP dispersion allowing NP diffusion into the swelling
polymer matrix, with both methodologies providing entrapment of large masses of NPs.227,228
An alternative means of NP incorporation into a hydrogel is through the synthesis of particles
within the network. This is commonly performed by the absorption of a metal salt solution
within a gel before addition of a reducing agent. Gupta et al. incorporated SPIONs into a
hydrogel through the hydration of a poly(vinyl alcohol)-g-poly(2-hydroxyethyl methacrylate)
(PVA-g-PHEMA) based hydrogel in a solution containing a mixture of ferrous and ferric salts
(0.5 and 0.6 M respectively).229 The swollen gel was then dried at room temperature before
being placed into a 10% v/v NaOH or NH4OH alkaline solution causing the precipitation of
magnetite NPs. Depending upon the PVA-PHEMA ratio, the SPIONs accounted for 6-15% of
the total mass of the gel. Metal ions can also bind with carboxyl groups loaded onto polymer
chains forming nucleation sites, where upon introduction of a strong reducing agent, NPs can
grow anchored to the hydrogel network.230 As such, the dimensions and porosities of the gel,
as well as the concentrations of ions and reducing agents, may be tuned to obtain specific NP
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Figure 2.18: Schematic illustrating the effects of compression on the interphase between a NP
and a hydrogel. A) NP-loaded hydrogel. B) An interphase is formed around the NP, comprising
of a higher polymer density at the NP surface. C) Under instantaneous compression, the polymer
density at the interphase is decreased. D) Under sustained compression, the interphase recovers
as the gel relaxes with an increased polymer density at the surface of the NP. Reproduced with
permission.232 Copyright 2017, Elsevier.
The incorporation of NPs within a gel network can alter the mechanical properties of the
hydrogel. The presence of NPs within a hydrogel causes a dense localised region of entangled
polymer chains to surround the NP, known as an interphase (Figure 2.18A and 2.18B).232,233 The
interphase has a heightened hyperelastic stress and increased viscoelastic properties in terms of
relaxation time and residual stress retention; as such the interphase will reform under continuous
compression (Figures 2.18C and 2.18D). The relaxation time of this interphase is hindered most
using high polymer to NP ratios. The increased viscoelasticity allows the production of hydrogels
that can be molded under the application of a shear stress and provides rapid self-healing upon
the removal of the external stress.
2.5.3 NP incorporated liposome-hydrogel hybrid systems
In addition to the liposomes, polymersomes, and hydrogel systems described earlier, NPs have
also been incorporated into hybrid systems comprised of different combinations of materials
for the stimuli-responsive release of therapeutics. These systems exploit the advantageous ca-
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pabilities of separate materials to further enhance the total therapeutic effects. Gao et al.
demonstrated the benefits of a dual delivery system by loading cationic liposomes, which are
stabilised electrostatically with carboxyl-modified gold NPs, into an acrylamide hydrogel, cross-
linked using poly(ethylene glycol) dimethacrylate (PEGDMA).217 By varying the concentration
of the crosslinker PEGDMA, it was found that both the viscoelastic properties of the hydrogel
and the gold NP loaded liposome release rate was altered. The NP-adsorbed liposomes would
remain stable until encountering an acidic environment triggering NP disassociation from the
cationic liposome, allowing the liposome to fuse to an S. aureus membrane inducing bacteri-
cidal effects. This system therefore provides a tuneable sustained release of both liposomes
and NPs, a multi-therapeutic delivery mechanism. Liposomes may also be chemically bonded
to the hydrogel network structure providing vesicle lesion upon high shear forces across the
hydrogel structure.234 NP conjugated therapeutics may therefore be encapsulated within the
liposomes and would therefore be protected from enzymatic degradation by the hydrogel whilst
ensuring low diffusive drug loss.This system therefore provides an adaptable means of delivery
of inherently antimicrobial or antibiotic-loaded liposomes for triggered bactericidal effects.
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2.6 Light responsive treatments of pathogenic bacteria
2.6.1 Mechanisms for the light-responsive release of antimicrobial agents
from NP-incorporated delivery systems
Laser Irradiation  
Magnetic Fields 
Changes in 
pH Released Antibiotic 
Damaged 
Bacteria 
0 14 7 
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Nanoparticle 
Figure 2.19: Remotely applied or local stimuli that are commonly utilised to induce conforma-
tional changes and disruption in the inorganic nanoparticle-associated drug delivery systems,
thereby triggering the selective release of loaded antibiotics to combat pathogenic bacteria at
infection sites.
The advantage of utilising inorganic NPs as a stimuli-responsive element within drug delivery
systems lies in their ease of synthesis and functionalisation, highly tunable optical properties,
excellent biocompatibility, and the ease of incorporation into the drug delivery systems. These
aspects avoid the need for often complicated and costly synthetic protocols to impart stimuli-
responsive moieties to lipids and polymeric systems. The incorporation of NPs into delivery
systems is also useful to trigger the release of antimicrobials for sustained or instantaneous
release during infections, Figure 2.19. AuNPs have been utilised to provide delivery antibiotics
and fluorescent dyes in response to light, magnetic fields and changes in pH, as described in
Table 2.1. However, discussion is restricted to triggered release due to photothermal heating
and bubble cavitation effects.
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Table 2.1: Inorganic NP-incorporated systems demonstrating NP-stimulated release of antibi-
otics or dye molecules.
Delivery system NP location NP type Trigger mechanism Released molecule Ref.
Liposome Within the AuNP Photothermal Calcein 235,236
bilayer SPION Magnetothermal Calcein 194
AuNP Bubble cavitation Calcein 237
Within the AuNP Bubble cavitation Allophycocyanin & 238
aqueous R-phycoerythin
core Au nanorod Photothermal Calcein 206,239
AuNP Photothermal Calcein 240
Adsorbed AuNP Photothermal Fluorescein 241
onto the AuNP Photothermal Carboxyfluorescein 222
surface AuNP pH-responsive Doxycyline 210
Au nanocage Bubble cavitation Carboxyfluorescein 180
Au nanoshell Photothermal Fluorescein 223
AuNP Photothermal Carboxyfluorescein 221
Free with AuNP Photothermal Calcein 226
dispersion
Polymersome Within the AuNP Photothermal Sulforhodamine & 194
bilayer 8-hydroxyl-1,3,6
-pyrenetrisul acid
AuNP Photothermal Lysozyme 242
SPION Magnetic field Methicillin 243
SPION Magnetothermal Calcein 244
AgNP Photothermal Ofloxacin 245
Hydrogel In the SPION Magnetothermal Ciprofloxacin 229,246
network SPION Magnetothermal Vancomycin 247,248
The unique optical properties of inorganic NPs have been respectively harnessed for the pho-
tothermal release of therapeutics from drug delivery systems due to the ease of achieving se-
lective disruption of the drug carriers by the external application of a laser. The generation of
heat from activated inorganic NPs incorporated within the drug delivery systems also enhances
the antibacterial efficiency of the delivered antibiotics through synergistic thermal ablative ef-
fects.223,249
Photothermal heating can be used to deposit thermal energy to a localised area or throughout
the drug carrier, thereby causing the destruction of the encapsulating material to trigger release
of the loaded therapeutics.223,244,250 An early demonstration on the use of photothermal effects
to release antibacterial agents from drug carriers was shown by Radt et al.242 In their study,
lysozyme crystals and 6 nm Au NPs were embedded within a polyelectrolyte shell built from
the layer-by-layer deposition of negatively charge poly(sodium 4-styrenesulfonate) and positively
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charged poly(allylamine hydrochloride). The capsules were first irradiated with a 10 ns pulsed
laser (λ = 1064 nm) at 50 mJ cm−2 for 5 mins at a frequency of 10 Hz before being added to a
suspension of Micrococcus lysodeikticus. Due to the release of lysozymes from photothermally
degraded capsules, rapid bacterial digestion was observed, with an associated decrease in the
extinction value at, 450 nm, decreased from 0.8 to 0.3 within 50 min, indicating a significant
decrease in bacterial viability. The extinction spectra for the photothermally degraded capsules
were identical to that obtained for the mechanically crushed capsules, hence indicating highly
efficient photothermal-mediated release of lysozymes from the capsules. In contrast, no changes
in the extinction spectra were observed for the non-irradiated mixture of intact capsules. In
another approach, Ag NPs were embedded within a poly(butyl methacrylate-co-acrylamide-
co-methacrylic acid) hydrogel to provide controlled release of the model antibiotic ofloxacin
following irradiation with a 405 nm laser for 15 s at the 10, 30, and 50 min mark after the start
of the experiment.199 After 70 min, a significantly higher amount of ofloxacin (> 80% of total
mass) was found to be released at both pH 7.4 and 1.2 when compared to the non-irradiated
samples. The enhanced drug release was attributed to the cross-linked polymeric hydrogel
system swelling as the temperature rose above its volume phase transition temperature after
laser irradiation.
Transient optically induced photothermal effects have also been exploited for the mechanical
disruption of drug carriers through micro- or nano-bubble cavitation without the involvement
of bulk heating.194,222,241 In the study by Wu et al., femtosecond pulsed laser irradiation of
liposomes encapsulating hollow gold nanoshells (HGNs) or mixed with free HGNs triggered
the release of encapsulated carboxyfluorescein above a threshold of ∼1.5 W cm−2 without the
induction of permanent liposomal damage or drastic temperature increases to the bulk solution,
thus suggesting that the triggered dye release occurred due to transient cavitation effects.180
The authors suggested that at sufficiently high temperatures, the water molecules surrounding
the HGN vaporise to form a gaseous cavity that violently expands and collapses, analogous to
the transient cavitation effects of microbubbles in response to applied ultrasound.251–253 The
collapse of the vapour bubble subsequently emits a shock wave that propagates through the
surrounding medium to transiently disrupt liposome membranes thus releasing the encapsulated
cargo. This theory was further supported by the lack of dye release seen when a continuous wave
laser was used to irradiate the HGN/liposome complexes even at a high power density of 89
W cm−2. Under continuous wave irradiation, HGNs are always near thermal equilibrium with
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the surrounding medium and are therefore unable to generate the thermal gradient required for
bubble cavitation.
2.6.2 AuNP mediated photothermal killing of bacteria
Recently, several studies have been published describing the photothermal treatment of bacterial
infections. For decades photothermal and photodynamic therapies have been in development for
the treatment of cancerous tumours, however in response to the growing demand for alternative
treatments to combat AMR, research focus has shifted to the photothermal treatment of bac-
terial infections. Heat can kill bacteria through disruption of the cell membrane, melting fatty
acids and denaturing proteins,254 and as of yet little to no resistance to photothermal treatment
has been observed in bacteria.255 Due to the substantial array of studies in this field discussion
will concentrate only the photothermal treatment of bacteria using AuNPs, however alternative
nanoscale photothermal agents comprised of alternative metals/metallic compounds,6,256–263
photoactive polymers7,264–269 and carbon structures270–276 have all demonstrated antimicrobial
efficacy.
Although there are several studies employing free AuNP suspensions to cause thermal bacteria
killing277–280 the most common means of utilising AuNPs to incite antimicrobial photothermal
heating is through the adsorption of the photothermal agent to the bacteria prior to irradiation.
A growing number of studies have adapted the AuNR surface coating to provide electrostatic
attraction to bacterial membranes only in an acidic infection environment.8,281–283 Hu et al.
(2018) developed a polydopamine (PDA) coated gold AuNR system functionalised with glycol
chitosan (GCS), and loaded with DAP, DAP-GCS-PDA@AuNRs, to provide synergistic pho-
tothermal and chemotherpeutic antimicrobial activity, Figure 2.20.284 GCS has a variable charge
depending on the pH, such that upon entering the acidic infection environment the polymer
becomes positively charged providing electrostatic attraction toward the anionic components in
the bacterial membrane. The charge between the chitosan molecules causes electrostatic repul-
sion, extending the polymer chains and partially releasing some of the DAP. This demonstrated
antimicrobial activity against MRSA, the effects of which were augmented through irradiation at
the AuNR plasmonic peak (0.5 W cm−2 at 808 nm for 7 mins). In vivo testing of subcutaneous
abscesses inoculated with MRSA showed that the dual photothermal and chemotherapeutic
approach resulted in a 98.5% reduction in bacterial colonies, whereas the pH-triggered release
of DAP (DAP-GCS-PDA@AuNR + pH 6.3) and photothermal heating (GCS-PDA@AuNR +
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NIR) antimicrobial effects alone resulted in 35% and 50% bacterial reductions respectively. The
in vivo testing of an equivalent GCS-PDA@AuNR system loaded with Ag+ ions (Ag+-GCS-
PDA@AuNRs) demonstrated the same synergistic antimicrobial effect upon NIR irradiation
resulting in a 0.9% bacteria survival rate, a statistically significant decrease compared to the
individual photothermal (GCS-PDA@AuNR + NIR) and Ag+ ion (Ag+-GCS-PDA@AuNRs +
pH 6.3) treatments, survival rates of 37.9% and > 70% respectively.285
Figure 2.20: Schematic representation of the step-by-step functionalisation of gold nanorods
(GNRs) with polydopamine (PDA) and glycol chitosan (GSC) before loading the structure
with daptomycin (DAP). The multi-stimulus responsive DAP release is then depicted, with
acidic environments (pH = 6.3) and NIR irradiation (0.5 W cm−2 at 808 nm for 7 mins)
induced heating causing conformational changes in the GSC, allowing DAP diffusion into the
surrounding region. The intention of this system is to provide a two-step antimicrobial action,
the initial pH change from an infectious environment will not only release DAP but create a
positive charge on the GSC providing electrostatic attraction to anionic bacteria membranes,
at which point NIR radiation is applied to incite photothermal bacteria killing. Reproduced
with permission.284 Copyright 2018, Applied Materials Today.
Rather than simply relying on electrostatic interactions for targeting many recent studies have
demonstrated active targeting using biological materials such as DNA,286 antibodies249,287–291
and antibiotics.292,293 In 2009 Huang et al. developed an iron oxide-gold (Fe3O4@Au NP) loaded
”Nanoegg” that possessed both photothermal and magnetic capabilities.293 The Nanoeggs were
functionalised using vancomycin to target the D-Ala-D-Ala moieties of peptides residing within
the bacteria walls. Upon the application of a magnetic field the bacteria covered in Nanoeggs
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aggregated at which point NIR radiation (250 mW cm−2 at 808 nm for 5 mins) was applied
to produce photothermal killing at 60◦C. Interestingly, all bacteria exhibited a decrease in
the survival fraction upon NIR irradiation in the aggregated state compared to being free
in suspension. A novel approach for the active targeting of AuNPs to bacteria by adapting
phage therapy was demonstrated by Peng et al. through the conjugation of AuNRs to the
thiol modified bacteriophage, M13KE-SH.294 Bacteriophages are viruses that specifically target
bacteria with no known effects upon mammalian cells.74 As such, AuNRs will readily bind
to the thiol groups of the filamentous bacteriophage creating a ”phagorod” complex (Figure
2.21A). Transmission electron microscopy (TEM) images of the phagorod show the targeting and
aggregation of AuNRs on the membranes of E. coli bacterium whereas the AuNRs alone show
no specific interaction, Figures 2.21C and B respectively. The high specificity of the Phagorod
targeting was demonstrated by treating a P. aeruginosa biofilm grown in the presence of the
epithelial Madin-Darby Canine Kidney II (MDCKII) cells. MDCKII cells and the P. aeruginosa
biofilm were sequentially cultivated into a well plate, before additional of the Phagorods and
irradiation for 10 mins (3 W cm−2, 808 nm) heating the sample to ∼75◦C. Using a SYTO9
and propidium iodide (PI) live/dead assay, a reduction of ∼98% in the bacteria viability was
observed (2.21D and E), whereas there was only a ∼16% decrease in the MDCKII viability,
demonstrating the specificity of the AuNR binding. Interestingly, the photothermal effects also
destroyed the the phage base eliminating the possibility of phage reproduction and reducing the
risks over the dosage control, a factor hindering clinical translation.295
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Figure 2.21: TEM images of A) AuNRs adhered to the bacteriophage (M13KE-SH) as it forms a
filament B) AuNRs mixed with E.coli, and C) M13KE-AuNRs binding to the bacterium. D) and
E), fluorescence microscopy images of a P. aeruginosa biofilm grown on epithelial Madin-Darby
Canine Kidney II cells, before and after treatment with M13KE-AuNRs and NIR irradiated for
10 mins (3 W cm−2, 808 nm). Bacteria were stained with a SYTO9 and propidium iodide (PI)
Live/dead assay, to identify the ratio of live (green) and dead (red) cells.(scale bar: 30 µm).
Adapted with permission.294.
Antibody functionalised particles have also demonstrated a synergistic photothermal bacteri-
cidal effect whilst providing triggered delivery of antibiotics. Meeker et al. synthesised gold
nanocages (AuNCs) functionalised with DAP (DAP@AuNCs).249 The irradiation of AuNCs
(1.67 W cm−2 at 808 nm for 10 mins) in the presence of a S. aureus resulted in an instanta-
neous reduction of bacterial viability below the plate reader sensitivity (20 CFU ml−1), however
after 24 hours the bacteria concentration rebounded to that of the untreated control, indicating
incomplete bacterial eradication. Irradiation of the bacterial sample containing Dap@AuNCs
however produced instantaneous bactericidal effects with a complete 6-log reduction observed
with no viable bacteria detected after 24 hours, indicating that the photothermal and antibiotic
effects worked synergistically. This construct was also applied to LAC (a stain of MRSA) in both
planktonic and biofilm forms. Complete bactericidal effects were observed against the plank-
tonic LAC immediately after irradiation with no bacteria growth over 24 hours. LAC biofilms
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exhibited initial photothermal resistance with only a 4-log reduction, however complete bacte-
ricidal effects were observed after 24 hours. The addition of the staphylococcal antibody aSpa
onto the AuNC surface enabled targeting that increased the immediate photothermal bacterici-
dal effects by inducing a complete 7-log reduction in bacteria viability within the biofilm. Zhang
et al. showed a similar synergistic effect through the loading of kanamycin (kana) into hollow
spherical AuNPs functionalised with the imaginatively named anti-E.coli antibody.288 E. coli
suspensions treated with the hollow AuNPs irradiated for 10 mins (200 mW cm−2 at 650 nm),
kana alone and irradiated kana-loaded hollow AuNPs exhibited bacterial survival rates of 90%,
87% and 50% respectively.
Recently there has been growing interest in loading AuNRs into hydrogel systems to formulate
potential wound dressings that provide light-responsive antibacterial properties.10,296–298 The
first instance of antimicrobial AuNR-gels was demonstrated by Jo et al. whom loaded CTAB-
stabilised AuNRs into an alginate gel.296 The incorporation of the AuNRs into the gel did
not affect the optical properties of the particles and exhibited photothermal heating to 50◦C
in 30 s and 70◦C after 90 s under NIR irradiation (0.45 W at 808 nm). Using the live/dead
stain SYTO 9, a 60% decrease in E. coli viability within a biofilm was observed after only
30 seconds of irradiation, however there was no increase in antibacterial activity for longer
irradiation times. This was attributed to the decreasing thermal profile within the biofilm,
with the majority of the viable bacteria located in the furthermost region from the AuNR-
gel. The affects of the heating on the bacteria membrane are clearly observed when imaging
using scanning electron microscopy, with bacteria within thermally treated biofilm exhibiting
significant blebbing and vesiculation (Figure 2.22B) compared to the smooth membranes of
bacteria in the untreated biofilm (2.22A). The experiment was replicated using Alamar blue
to determine the metabolic activity of the biofilm after photothermal treatment. After 30 s
irradiation a 25% reduction in bacterial metabolic activity was observed, rising to 84% after a
60 s irradiation. This is significantly higher than the 60% reduction in E. coli viability depicted
by the SYTO 9, which relies on membrane disruption to induce the colour change, indicating
that the antimicrobial activity of photothermal heating is not solely through membrane damage.
AuNRs have also been incorporated into clinically approved gels. Al-Bakri and Mahmoud loaded
phospholipid (DSPE-PEG-SH) AuNRs into a Pluronic R© F127 gel, a block co-polymer used in
novel drug delivery systems and tissue engineering.10,299 Under laser irradiation (3 W cm−2,
805 nm for 15 mins) the gel exhibited heating to 62◦C using 0.125 mM AuNRs. The heating
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demonstrated a 4.5-log reduction in P. aeruginosa CFUs in a biofilm. The AuNR-gels have
also demonstrated antimicrobial efficacy in vivo. Abdou mohamed et al. loaded mPEG-SH
AuNRs into a thermosensitive n-vinylpolycaprolactam polymer that provided a photothermal
mediated increase of 30◦C under laser irradiation (0.65 W cm−2 at 785 nm). Upon testing on
planktonic bacteria a difference in the thermal sensitivity between Gram-negative and Gram-
positive bacteria was observed, with 94-96% reductions in the viability of Gram(-ve) E. coli
and Acinetobacter baumannii, and a 65% reduction in the Gram(+ve) Enterococcus faecalis.
In vivo testing performed by placing the AuNR-gel in direct contect with a biopsy punch on
the dorsum of a murine model inoculated with 1–2× 106 CFU of E. coli, demonstrated a 98%
reduction in bacteria viability upon laser irradiation for 40 mins (∆T = 30◦C). The treatment
showed no detrimental affects on the wound healing process with complete re-epithelialisation
occurring in the same time frame as the non-infected wounds.
A) B) 
Figure 2.22: Scanning electron microscopy micrographs of E. coli biofilms A) without and B)
with photothermal heating from an AuNR-loaded alginate gel (0.45 W, 808 nm for 30 s). Scale
bars are 1 µm. Adapted with permission.296 Copyright 2013, IOP Publishing.
Biofilm formation on the surface of medical devices/implants has been identified as a leading
cause in nosocomial infections.300,301 As such, AuNPs have also been utilised to provide pho-
tothermal antimicrobial activity on functionalised surfaces to denote the potential for implemen-
tation on surgical apparatus. Khantamat et al. demonstrated this by binding gold nanoshells
onto a poly(amidoamine) dendrimer coated polydimethylsiloxane (PDMS) surface. An E. fae-
calis biofilm was then grown on to the Au nanoshell coated surface, achieving ∼70% coverage
before irradiation for 10 mins (2.5 W cm−2, 810 nm) heating the surface to 73◦C and resulting
in complete bacteria eradication. Yang et al. used electrostatic attraction to deposit positively
charged cetrimonium bromide (CTAB) stabilised AuNRs onto a treated titanium surface after
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the layer-by-layer addition of cationic 3-aminopropyltrimethoxysilane and anionic poly(styrene)
sulfonate.302 Laser irradiation at 0.5 W cm−2 (808 nm for 20 mins) heated the sample to 49◦C,
which is lower than the temperatures required for thermal ablation in the majority of studies
but still resulted in antibacterial rates of 62%, 67%, 26% and 32% against E.coli, P. aerug-
inosa, S.aureus and S. epidermidis respectively. Similarly, Au nanostars (AuNSs) bound to
glass surfaces using a 3-mercaptopropyl-trimethoxy silane coating have demonstrated a >90%
S. aureus cell reduction from a biofilm upon irradiation for 30 mins (0.12 W cm−2, 808 nm).303
de Miguel et al. took this one step further by demonstrating the first instance of antimicro-
bial photothermal heating from a medical implant that is currently on the market; adhering
citrate-stabilised AuNRs onto a polypropylene monofilament surgical mesh from B. Braun Sur-
gical, S.A. (Optilene Mesh LP), that is widely used in hernia repair.304 The AuNRs adhesion
was performed by oxygen plasma activation of the polypropylene mesh that was dipped into
pure ethylene diamine to coat the surface in activated amine-groups that, upon submersion in
the AuNR solution, anchor the particles to the mesh. As shown in the Figure 2.23A inset, the
AuNRs display a homogeneous distribution on the mesh surface with no substantial aggregation
after drying. A S. aureus biofilm was grown onto the mesh, Figure 2.23B, before irradiation
at fluences of 12-16 J cm−2 for 40, 100 or 300 ms. Irradiation at 14 J cm−2 in 40 ms resulted
in a 99.4% biofilm reduction, 15 J cm−2 in 100 ms a 99.3% reduction and 16 J cm−2 in 300
ms a 99.5% reduction. Despite the deposition of higher energies the bactericidal activity was
unaffected, meaning either that the rate of energy deposition is more important than the total
energy deposition or that the thermal or that there was no substantial difference in the heating
profiles between pulses of 14 J cm−2 in 40 ms and 16 J cm−2 in 300 ms. The bacteria were also
treated with a live/dead stain for quantification of the cell viability, when irradiated at 14 and
15 J cm−2 for 300 ms. Control samples, Figure 2.23C and F, showed thick biofilms on the mesh
surface with no decrease in viability, whereas the sample irradiated at 14 J cm−2 (Figure 2.23D
and G) showed an increase in the proportion of dead bacteria but a significant decrease in the
total number of bacteria. The sample irradiated at 15 cm−2 (Figure 2.23E and H) showed even
fewer bacteria adhered to the mesh, but a lower proportion of dead bacteria, Figure 2.23I. The
decrease in bacteria is attributed to the biofilm desorption from the mesh surface due to the
thermal denaturation of adhesive exopolysaccharides. As such, the proportion of dead bacteria
is not decreased with increasing fluence from 14 to 15 J cm−2, as the dead bacteria are more
likely to have been removed from the mesh than the live bacteria.
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Figure 2.23: Scanning electron micrographs of a polypropylene monofilament surgical mesh
from B. Braun Surgical, S.A. (Optilene Mesh LP), coated in A) citrate-stabilised AuNRs and
B) a S. aureus biofilm. C-H) Fluorescence confocal microscopy images of the mesh surface with
bacteria labelled using a live/dead stain (green/red colouration). Bright field images (C-E) are
included above the fluorescence images (F-H) to clarify the positions of the mesh, scale bars
are equal to 50 µm. Images are of a control mesh with AuNRs but no irradiation (C,F), and
meshes irradiated for 300 ms at laser fluences of 14 and 15 J cm−2 (D,G and E,H respectively).
I) The total percentage of bacteria remaining on the mesh after irradiation, compared to the
non-irradiated control, and the proportions of the remaining bacteria that are alive and dead.
Adapted with permission.304 Copyright 2019, American Chemical Society.
The recent advances in the photothermal treatment of pathogenic bacteria indicate that this
chemotherapeutic free approach to infection management has the potential for clinical us-
age. Furthermore, the photothermal enhancement of classical antibiotic efficacy is an exciting
prospect that could enable a reduction in the drug dosage required for treatment, possibly reduc-
ing the risks of resistance development. This therefore offers two significant pathways for future
research; demonstration of reduced resistance in combination chemo-photothermal therapies,
and investigating whether photothermal therapies can be used in conjunction with antibiotic
alternatives (AMPs, bacteriophages) to further reduce the risks of resistance development. The
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work covered in this thesis will attempt to answer the latter question by analysing the whether




3.1 Lipid preparation and liposome fabrication
Upon arrival, lipids were dissolved in chloroform before aliquoting into 200 mg ml−1 glass vials.
The chloroform was then extracted by drying under nitrogen for one hour, until an opaque lipid
film was formed on the walls of the vial. These vials were stored in a -80◦C freezer until use, at
which point the lipids were resuspended in chloroform. To fabricate multilamellar lipid vesicles
(MLVs), lipids were mixed in the desired proportions and added to a round bottom flask. Lipid
mixtures were always prepared in relation to the molar percentage (mol%) of each lipid required
within the liposome bilayer. The chloroform was then evaporated through drying under nitrogen
for an hour. Next, the flask was added to a water bath, preheated to 10◦C above the gel-fluid
phase transition temperature of the most abundant lipid, before the addition of an aqueous
solution and left to gently mix for an hour. The MLVs were homogenised through extrusion
by passing the sample through a 0.4 µm polycarbonate membrane 11 times, the extruder was
preheated to the same temperature as the water bath.
3.1.1 Fabrication of calcein loaded liposomes
Calcein loaded liposomes were fabricated through the hydration of the lipid film using a solution
of 0.1 M calcein dissolved in phosphate buffered saline (PBS). The liposomes were subsequently
extruded at above the gel-fluid phase transition temperature and placed in a fridge at 4◦C.
A Sephadex G-50 size chromatography column was prepared by mixing the Sephadex G-50
powder with Milli-Q at 10 mg ml−1, before 10 ml of the suspension was added to an empty
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filtration column. Bubbles were removed from the column by firming striking the tube with
a spatula, before being left to rest for two hours. PBS was then gently flowed through the
column until twice the volume of the column had passed through the gel. The calcein-liposome
suspension was then added to the surface of the gel and was gently eluted using PBS. When
the solution exiting the column became slightly coloured, the solution was then collected in 0.5
ml increments.
3.1.2 Fabrication of AMP loaded liposomes
IK8 loaded MLVs were fabricated as previously described with the hydrating solution comprised
of IK8 dissolved in PBS, Figure 3.1. After extrusion the liposomes were placed in a fridge at
4◦C. A 15 kDa regenerated cellulose Spectra/Por membrane was left to hydrate in Milli-Q water
for 30 mins before the liposomes were added to the dialysis membrane. The sample was then
added to a 2 litre bucket of Milli-Q and left to dialyse for 48 hours. The water was replaced
after 2, 18 and 26 hours. The liposome sample was then removed from the dialysis membrane
and added to an eppendorf to be stored at 4◦C.
A B C D E 
Figure 3.1: Schematic of liposomes fabrication using a lipid-film hydration and cleaning proto-
col. A) Formation of a thin lipid-film in a round bottom flask, by nitrogen drying lipids dissolved
in chloroform. B) Hydration of the lipid-film using a solution containing the material to be en-
capsulated. C) Liposomes are formed by gently mixing the solution at above the gel-fluid phase
transition temperature of the lipids in solution. D) Liposomes are homogenized using extrusion,
whilst heated above the lipid gel-fluid phase transition temperature. E) Unencapsulated mate-
rials are removed through dialysis.The sample is placed into a dialysis membrane (pore size >
5 times the material to be removed) and placed into a 2 litre bucket of Milli-Q for 48 hours,
replacing the water after 2, 18 and 26 hours.
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3.2 Liposome characterisation
3.2.1 Dynamic light scattering
Dynamic light scattering (DLS) was performed using a Zetasizer Nano ZS with a 4 mW He-Ne
laser at 633 nm and a measurement angle of 173◦. Typically 10 µl of sample was diluted into
1 ml of buffer, or Milli-Q, and analysed within polystyrene cuvettes. Samples were measured
thrice and the average size distribution was taken.
DLS is a technique used to determine the size distribution of particles in solution. A monochro-
matic laser source is used to irradiate the particles creating a scattering pattern, made from the
constructive and destructive interference of light from each particle scattering event. As the
particles diffuse with Brownian motion the intensity of the scattering pattern fluctuates and in-
formation regarding the dynamic motion of the particles is obtained by observing the scattering
intensity fluctuations, otherwise known as the autocorrelation function, over time.305,306For a
monodisperse sample the autocorrelation function, g(t), can be defined as a single exponential
g(t) = e−q
2Dt (3.1)
with a time decay that is determined by the translational diffusion coefficient of a particle, D,
and the length of the scattering vector q, where q = 4πnλ sin
θ
2 .
307 The hydrodynamic radius
of the solute, R, can be extracted from this equation by relating the translational diffusion





where kB is Boltzmann’s constant, T is the absolute temperature and η is the viscosity of the
suspension medium.
3.2.2 Single particle tracking
Single particle tracking is a technique used to determine the size and concentration of a solute.
Unlike DLS that observes ensemble averages, single particle tracking measures the scattering
off individual particles and tracks their motion through a medium. As such, a known number of
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particles can be analysed within a given volume allowing the calculation of the concentration.
Within this thesis all single particle tracking measurements were performed using a Malvern
Nanosight NS300. Samples were diluted 10,000 times in buffer, or Milli-Q, and were inserted
into a microfluidic chamber affixed on top of a laser module. The sample was then irradiated
with a 50 mW laser at 532 nm, and the scattered light from each particle was observed using a
microscope with 20 times objective lens. A 60 second video was then recorded whereby nanopar-
ticle tracking analysis software analysed the Brownian diffusion the particles and obtained the
radius from the Stokes-Einstein equation 3.2. The concentration was ascertained by measuring
the number of particles that flowed into the imaging area, of known volume, and multiplied by
the initial dilution factor. Three videos were taken of each sample from which the average size
distribution and concentration were obtained.
3.2.3 Zeta-potential measurements
Figure 3.2: A charged particle will attract ions of the opposite charge from within the sur-
rounding medium, binding them tightly to form the stern layer. As the electrostatic attraction
decreases beyond the stern layer the density of bound ions decreases to the point at which the
ions diffuse freely around the particle, this boundary is the slipping plane. It is the potential at
the slipping plane that defines the zeta-potential.308
In polar solutions a particle’s colloidal stability may be controlled by the surface charge. This is
due to the electrostatic repulsion between the particles keeping them dispersed throughout the
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medium and inhibiting aggregation or flocculation. The zeta-potential is a means of determining
the strength of the electrostatic repulsion between adjacent similarly charged particles and is
defined as the potential difference between the dispersion medium and the stationary layer of
fluid attached to the particle, Figure 3.2.309 The zeta-potential is also highly dependent upon the
ionic strength and pH of the solution, with each variable potentially screening the the particle
charge, hence reducing the zeta-potential, which can cause particle agglomeration. Particles
with zeta-potentials greater than ± 30 mV are generally considered as moderately stable in
low ionic strength solutions however these particles may agglomerate over long time periods,
particles with charges greater than ± 60 mV are considered extremely stable and thus can
withstand high electrolyte concentrations.310,311
Zeta-potentials are commonly determined using electrophoresis, the motion of a dispersion in
response to an applied electric field. An oscillating electric field is applied across the dispersion
and the particles migrate toward the electrode of opposing charge the velocity of which is
proportional to the magnitude of the zeta-potential.312 The particle velocity is then measured
using laser Doppler anemometery, whereby a monochromatic laser beam is used to irradiate the
sample, causing Rayleigh scattering that produces an interference pattern. The change in the
interference pattern due to the motion of the particles is used to generate a correlation function






where UE is the electrophoretic mobility, ε is the dielectric constant of the medium, f(ka) is
Henry’s function (k is the debye-length and a the particle radius), and η is the medium viscosity.
Henry’s function can be assumed to be 1 under the Debye-Hückel approximation (a < 1/k) and
1.5 using Smoluchowski’s model (a  1/k).313,314
3.2.4 Calcein leakage
Liposome leakage was determined using the fluorescent dye calcein, Figure 3.3A. Fluorescence
occurs when an orbital electron of a molecule absorbs a photon causing it to move into a
higher energy state, and upon returning to the ground state the electron emits a photon. At
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concentrations > 1 mM the innate fluorescence of calcein is self-quenched through excited
electron transfer to molecules in the ground state, rather than re-emitting the energy as a photon
(See Figure 3.3B).315,316 Liposomes encapsulating calcein at high concentrations produce very
little fluorescence until they leak causing a decrease in the concentration of encapsulated dye
and providing a fluorescent response.
A) B) 
Figure 3.3: A) The excitation (dashed line, peak at 496 nm) and emission (solid line, peak at
515 nm) spectra of calcein.317 B) The fluorescence of calcein with concentration, demonstrating
the self-quenching effects above 1 mM.
Calcein loaded liposomes were diluted 100 times in buffer before addition of 100 µl to an opaque
96-well plate, along with 100 µl of either MHBII, fibroblast growth media or more buffer. The
initial fluorescence was measured (EX/EM, 496 nm/515 nm), and the plates were placed in
an incubator preheated to 37◦C, after which the fluorescence was measured daily. 1% Triton
X-100 was added to control wells on day 0 and at the end of the experiment to determine the
maximum fluorescence and to ensure the calcein fluorescence was constant. Six replicates wells
of each sample were measured. The liposome leakage was calculated using
Leakage(%) = 100× (FSample − FBackground)− (FInitial − FBackground)
(FMaximum − FBackground)− (FInitial − FBackground)
(3.4)
3.2.5 Thermally induced calcein release
To determine the thermal release profile, liposomes were heated beyond their gel-fluid phase
transition temperature and the proportion of calcein released was quantified. 200 µl of calcein-
loaded liposomes, diluted 100 times in PBS, was added to an opaque 96-well plate. The initial
fluorescence of the sample was measured before the plate was then placed into an incubator
preheated to 25◦C. Thermocouples were places into wells containing 200 µl of PBS to observe
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the solution temperature. Once the temperature within the wells was within 1◦C of 25◦C the
plate was left for a further 5 mins. The fluorescence was again measured, whilst the incubator
temperature was increased to 30◦C. The plate was placed into the incubator and once more
maintained at within 1◦C of 30◦C for 5 mins, before again measuring the fluorescence. This
process was repeated increasing the temperature in 5◦C increments up to 65◦C. The percentage
of calcein released was calculated using Equation 3.4. 1% v/v Triton X-100 was added to control
wells at the start of the experiment, as well as to heated wells at the end of the experiment to
provide the total release fluorescence value and to ensure that this value did not change over
the course of the experiment.
3.2.6 IK8 encapsulation efficiency
3.2.6.1 High performance liquid chromatography
High-performance liquid chromatography (HPLC) was used to quantify the IK8 concentration.
IK8-liposomes were fabricated as described in section 3.1.2. The encapsulation efficiency (EE)
of IK8 was determined post dialysis to ensure no peptide external to the liposomes remained. 10
µl of the liposome sample was added to an equal volume of DMSO, to lyse the vesicles releasing
the encapsulated IK8, before dilution in Milli-Q to 300 µl. The sample was fed into a 4.6 x 250
mm Insertil ODS-SP column in an acetonitrile gradient (acetonitrile/water ratio at 0.01 mins
13:87, at 10 mins 100/0) at a rate of 2 µl min−1. The column led into a UV-vis spectrometer
where the absorbance was read at 220 nm. A peak corresponding to the IK8 was observed after
2.26 mins, Figure 3.4A. The concentration of AMP was determined by integrating beneath the
peak and comparing to a predetermined concentration calibration curve, Figure 3.4B. The EE
was determined as:
EE(%) = Dilutionfactor × 100× MFinal
MInitial
(3.5)
where MFinal is the final mass of IK8 after dialysis and MInitial is the mass of IK8 used during
the hydration of the lipid film.
66
Section 3.2 Chapter 3. Experimental techniques








500 SM2017 #14 [modified by chmhplc] Sam IK8 250ug/ml EXT220NM
mAU
min
1 - IK8 - 2.163
WVL:220 nmA) B) 
Figure 3.4: A) A HPLC graph used to quantify the concentration of IK8 within a sample. The
distinctive peak of IK8 can be seen at 2.26 mins. B) A calibration plot of IK8 obtained using
HPLC.
3.2.6.2 Bicinchoninic acid protein assay
IK8 quantification in Chapter Results chapter 3, was performed using the bicinchoninic acid
(BCA) protein assay. The BCA assay utilises a two stage process to quantify the amount of
peptide within a sample.318 Firstly, Copper(II) sulphate is reduced to Cu1+ (cupric cation) by
the chelation of the copper with a protein in a basic envronment containing potassium tartare,
known as a biuret reaction. The number of cupric cations that form is directly proportional to
the quantity of amine bonds between the amino acids of the peptide. The second step of the
reaction occurs when two BCA molecules react with a cupric cation to form a structure that
absorbs strongly at 562 nm.
The assay was performed by initially mixing Reagents A and B (50:1) of the PierceTMBCA
Protein Assay Kit. 175 µl of the assay was then added to 25 µl of the peptide sample in a clear
bottomed 96-well plate. The plate was incubated at 37◦C for 30 mins before the absorbance at
562 nm was measured. The background absorbance of the assay in the absence of peptides was
subtracted from the sample absorbance.
3.2.7 Protection of encapsulated peptides from protease degradation
The efficacy of liposomal protection of encapsulated AMPS from proteolysis was assessed
through the addition of protease to solutions containing free IK8 and IK8-loaded liposomes.
This protocol was adapted from Banerjee and Onyuksel (2012).319 10 µl of trypsin (50µg ml−1)
was added to 1 ml of 0.1 mg ml−1 of IK8 dissolved in Milli-Q and to liposomes encapsulating
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the equivalent mass of peptide. The solutions were then left to incubate at room temperature.
After 1 hour 150 µl of the sample was extract and 10 µl of a 40% w/w glacial tricholoacetic acid
was added to inactive the trypsin. This was repeated each hour for 5 hours. 5% v/v DMSO
was added to the samples containing liposomes to release the encapsulated peptide before the
concentration of IK8 remaining was quantified using HPLC, as described in section 3.2.6.
3.3 Gold nanoparticle synthesis
All glassware was cleaned by sonication of a 10% Decon90 solution for 30 mins, followed by a
thorough rinsing using Milli-Q water and further sonication of Milli-Q for 30 mins. Additional
cleaning was then performed by soaking glassware in aqua regia for 30 mins. Aqua regia is
formed by mixing HNO3 and HCl at a 1:3 ratio. The strong oxidising activity and Cl
− ions
dissolve metals removing any remnants of gold that may act as nucleation sites during the
reduction of Au+3 during the AuNP synthesis. The glassware was then rinsed thoroughly with
Milli-Q before being placed in an oven at 80◦C overnight. All glassware was allowed to cool to
room temperature before any synthesis.
3.3.1 Binary surfactant stabilised AuNR synthesis
AuNRs were synthesised in a large 0.5 l one-pot syntheses. Initially 250 ml of Milli-Q was
heated to 70◦C using a water bath before the addition of CTAB and NaOL, 48 mM and 12.5
mM respectively, and stirred vigorously until the surfactants were completely dissolved, before
allowing to cool to 30◦C. The solution was continuously stirred as 250 ml of HAuCl4 (1 mM),
12 ml AgNO3 (4 mM), 2.5 ml HCl (11.8 M), 3.75 ml ascorbic acid (AA, 85.8 mM) were added
sequentially, allowing 5 mins of continuous mixing in between addition of each solution. Lastly,
the speed of stirring was increased to 1200 rpm and 0.375 ml of ice-cold NaBH4 (10 mM) was
rapidly injected. The stirring was stopped immediately and the solution was maintained at 30◦C
for 4 hours. The binary surfactant stabilised AuNRs were then pelleted through centrifugation
at 17,000 g for 30 mins. The supernatant was disregarded and the AuNR pellet was dispersed
in Milli-Q. The AuNR solution was then stored in the dark at room temperature.
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3.3.2 Replacement of the AuNR binary surfactant coating with a phospholid
bilayer
3.3.2.1 PEGylated phospholipid bilayer
Prior to the phospholipid functionalisation of AuNRs a solution containing lipid SUVs was
prepared. A lipid mixture of DSPC/DSPE-mPEG2k (95/5 mol%) in chloroform was added to
a round bottom flask before removal of the solvent through drying under nitrogen until only a
translucent lipid film remained. The thin-lipid film was then hydrated for 1 hour using Milli-Q
to produce a MLV solution containing 10 mg ml−1 of lipid. The lipid solution was then tip
sonicated for 2 hours to produce SUVs which were sized using DLS, and provided the vesicles
were > 50 nm they were used for the binary surfactant replacement. 10 ml of binary surfactant
stabilised AuNRs at 60 µg ml−1, cleaned once with centrifugation, were centrifuged a second
time and the pellet was dispersed in 3 ml of the SUV suspension. The mixture was then placed
into a refrigerated bath sonicator for 24 hours. The AuNRs were then centrifugated at 9,000
g for 15 mins and redispersed into 3 ml of a fresh 10 mg ml−1 SUV suspension. This process
was repeated three times, following the final centrifugation process the pellet was dispersed in
Milli-Q. In order to remove excess lipid the NRs were cleaned via centrifugation once more and
again dispersed in Milli-Q.
3.3.2.2 Maleimide-functionalised phospholid bilayer
The replacement of the binary surfactant bilayer with maleimide-functionalised phospholipids
was performed identically to the PEGylated phospholipid replacement as previously described,
however the final round of SUVs were fabricated with 1% of the DSPE-mPEG2k substituted
for DSPE-mPEG2k-maleimide.
3.3.3 Polystyrene sulfonate functionalisation of binary surfactant AuNRs
Binary surfactant AuNRs, twice cleaned using centrifugation, at 60 µg ml−1 were collated into a
1.5 l beaker and stirred vigorously. An equal volume of 10 mg ml−1 polystyrene sulfonate (PSS)
dissolved into Milli-Q with 5 mM NaCl was then added to the AuNRs. The solution was then
left to mix for 24 hours before centrifugation (9,000 g, 30 mins), removal of the supernatant,
and resuspending the pellet in a 1 mg ml−1 PSS solution. This was repeated twice with the
final pellet resuspended in Milli-Q.
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3.3.4 Synthesis of AuNP coated liposomes
The synthesis of AuNP coated liposomes was adapted from work by Rengan et al., as described
by Figure 3.5.213,214 Liposomes were fabricated as described in section 3.1 to ∼350 nm and
were diluted to 2 mg ml−1 in PBS. 200 µl of the liposome suspension was then mixed with
100 µl of 1-10 mM HAuCl4, before the addition of 400 µl of AA. This produced a rapid colour
change that was dependent on the morphology of the NP that was synthesised. The mixture
was then left for an hour before cleaning using centrifugation (500 g, 30 mins), the supernatant
was removed and the pellet dispersed in Milli-Q.
+ Chloroauric acid 
+ Ascorbic acid 
Figure 3.5: A schematic representation of the synthesis of AuNPs onto the surface of a liposome.
3.3.5 Adhering AuNPs to thiolated liposomes
Liposomes were fabricated containing DPPE-Ptd, a lipid molecule functionalised with a sulphur
atom to allow the formation of thiol bonds. Liposomes (67/30/2/1 mol%, DSPC/cholesterol/DSPE-
PEG2k/DPPE-Ptd) were fabricated to ∼350 nm through thin-lipid film hydration and extrusion
through a 400 nm extrusion membrane, as described in section 3.1.2. AuNPs were synthesised by
mixing equal volumes of 5 mM HAuCl4 with 5 mM AA in Milli-Q, resulting in a rapid colour
change to a deep red. After the colour change equal volumes of the AuNP and DPPE-Ptd
suspensions (10 mg ml−1) were mixed and left overnight.
3.3.6 Adhering maleimide-functionalised phospholipid AuNRs to thiolated
liposomes
Phospholipid AuNRs functionalised with 1 mol% DSPE-mPEG2k-maleimide (200 µg ml−1 of
Au), were mixed with an equal volume of liposomes containing 1 mol% DPPE-Ptd (10 mg
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ml−1) and left overnight. The following day the solution was centrifuged (9,000 g, 30 mins),
the supernatant was disregarded and the pellet suspended in Milli-Q.
3.4 NP characterisation
3.4.1 UV-Vis-NIR spectroscopy
Ultra-violet/visible/near-infra-red absorption spectroscopy was utilised to determine the sam-
ple absorption of monochromatic light at wavelengths between 400-1,000 nm. The plasmonic
properties of AuNPs provide characteristic absorption spectra that are dependent upon the
particle size and morphology, meaning absorption spectroscopy can be particularly useful in
giving initial indications of sample quality.
The absorbance spectrum is obtained by varying the wavelength of applied light using a monochro-
mator, and measuring light intensity once it has passed through the sample. The spectrum of a
’blank’ well containing only the dispersion medium is simultaneously measured with any sam-
ple to provide a background subtraction from the particle absorbance spectrum. Absorbance
spectra were obtained using a PerkinElmer Lambda 35 spectrophotometer.
3.4.2 Transmission electron microscopy
Electron microscopy was used throughout this thesis to provide visual identification of AuNPs
and liposomes. Electron microscopy was required due to the Abbe diffraction limit restricting





where d is minimum imaging resolution, λ is the wavelength of applied radiation, n is the
refractive index of the medium and sinθ is the angle of convergence. Therefore, for light in
the visible wavelengths (∼ 400-700 nm) with a reasonable numerical aperture (∼0.9) the Abbe
resolution is in the order of several hundred nanometers, making optical imaging unsuitable for
the analysis of nanoscale structures. However, due to particle-wave duality electrons have a De
Broglie wavelength, Equation 3.7, which allows for a dramatic reduction in the imaging spot
size, circumventing the Abbe resolution limit.320
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where h is the planck constant, m and v are the rest mass and velocity of the electron respec-
tively.321 This means that the resolution of the microscope is governed by the velocity of the
electrons.322 Transmission electron microscopy (TEM) utilises a potential difference to acceler-
ate electrons that are focused to a beam using a pair of condensing lenses. The beam is then
trimmed using an aperture before striking the sample. The electrons incident to the sample
are scattered by atomic nuclei or absorbed, whereas the other electrons can pass through the
grid unimpeded. This creates a 2D rendering of the sample which is captured using a charge
coupled device camera.
Throughout this thesis TEM imaging was performed using a Tecnai G2 Spirit TWIN/BioTWIN
with an acceleration voltage of 120 kV. Image processing and analysis was performed manually
using Fiji.
TEM samples were prepared through the addition of 5 µl of AuNRs (∼600 µg ml−1) in Milli-
Q onto a carbon-coated 400-mesh copper grid (Electron Microscopy services, CF400-Cu). The
samples were allowed to dry at room temperature before gently blowing across the surface of the
grid. The low density of liposomes make visualising them using he TEM can be very difficult,
and as such a negative-stain was applied to increase the sample density making the vesicles
easier to identify.323 The liposome samples were diluted 1,000 times before 5 µl was added to
the TEM grid and held near a heat source for 30 seconds. The sample was then wicked away
using blot paper before 5 µl of 2% uranyl acetate was added to the grid. The negative stain was
then immediately wicked away, before this process was repeated thrice with Milli-Q to remove
excess stain. The sample was then left to dry at room temperature.
3.4.3 Atomic absorption spectroscopy
Atomic absorption spectroscopy (AAS) uses the unique absorption profiles of atoms in order
to both identify and quantify the concentrations of an element within a sample. Gold concen-
trations were determined using a Varian 240FS atomic absorbance spectrometer (AAS). The
NR sample was initially dissolved into aqua regia and diluted in Milli-Q, before being fed into
a nebulizer where the solution is vaporised. The sample was then fed into the flame atomizer
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fuelled by an air-acetylene mixture igniting a flame with a temperature 2,300◦C.324 Monochro-
matic light at 242.8 nm, the resonance absorbance wavelength of atomized gold, was shone into
the sample and the absorbance was measured. The concentrations of Au within a sample after
a AuNR synthesis was determined through comparison to a calibration plot, Figure 3.6.
Figure 3.6: The absorbance of increasing concentrations of atomized gold, 0-20 ppm, at 242.8
nm using atomic absorption spectroscopy. This calibration plot of Au concentration was used
to quantify the mass of particles after an AuNR synthesis.
3.5 Laser optical set-ups
3.5.1 Continuous wave laser
A custom-made laser rig was designed in order to provide automated irradiation of a 96-well
plate, Figure 3.7. The system provided control of the irradiation area through the use of an
XY-stage that could move a well plate to align the desired well with the laser beam. The
duration of irradiation could also be regulated through the use of a solenoid shutter to block
the beam. A cabinet incubator afforded temperature control within the enclosed rig casing to
maintain samples at a desired temperature when not under irradiation. The entire path of the
beam was enclosed in black piping to ensure there was no chance of potentially dangerous laser
exposure.
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Figure 3.7: A) A schematic representation of the optical set-up directing and shaping the beam
into the sample box during photothermal experiments. B) Schematic of the beam as it is directed
past the XY-stage, into a 96-well plate before striking the beam dump. C) The maximum power
out-put between 680-1,000 nm of the Mira 900-F laser connected to different pumps. The 10
W Verdi pump was used in this laser system.325
A Coherent Mira 900-F provided the laser source connected to a 10 W Verdi pump. This
Ti:Sapphire femtosecond pulse laser was utilised in a continuous wave mode, with a tunable
wavelength between 700–980 nm and a 0.6 mm beam diameter. Upon exiting the laser cavity
the beam was passed through a polarised beam splitter where 1% of the beam is redirected to
a fibre-coupled Ocean Optics Flame spectrometer and a Thorlabs PM100D power meter with
a S120C photodiode power sensor. The remaining 99% of the initial beam was expanded 7.5
times such that the full-width half-maximum of the Gaussian beam intensity was 6 mm, the
diameter of a well in a 96-well plate, with the beam periphery removed using a 6 mm aperture. A
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solenoid shutter then provided remote control of the beam application to a sample (the shutter
was coupled to an interlock to block the beam if the box enclosing the sample was open). A
mirror then redirected the beam vertically into the box and into a sample before striking the
beam dump attached to the lid of the box. Inside the chamber a Prior H128 motorised XY-stage,
fitted with a standard 96-well plate mount, allowed the positioning of a well-plate along the beam
path to irradiate a sample. The temperature within the enclosure was maintained at 37◦C using
a IncuKit cabinet incubator heater, while the temperature within a well-plate was monitored
using thermocouples connected to an 8-channel Pico Technology TC-08 Thermocouple Data
Logger.
3.5.2 Pulsed laser system
A pulsed laser beam was produced by a SureliteTMOPO Plus neodymium-doped yttrium alu-
minum garnet (Nd:YAG) laser connected to a 532 nm SL I-10 pump source, Figure 3.8. The
beam produced can be tuned between 700-2500 nm with a 10 Hz repetition rate and a 5 nanosec-
ond pulse duration. After leaving the laser cavity the beam was passed into a beam splitter
where 10% was redirected into a fibre-coupled Ocean Optics Flame spectrometer. The remain-
ing 90% of the beam passed through a natural density (ND) filter between 0-4, an increase in
the ND of 1 will reduce the fluence by 90%. The beam was then passed into a quartz curvette
containing the sample, before striking the beam dump at the back of the curvette holder.








and beam dump 
Figure 3.8: Schematic of the optical pulsed laser set-up. A SureliteTMOPO Plus tunable laser
was directed into a beam splitter where 10% of the beam was redirected into a spectrometer.
The remaining 90% of the beam was then passed through a natural density filter of 0-4 before
striking the sample within a quartz curvette that was placed into the holder.
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3.6 Hydrogel fabrication and characterisation
A) 
B) 
= PEG dithiol 
= 4-arm PEG maleimide 
Figure 3.9: A) Schematic of the Michael type addition between a maleimide group and a thiol.
B) Schematic of the 4APM
The hydrogel was composed of a four-arm PEG maleimide (4APM, 20 kDa) cross linked with
PEG dithiol (3.4 kDa), see Figure 3.9B. The ’click’ reaction between the maleimide and thiol
groups was formed using a michael type addition, Figure 3.9A, providing control over the
reaction rate using the buffer pH and salt concentration.326 The gel was fabricated by separately
dissolving the 4APM and PEG dithiol into 10 mM citrate buffer (pH 6) followed by mixing to
initiate gelation. The mass of each component was determined by the desired final gel wt%,
whilst maintaining a 1:1 ratio of maleimide to thiol groups. The PEG ditiol was injected directly
into the middle of the 4APM solution and the mixture was continuously withdrawn into and
ejected from a pipette until the gel was formed stopping the solution from being withdrawn.
The duration of the mixing was defined as the gelation time. IK8-loaded liposomes and AuNRs
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were incorporated into the gel by mixing the particle suspensions into the 4APM solution prior
to the addition of the PEG dithiol.
3.6.1 Liposome and AuNR retention
The retention of liposomes and AuNRs within the hydrogel was determined by incubating the
gels with buffer and measuring the leakage of the particles daily. 50 µl PEG gels containing
both liposomes and AuNRs were fabricated into opaque 96-well plates and 150 µl of citrate
buffer was added to the gels after gelation. To quantify the amount of AuNRs lost from the gel
the supernatant absorbance at 860 nm, the longitudinal absorbance wavelength of the AuNRs,
was measured. The liposome retention was assessed by including the dye Texas Red within the
liposome bilayer, thus providing them with a measurable fluorescence (EX/EM, 561 nm/594
nm). The Texas Red was included by the addition of 0.5 wt% Texas Red to the lipid mixture,
prior to the formation of the thin lipid film, the rest of the fabrication protocol was unchanged.
The absorbance and fluorescence of the citrate buffer was measured before addition to the gels,
and the absorbance and fluorescent values were obtained for the gels on day 0. After 24 hours
the supernatant was added to a clean well and the absorbance and fluorescence were both
measured, after which the solutions were added back to the gels. The liposome and AuNR
release was determined using the equation
Release(%) = 100× XSample −XBuffer
XInitial −XBuffer
(3.8)
where X is the fluorescence when of the liposomes (EX/EM, 561 nm/594 nm) or the absorbance
of the AuNRs (860 nm).
3.6.2 Rheology
The mechanical properties of the IK8-liposome and AuNR loaded gels was assessed using an
Anton Paar modular compact rheometer 302. The storage and loss moduli (G’ and G” respec-
tively) of the gels was obtained through applying a constant strain of 1% to the gel and by
applying a 1% strain at frequencies of 0.1-100 Hz. A 500 µl gel was fabricated on the bottom
plate of the rheometer that was preheated to 37◦C. Immediately after gelation the 25 mm diam-
eter top plate was lowered to 1 mm above the bottom plate before initiating the measurement.
Silicon oil was applied to the periphery of the rheometer plates to restrict evaporation from the
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hydrogel.
3.6.3 Swelling ratio
The swelling ratio is the fractional increase in the weight of the hydrogel due to the absorption
of water.327 PEG gels of 2.5, 5 and 10 wt% were fabricated into the eppendorfs, before freeze-
drying. The gels were then weighed before 1 ml of Milli-Q was added. After 10, 30, 60, 120,
180 and 240 mins the excess Milli-Q was removed and the gel was weighed again. The swelling





Where W1 is the weight of the swollen gel and W2 is the initial weight of the gel before hydration.
3.6.4 Photothermal heating
The photothermal response of the AuNR loaded gels was determined using the Mira 900 laser
system as previously described (Section 3.5). 50 µl hydrogels containing AuNRs were fabricated
in 96-well plates and subjected to laser irradiation at varying intensities. The photothermal
response was measured using thermocouples fixed into the lid of a well plate. To assess the
reproducibility of the photothermal heating profile the gels were also subjected to multiple
rounds of heating with a 10 minute cooling period between the irradiation cycles.
The photothermal bulk heating produced by the pulsed laser system was determine by filming
the samples during irradiation using a thermal camera.
3.6.5 Calcein release from liposomes loaded in gels
Calcein-loaded liposomes were diluted 100 times into citrate buffer and the fluorescence was
compared to liposomes diluted in the same amount of Milli-Q, to ensure that the buffer itself
did not trigger the release of the encapsulated dye. The liposomes in citrate buffer were then
used to dissolve the 4APM before the fabrication of a 50 µl hydrogel in a clear bottom 96-well
plate, as described at the beginning of section 3.6. The fluorescence was measured to determine
whether the formation of the gel structure impacted the liposome integrity. The gel was then
topped up to 200 µl with either buffer, MHB II or a a suspension of 0.5 McFarland standard
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bacteria diluted a further 100 times. The fluorescence was then measured immediately before
incubation at 37 ◦C, the fluorescence was then measured daily. 1% Triton X-100 was mixed with
control samples at the start and end of the experiment to ensure that the maximum fluorescence
did not change.
3.7 Cell culture
Cell culture was performed under sterile conditions in a class II A1 biosafety cabinet. All
consumables were autoclaved at 131◦C for 30 mins unless purchased sterile. All cell culture
in this thesis was performed upon human dermal fibroblast (HDF) cells. Cells were incubated
at 37◦C in 5% CO2 and a high humidity environment, cells were split at 1:3 upon reaching
80% confluency, approximately every 4 days. Cell splitting was performed by aspirating the
spent fibroblast growth media from a flask before gently rinsing with sterile PBS. The flask was
then covered in a trypsin/ethylenediaminetetraacetic acid (EDTA) solution and incubated for
5 mins ensuring detachment of all adhered cells. The trypsin was then deactivated through the
addition of 5 ml media and centrifuged at 220 x g for 5 mins. The supernatant was discarded
and the cell pellet dispersed in 3 ml media. A 10 µl sample was removed and diluted in an equal
volume of trypan blue, before addition to a Neubauer haemocytometer. The number of cells in
each quadrant of the haemocytometer was counted and the average was taken to calculate the
cell concentration. The ratio of bright blue alive cells to the dark dead cells was also measured
to determine the cell viability. The concentration was kept at 1 x 106 cells per ml, prior to
dilution in the flask, and the viability was maintained above 95%. The remaining cells not
added to the haemocytometer were seeded into new T75 flasks with 12 ml of fresh media.
The HDF cells were frozen for long term storage by concentrating 2 x 106 cells into a cryovial
with fibroblast growth media and 10% sterile DMSO. The cryovials were then placed into a
Mr Frosty Freezing Container that was filled with IPA and placed in a -80◦C freezer overnight,
before long term storage in liquid nitrogen. Cells were utilized for toxicity assays between 6-12
passages, after which the cells were discarded.
3.7.1 Cell viability assays
Cell viability assays were performed using the WST-1 cell proliferation reagent. The cytotox-
icity of IK8, AuNRs and the 4APM-PEG dithiol hydrogel was assessed on HDF cells. 100 µl
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of fibroblast growth media containing HDF cells in were seeded into a 96-well plate at a con-
centration of 7 x 104 cells per well, before incubation at 37◦C for 24 hours. Post-incubation
the media was replaced with 90 µl of growth media and 10 µl of Milli-Q containing either 32
µg ml−1 of IK8 or 48 µg ml−1 of lipid coated AuNRs and incubated for 24 hours. The media
was then aspirated and the cells were gently rinsed twice with sterile PBS before the addition
of fresh media containing 10% v/v of the cell viability reagent WST-1, and incubated for a
further 2 hours. An equal volume of the media containing 10% v/v WST-1 was added to wells
containing no cells to account for the background absorbance by the WST-1 reagent. The media
was transferred to wells that did not contain cells and the absorbance was measured at 440 and
660 nm. The cell viability is conveyed as a percentage of untreated control cells. The relative
viability was calculated using:
V iability(%) = 100× (OD440nm −OD660nm)Sample − (OD440nm −OD660nm)Background
(OD440nm −OD660nm)Media − (OD440nm −OD660nm)Background
(3.10)
The cytotoxicity of the PEG hydrogel and the PEG gel containing IK8-liposomes and AuNRs
was performed as previously described with the addition of a prefabricated 10 µl gel to the HDF
cells. The gels were fabricated on top of a glass slide wrapped in ParafilmTMtape, such that the
gel droplet formed could slide across the surface. These gels could then simply be tipped into
the wells containing the HDF cells.
3.8 Microbial handling techniques
All microbial handling was performed under sterile conditions in a Monmouth Guardian MSC
T800 biohood (inlet and downflow air velocities of 0.8 and 0.4 m sec−1). Before any microbial
work the biohood was cleaned using Distel disinfectant diluted in Milli-Q, 1:10, and 70% ethanol.
All microbial handling equipment was purchased sterile, autoclaved at 121◦C for 30 mins or
filtered through a 0.2 µm membrane. All equipment entering the hood was coated with 70%
ethanol. Once finished, the biohood was cleaned using 70% ethanol and sterilised with a UV
lamp for 20 mins. The bacteria used for experimentation are S. aureus (NCTC 12981) and P.
aeruginosa (NCTC 12903).
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3.8.1 Preparation of MHB II and MHB agar II plates
All glassware was cleaned with a solution 10% Decon-90 in Milli-Q and placed into a sonic bath
for 30 mins, before rinsing thoroughly with Milli-Q and being left to dry at 80◦C in an oven.
Cation-adjusted Mueller-Hinton broth 2 (MHB II) was prepared by weighing MHB II powder
on a balance scale, 22 g l−1, before pouring into a glass flask. The corresponding volume of
Milli-Q was measured out into a volumetric flask before addition to the MHB II powder. The
mixture was then mixed vigorously until no large agglomerates of the powder remain. The lid
of the flask was then opened such that it was resting on top of the flask and held in place using
autoclave tape. The flask was then autoclaved at 10-15 lbs pressure at 121◦C for 10 mins. Once
cool the lid was screwed tightly and the flask was placed into a 4◦C fridge.
MH agar II plates were prepared by first weighing Mueller-Hinton agar II (MH agar II) powder
into a glass flask, and dissolved in Milli-Q (38 g l−1). Autoclave tape was used to hold the loose
lid in place and the flask was autoclaved at at 10-15 lbs pressure at 121◦C for 10 mins. Once
cool enough to touch, the lid was screwed on and the flask was placed into the biohood. Sterile
petri dishes were then laid out and 15 ml of the MH agar II solution was dispensed into each
dish using a sterile 25 ml polystyrene serological pipette and pipette controller. Any bubbles
in the plate were extracted to ensure a solution of homogenous thickness and smooth surface.
The plate lids were rested on the side of the petri dish, ensuring not to cover more than 25% of
the plate, otherwise condensation began to form as some of the hot liquid evaporated from the
dish. The plates were left to cool for 5 mins until the transparent solution became completely
opaque and was no longer warm, before they were then inverted and placed into a refrigerator
at 4◦C. All agar plates were used within 2 weeks of fabrication and were checked to ensure there
was no condensation on the lids that could in increase chances of infection.
3.8.2 Bacteria growth and making stocks
Frozen bacteria stocks were warmed up until no ice crystals remained in the cryotube. A petri
dish containing MH agar II was placed in the biohood and left for 10 mins to reach room
temperature. 20 µl of the bacteria stock was then added to a spot ∼1 cm from the edge of
the plate. An inoculating loop was then used to drag the solution in a zig-zag pattern across
one quarter of the plate. Another zig-zag pattern crossing the first was drawn into the quarter
adjacent to the end of the first. This was repeated until all four quarters had been inoculated.
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The dish was then inverted and placed into a 37◦C incubator overnight. The following morning
3-5 isolated colony forming units (CFUs) were touched with a pipette tip and placed into 10
ml of MHB II. The suspension was incubated at 37◦C and shaken at 300 rpm for 6 hours. The
bacteria suspension then diluted in MHB II to achieve an optical density at 600 nm (OD600)
of 0.07. An OD600 value of 0.07 correlates with a turbidity of 0.5 McFarland standard, as
ascertained using a Pro-lab diagnostic latex bead standard, which is comparable to a bacterial
suspension of approximately 1.5 x 108 CFU ml−1. 0.9 ml of the bacteria suspension was then
added to a cryovial followed by 0.1 ml 100% sterile glycerol. The solution was then slowly mixed
and added to a -80◦C freezer.
3.8.3 MIC testing and CFU quantification
The minimum inhibitory concentration (MIC) of a drug is the concentration of antimicrobial
required to completely inhibit any visible growth of a bacteria in solution over an 18-hour
incubation. MICs are widely used to determine resistance development and to determine the
efficacy of an antimicrobial agent in vitro.
A frozen bacteria stock was grown to 0.5 McFarland standard, as described in Section 3.8.2,
before a further 100-fold dilution in MHBII. The antimicrobial agent was dissolved into sterile
PBS at 20 times the highest concentration required for testing on the bacteria, before being
diluted ten times in MHBII. A serial dilution in MHB II was then performed, halving the
antimicrobial concentration at each dilution. 0.1 ml of the bacteria suspension and 0.1 ml of the
antimicrobial agent solution were mixed in a corning costar 96-well plate, six repeats were made
for each concentration. Controls containing 10% PBS and 100% MHB II with no drug ensured
the PBS did not affect bacteria proliferation, while wells containing 0.2 ml of bacteria-free MHB
II ensured handling procedures were aseptic. The OD600 values were measured immediately after
treatment and after an 18-hour incubation at 37◦C. The MIC was determined as the minimum
concentration of antimicrobial that showed no increase in the sample OD600, indicating that
there is no increase in turbidity and in turn no bacteria proliferation.
To quantify the number of CFUs, all bacteria suspensions treated with the same concentration
of antimicrobial were collated and mixed. This solution was then subjected to a ten-fold serial
dilution six times. On the reverse of a sterile MHBII agar plate a cross was used to divide
the plate into 4 equal sections, each labelled to indicate each dilution between 103 and 106. 20
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µl of the corresponding bacterial sample dilution was added to each section and, using sterile
L-shaped spreader, spread evenly across the segment. This was performed in triplicate for each
sample. The sample plates were then inverted and placed into an incubator at 37◦C for 18
hours, a blank plate that was not inoculated with bacteria was incubated alongside the sample
plates to ensure no wild bacteria contaminated the plates. The following day the number of
individual CFUs in each section was counted and the quantity of bacteria was calculated using
CFUml−1 = CFUs×Dilutionfactor × 50 (3.11)
Distel disinfectant diluted 100 times was added to contaminated plates and falcon tubes to kill
of any remaining bacteria. This was left for 24 hours before the dead bacteria were poured
down the sink and the tubes and petri dished autoclaved before disposal.
3.8.4 Treatment of bacteria with IK8-liposomes in suspension
Bacteria were grown to 0.5 McFarland standard and diluted a further 100 times. IK8-liposomes
were diluted in MHB II and a serial dilution was performed halving the concentration of IK8
from 16 to 2 times the MIC. Lipid coated AuNRs were diluted to 192 µg ml−1 in MHB II.
50 µl of both the AuNRs and IK8-liposomes were mixed and added to 100 µl of the bacteria
suspension in a 96 well plate. The plate was then placed in an incubator, preheated to 37◦C and
shaking at 300 rpm, for 1 hour before being irradiated at 860 nm for 10 mins at laser intensities
between 1.8 - 2.8 W cm−2. The sample OD600 values were measured and the plate was then
placed back into the incubator for 18 hours. The OD600 was again measured to provide and
indication of the bacteria proliferation before the bacteria was collated for quantification of
viable CFUs ml−1 using microdilution and agar plating techniques.
3.8.5 Treatment of bacteria with IK8-loaded liposomes and AuNRs within
a hydrogel
Three distinct gels were fabricated in order to test different antimicrobial properties properties.
A gel containing only AuNRs was used to test the antimicrobial effects of photothermal heating.
The second gel contained AuNRs and the MIC of free IK8, to demonstrate the antimicrobial
effects of the AMP when delivered alongside the photothermal heating. The third gel contained
AuNRs and IK8-loaded liposomes, to demonstrate the triggered delivery of the AMP. All gels
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were fabricated into wells of a 96-well plate to a total of 50 µl. The wells were topped up to
100 µl with MHB II before the addition of 100 µl of bacteria, 1x106 CFU ml−1. After 1 h of
incubation wells were irradiated with 860 nm laser, at intensities between 1.8 and 2.8 W cm−2,
for 10 min. The plate was then incubated overnight before quantification of the bacteria CFU
ml−1. The treated bacteria was then compared to the concentration of bacteria in an untreated
control sample in order to determine the number of log reductions in viable bacteria.
3.8.6 Repeated treatment of bacteria with an IK8-loaded liposomes and
AuNR containing hydrogel
This experiment was performed similarly to that described in section 3.8.5. Hydrogels containing
2.5 x MIC of IK8 and AuNRs were fabricated into a 96-well plate. They were then innoculated
with 100 µl of 100 times diluted 0.5 McFarland standard of bacteria and the well was topped
up to 200 µl with MHB II. After incubation for one hour the wells were irradiated at 2.1 or 2.4
W cm−2 for 5 mins. The plates were then left to incubate for 18 hours before measuring the
change in OD600 value and the subsequent removal of the bacteria suspension for quantification.
Instead of treating the gels with Distel, they were rinsed with 150 µl of sterile PBS before being
inoculated with 100µl of fresh bacteria (1x106 CFU ml−1) and left to incubate for an hour. The
samples were then irradiated for 10 mins, ensuring the same laser intensity over both treatments.
The plates were then left to incubate for another 18 hours before the second batch of bacteria
was removed for quantification.
3.8.7 Pulsed laser induced release of IK8 for the treatment of S. aureus
Equal volumes of IK8-loaded thiol-functionalised liposomes (DSPC/cholesterol/DSPE-mPEG2k
/DPPE-Ptd, 67/30/2/1 mol% at 10 mg ml−1) and maleimide-functionalsied phospholipid AuNRs
(DSPC/DSPE-mPEG2k/DSPE-mPEG2k-maleimide, 95/4/1 mol% at 200 µg ml−1) were mixed
and left overnight. The following day the sample was pelleted (9,000 g, 30 mins) and dispersed
in fresh Milli-Q. The AuNR-liposome complex was then added to a quartz curvette, that had
been sterilised with a 70% ethanol solution and allowed to dry in a biological hood. The sam-
ple was then irradiated for 10 mins at a fluence of 450 µJ cm−2 with a repetition rate of 10
Hz at 738 nm. The Sample was then diluted in MHB II to approximately 4 times the MIC
of IK8 against S. aureus. 100 µl of the sample was then added to a 96-well plate along with
an equal volume of MHB II containing 0.5 McFarland standard of S. aureus diluted a further
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100 times. Control samples of IK8-loaded liposome-AuNR complexes, the IK8-loaded thiolated
liposomes and maleimide-functionalised phospholipid AuNRs (100 µg ml−1) were also added
to the bacteria to determine whether the system itself affected the S. aureus viability without
the pulsed laser irradiation. The samples was then left to incubate for 18 hours before a serial
microdilution was performed and the bacteria samples spread onto MH II agar plates. The next
day the number of CFUs was counted.
3.9 Statistical analysis
All statistical analysis was performed using two-tailed student’s t-testing. Results where consid-
ered as statistically significant when P < 0.05, all significant results are denoted with asterisks
with the probability range denoted in the corresponding figure caption. Unless otherwise stated
error bars indicate the standard deviation.
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Synthesis and characterisation of
gold nanorods
Some of the content within this chapter can be found within the following the following publi-
cation:
L. Roach et al. 2018. ‘Morphological control of the seedless synthesis of gold nanorods using
binary surfactants’ in Nanotechnology 29:359501
Motivation:
Throughout this thesis gold nanorods (AuNRs) have been utilised as photothermal agents to
produce heating effects that can provide triggered delivery of antimicrobial peptides. AuNRs
have been chosen as they provide the highest absorption cross-section of any gold nanoparticle
(AuNP). This provides highly efficient photothermal light-to-heat energy conversion which,
coupled with the ease of surface functionalisation and tunable optical properties, make AuNRs
ideal for medical applications.
In this chapter we will discuss the controlled synthesis of AuNRs, the replacement of the sta-
bilising centrimonium bromide (CTAB) and sodium oleate (NaOL) with phospholipids, and
the photothermal properties of AuNRs under continuous wave laser irradiation. AuNR char-
acterisation was performed using UV-vis spectroscopy, TEM imaging and atomic absorption
spectrometry. We will also compare the surface functionalisation on AuNR colloidal stability
in different media and determine their toxicity against S. aureus.
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4.1 Binary surfactant AuNR synthesis
The one-pot synthesis of the binary surfactant AuNRs was based upon work from Lai et al.
(2014), however the work presented in this thesis expands upon the range of surfactants in order
to demonstrate morphological control over the AuNRs.208,328 The AuNR synthesis protocol is
described in detail in section 3.3.1. The AuNRs were synthesised in a solution containing the
surfactants CTAB and NaOL, the mild reducing agent ascorbic acid (AA) and silver nitrate.
Initially, a HAuCl4 solution was added to the surfactant mixture turning the solution a dark
yellow as the CTA+ molecules started to form complexes with the [AuCl4]
− ions.329 To this
solution NaHO3, HCl and ascorbic acid (AA) were sequentially added. Upon the addition
of AA the solution became transparent as the Au3+ ions were reduced to Au1+. The final
rapid injection of ice-cold NaBH4 caused an initial red plume as the strong reducing agent
reduced the Au+1 to Au0, causing the rapid nucleation of nanospheres that form the seeds
from which the anisotropic deposition of gold occurs to form AuNRs. The solution was then
maintained at 30◦C for 4 hours, during which time the characteristic brown AuNR colouration
developed. The AuNR suspension was then pelleted using centrifugation (9,000 x g, 30 mins),
and the supernatant was removed and replaced with Milli-Q. The solution could then be stored
for several months before use, with very little change to the AuNR optical properties. The
binary surfactant bilayer stabilising the AuNR however required replacement or coating with
polyelectrolytes due to the propensity of the NRs to aggregate after more than one centrifugal
cleaning step, Figure 4.1D. In order for CTAB and binary surfactant AuNRs to retain colloidal
stability a critical ratio of 740,000:1 of CTAB molecules in solution to AuNRs is required, after
one cleaning step CTAB-NaOL stabilised AuNRs demonstrated no change in optical properties
18 months after synthesis, Figure 4.1E.330 As the amount of excess CTAB is solution is reduced
with each pelleting cycle CTAB is removed from the AuNR surface to equilibriate with the
surrounding medium causing a decrease in the AuNR zeta-potential that contributes to the
aggregation.331 The binary surfactant AuNRs had zeta-potentials of +68.5 ± 13.4 mV, +31.6
± 12.3 mV, +22.0 ± 4.2 mV after the first, second and third cleaning step.
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40 mM CTAB, 20 mM NaOL
47.5 mM CTAB, 20 mM NaOL
47.5 mM CTAB, 15 mM NaOL
60 mM CTAB, 15 mM NaOL
60 mM CTAB, 12.5 mM NaOL























 AuNRs post fabrication
 AuNRs 18 months later
Figure 4.1: A) The longitudinal absorbance peak of AuNRs could be finely controlled by varying
the concentration of CTAB and NaOL. B) AuNR production could be scaled up to 0.5 litres,
with little detriment to the particle quality. An image of after the 0.5 litre synthesis is inset.
C) Absorbance spectra of 2 different batches of AuNRs made with the same CTAB to NaOL
concentrations. D) The effects of centrifugal cleaning upon binary surfactant AuNR stability.
E) Absorbance spectra of AuNRs immediately after synthesis (solid black) and after 18 months
(dashed grey).
This synthesis process was found to be highly versatile, allowing fine tuning of the longitudinal
plasmon band between between 650-1,000 nm, Figure 4.1A, by controlling the concentrations of
CTAB and NaOL in the growth solution. In general, as the CTAB to NaOL ratio increased the
longitudinal plasmonic peak was red shifted. The protocol also exhibited excellent reproducibil-
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ity, Figure 4.1C, and scalability with the maximum synthesis attempted at 0.5 litres, Figure
4.1B, this was only limited by the volume of the receptacles available.
The control of the longitudinal plasmon peak through varying the concentrations of CTAB and
NaOL was extensively investigated by L. Roach.208 Figure 4.2A plots the longitudinal surface
plasmon peak absorbance as a function of the surfactant concentrations, depicting a region
with high AuNR yield (>98%), between 27.5-70 mM CTAB and 12.5-20 mM NaOL. Beyond
this parameter space the sample quality diminishes rapidly. Using TEM imaging, the effect
of the ratio of surfactants upon the AuNR dimensions was investigated. Firstly, Figure 4.2B
depicts that an increasing CTAB to NaOL ratio produced a significant increase in the AuNR
length, whereas only a small increase in the width. This resulted in AuNRs with aspect ratios
of ∼2.5 and ∼3.0, at 1:1 to 3.5:1 CTAB:NaOL ratios respectively, correlating to plasmonic
absorption peak wavelengths at 650 and 800 nm; meaning an increase in the AuNR aspect
ratio produced a red-shift in the longitudinal peak. The validity of these results is reinforced
by observing the converse conditions, as shown in Figure 4.2C. Increasing the NaOL to CTAB
ratio from 1:5 to 2:5 produced a decrease in the aspect ratio from ∼4.0 to ∼2.7, which correlated
to peak wavelengths of 900 and 725 nm respectively. The observed increase in the aspect ratio
producing a red-shift in the longitudinal absorption peak is in line with the literature.332,333
The significant effects on the AuNR dimensions by utilising binary surfactants as opposed to
CTAB alone are attributed to an increased packing density within the bilayer. The inclusion of
anionic NaOL into a CTAB bilayer screens the electrostatic repulsion between cationic CTAB
headgroups, decreasing the area per molecule. The increased bilayer packing density decreases
the Au ion permeation, and given studies of the molecular dynamics of CTAB indicate similar
densities on the {100} and {110} facets (i.e. both the AuNR sides and ends), the growth rate is
reduced isotropically. The lateral Au deposition is already blocked by the Ag layer on the sides
of the AuNR meaning the growth rate at the ends of the rod is reduced to a greater extent than
on the sides; the higher the NaOL to CTAB ratio the smaller the aspect ratio.
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A) B) 
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Figure 4.2: A) The effect of the CTAB and NaOL surfactant concentrations upon the longitu-
dinal plasmon absorbance wavelength, holding all other components constant. The AuNR yield
for each synthesis is denoted by the shape of the point;  >98% AuNRs,© >90% AuNRs and 
<90% AuNRs. B) The morphological effects of varying the CTAB concentration, whilst holding
NaOL constant at 17.5 mM. Black points represent the AuNR length along the major axis and
red points are the AuNR width along the minor axis. C) The effect on AuNR length (black)
and width (red) when holding the CTAB at 48 mM and varying the NaOL concentration.208
Figure created by Dr. Lucien Roach.
4.2 Phospholipid replacement of binary surfactants as stabilis-
ing agents on AuNRs
CTAB is essential for promoting the anisotropic growth of AuNRs and therefore has been used in
the initial synthesis. However, it has been found that CTAB stabilised AuNRs are not suitable
for biological applications, demonstrating high levels of toxicity against both bacterial and
mammalian cells.334–337 CTAB derives its toxicity from two effects; 1) the cationic surfactant
can interact with phospholipids to disrupt biological membranes, 2) the CTA+ molecule can
halt/stop the production of the ATP synthase enzyme thereby inhibiting ATP production and
eventually leading to cell death.338–340 Biocompatible alternative surfactants (e.g. peptides)
demonstrate potential as directional agents to induce the uniaxial growth of AuNRs however
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further synthesis optimisation is required before these are viable.341 As such, to reduce toxicity
of the CTAB-coating a surface ligand exchange is performed to replace the CTAB layer with
more biocompatible phospholipids. Phospholipids are a key component within the cellular
membrane and are widely regarded as non-toxic.342 Zwitterionic PC lipids are commonly the
most abundant lipid used in particle coating, however a mixture of PC and cationic or anionic
charged lipids is usually required to prevent aggregation.343 In our liposome-AuNR system we
are attempting to keep both components neutrally charged so as to reduce interactions with
both the delivered AMP and the bacteria itself. As such, we decided to include PEGylated-PE







Figure 4.3: A) The absorbance spectra of AuNRs before (solid line) and after (dashed line) the
phospholipid replacement of the binary surfactant bilayer. B) TEM image of AuNRs after the
surface exchange of the binary surfactants CTAB-NaOL with DSPC:DSPE-PEG2k. C) The
length (left) and width (right) distributions of the phospholipid coated AuNRs (n= 431).
The phospholipid surface exchange protocol was based on that of Matthews et al., the key
difference being the sonication time was significantly increased.345 Briefly, 1 ml samples of
AuNRs (75 µg ml−1) cleaned once through centrifugation were pelleted a second time and
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dispersed into 300 µl of a 10 g L−1 SUV suspension (<100 nm) comprised of DSPC:DSPE-
PEG2k (19:1 mol ratio). The suspension was then placed into a cooled bath sonicator for
24 hours. This process was repeated three times, after the final sonication the sample was
pelleted and dispersed into Milli-Q. Absorbance spectra and TEM images of the lipid coated
AuNRs show no aggregation or morphological changes were induced through the replacement
procedure, Figure 4.3A and C, indicating a successful exchange with the CTAB-NaOL bilayer,
which otherwise would have demonstrated considerable aggregation after just two centrifugation
cleaning steps. The phospholipid surface exchange protocol also showed little effect on the
optical properties of the AuNRs, Figure 4.3B.
4.3 Colloidal stability of phospholipid stabilised AuNRs in Mueller-
Hinton Broth II
To determine whether the phospholipid surface functionalisation could enhance the stability of
the AuNRs in biologically relevant media the DSPC:DSPE-PEG2k AuNRs were added to MHB
II and the UV-vis spectra was measured after 24 hours. The lipid coated rods demonstrated no
significant change in their optical properties, retaining the peak absorption at 860 nm, Figure
4.4. This compared favourably with the cationic CTAB-NaOL coated AuNRs, which rely upon
electrostatic repulsion for stability, which showed substantial aggregation, indicating that steric
hindrance, associated with the lipid coating, offers is a more effective means of ensuring stability.
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Figure 4.4: The absorbance spectrum of binary surfactant and lipid-coated AuNRs after incu-
bation in Milli-Q or MHB II for 24 hours.
4.4 AuNR toxicity to S. aureus
The AuNR effects on bacteria viability were next investigated. CTAB-NaOL, poly(styrene
sulfonate) (PSS) and phospholipid coated AuNRs at gold concentrations between 16-250 µg
ml−1 were added to S. aureus suspensions and incubated for 18 hours. The samples were then
centrifuged at 200 x g for 5 mins to pellet the bacteria, the AuNRs in the supernatant were then
discarded and the pellet redispersed in 200 µl of MHB II. This process was repeated thrice. The
optical density of the S. aureus suspension was then measured at 600 nm (OD600) to determine
whether the AuNRs affect the bacteria proliferation. The OD600 is used to determine the
concentration of a bacteria sample at low densities where the bacteria grow linearly, bacteria do
not absorb light at 600 nm meaning the OD600 is related purely to scattering effects. Therefore,
in the linear growth region the bacterial concentration is linearly proportional to the OD600.
As predicted the CTAB-NaOL coated AuNRs demonstrated the highest toxicity with inhibition
of growth at 63 µg ml−1, Figure 4.5. The PSS coated AuNRs, included to observe whether
the AuNRs stabilised with an anionic polymer showed any difference to the cationic CTAB,
exhibited increasing antimicrobial effects on the S. aureus proliferation with Au concentration,
however the minimum inhibitory concentration was not reached. The phospholipid coated
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AuNRs only started to affect the bacteria proliferation at 250 µg ml−1, clearly indicating that
the phospholipid coating was less toxic than the alternatives and that non-toxic concentrations






















Figure 4.5: The change in optical density of S. aureus bacteria when incubated with increas-
ing concentrations of CTAB-NaOL (diagonal slashed), PSS (hashed) and phospholipid (grey)
stabilised AuNRs for 18 hours. Results are the average of 6 replicates.
The phospholipid stabilised AuNRs offer lower toxicity to mammalian cells, increased colloidal
stability in ionic media, a substantial change in zeta-potential (+60 mV to ∼-2-4 mV), and a
lack of antimicrobial activity, compared to the binary surfactant AuNRs; this indicates that
the vast majority of the positively charged and toxic CTAB has been removed from the AuNR
surface. As such, the phospholipid AuNRs enable the study of the antimicrobial effects of
delivered AMPs and photothermal heating without the particles affecting the bacteria viability.
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4.5 Photothermal heating from phospholipid coated AuNRs
A) B) 
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Figure 4.6: A) The temperature of a 200 µl solution containing increasing concentrations of
gold, when irradiated at 860 nm for 10 mins at 0.3 W cm−2 (squares), 1.0 W cm−2 (circles) and
2.1 W cm−2 (triangles). B) The photothermal heating profile when 200 µl of AuNRs at 90 µg
ml−1 was irradiated at 860 nm, for 10 minutes at 1 W cm−2, starting from a base temperature
of 37◦C. The dashed line indicates 55◦C, the Tm of DSPC.
The photothermal heating generated from the phospholipid coated AuNRs was investigated in
order to ensure that the the phase transition temperature of DSPC could be reached, 55◦C, to
trigger the release of encapsulated materials. Liposomes exhibit maximum release of encapsu-
lated materials 1-2◦C below the phase transition temperature of the vesicle, due to enhanced
small molecule permeability at the grain boundaries between the different lipid phase domains.
As such, the Au concentration and laser intensities were optimised to determine how each pa-
rameter affected the maximum photothermal temperature increase.346–348 200 µl of AuNRs was
added to the wells of a clear bottom 96-well plate and irradiated with a continuous wave laser
at 860 nm (the longitudinal plasmon peak) with intensities between 0.3-2.1 W cm−2 for 10
mins. Thermocouples were placed in the wells in order to observe the temperature increase
and to ensure that the solutions all started at a base temperature of 37◦C. It was found that
after 5 mins of irradiation the bulk temperature within the well would be close to the maximum
temperature achievable at a given AuNR concentration and laser intensity, and as such could
be maintained within ± 1◦C of a target temperature for a further 5 mins, Figure 4.6B. Initially
AuNRs were irradiated at 0.3 W cm−2, the ANSI laser intensity limit for the application of
a continuous wave laser directly to the skin for 10-1000 s, however even at 300 µg ml−1 of
AuNRs the maximum temperature that could be reached was 46◦C, significantly lower than the
phase transition temperature of DSPC, Figure 4.6A.349 Increasing the laser intensity to 1 W
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cm−2 and above showed a significant increase in achievable temperatures, such that using laser
intensities of 1 and 2.1 W cm−2 heating to 55◦C was achieved upon irradiation AuNR solutions
of 90 and 35 µg ml−1 respectively. It is preferable to utilise a higher laser power with low Au
concentrations to obtain a desired photothermal mediated temperature increase as this could
potentially reduce both the system toxicity and the cost of fabrication.
Conclusion
In this chapter we have described the one-pot synthesis of binary surfactant stabilised AuNRs,
with tunable optical absorption properties, and exceptional scalability and reproducibility. We
also demonstrate the replacement of the binary surfactant coating with phospholipid bilay-
ers of DSPC/DSPE-mPEG2k (95 mol%) with little detriment to the optical properties. The
steric hinderance provided by the PEGylated lipids within the phospholipid coating provided
enhanced stability in Meuller-Hinton broth II compared to AuNRs stabilised through electro-
static repulsion provided by CTAB. The lipid stabilised AuNRs also exhibited only a small
decrease in S. aureus viability even at the highest concentration of AuNRs, 250 µg ml−1 of Au,
compared to binary surfactant that induced complete bacteriostatic effects at 63 µg ml−1, and
PSS stabilised AuNRs that showed a significant reduction in bacteria viability at Au concen-
trations of 125 µg ml−1 and above. Finally, the photothermal heating effects from the AuNRs
achieved a maximum temperature of 70◦C that at a laser intensity of 2.1 W cm−2. The pho-
tothermal heating profile of the AuNR solution demonstrated a rapid temperature increase for
the first five minutes followed by a < 2◦C increase over the following five minutes, meaning the
temperature can be controlled to within ±1◦C of a target temperature by varying the AuNR
concentration.
The superior colloidal stability and biocompatibility of phospholipid stabilised AuNRs meant
that these particles where taken forward for inclusion in within the photothermal responsive
triggered delivery systems developed in the future results chapters.
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Some of the content within this chapter can be found within the following the following publi-
cations:
S. C. T. Moorcroft et al. Nanoparticle-Loaded Hydrogel for the Light-Activated Release and




Despite the significant advantages of AMPs over traditional antibiotics their clinical transla-
tion has been hindered by their instability in vivo, susceptibility to proteolytic degradation
and toxicity.351 As such, we propose the use of a liposomal delivery system to offer spatial and
temporal control over the release of AMPs, alleviating the issues of instability in ionic media,
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reducing systemic toxicity by both encapsulating the drug and decreasing the administered con-
centration, whilst providing protection against proteases. The incorporation of human pancre-
atic polypeptides into sterically-stabilised lipid micelle has previously demonstrated protection
against protease degradation, with the micelle providing approximately a 2.5-fold enhancement
of the peptide stability when in the presence of the proteolytic enzyme trypsin.319,352 It is hy-
pothesised that the encapsulation of AMPs within the aqueous core of liposomes would provide
a similar protective effect whilst utilising the many benefits of liposomes such as; the potential
for high encapsulation efficiency, biocompatibility, increased drug bioavailability and versatility
to incorporate different functionalities by varying the lipid composition.353–355 Liposomal drug
delivery can be achieved through stimuli-responsive triggered release where a large dose of the
drug is released rapidly in response to an exogenous stimulus or a change in the environmental
conditions. Whilst there are benefits of using both means of release, triggered delivery offers a
greater degree of spatial and temporal control over the release kinetics.356–358 This is advanta-
geous when delivering antimicrobials as it minimises premature leakage into healthy peripheral
tissue and reduces the chances of delivering sub-lethal doses to local microflora that can increase
the likelihood of the bacteria developing resistance.84 Whilst many exogenous stimuli-responsive
systems have been developed for anticancer chemotherapeutics, to our knowledge no such sys-
tems have been adapted for the delivery of AMPs to treat bacterial infections. The unique
properties of inorganic NPs in response to exogenous stimuli (magnetic fields for iron oxide NPs
and light irradiation for Ag, Cu and Au NPs), mean that the incorporation or co-delivery of
antimicrobial-loaded soft matter systems can offer a simple means of stimuli-responsive release.
Traditionally, stimuli-responsive mechanisms have been integrated into a soft matter systems
through the inclusion of responsive-biomaterials and -polymers, however such materials can be
difficult to synthesise, the scaling-up of production can be challenging and the intrinsic proper-
ties of the delivery system may be compromised.359–361
This chapter will discuss the development of leakage free liposomes that release encapsulated
cargoes in the presence of bacteria when heated to their gel-fluid phase transition tempera-
ture (Tm). These liposomes are subsequently loaded with IRIKIRIK-CONH2, a model AMP,
to demonstrate protection against protease degradation and, upon mixing with phospholipid
stabilised gold nanorods (AuNRs), elicit bactericidal activity under laser induced photothermal
heating, see Figure 5.1. Furthermore, this system was used to investigate the potential for pho-
tothermal killing of bacteria and whether it can be used in conjunction with the AMP delivery,
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as a combination therapy.
AMP triggered release + Photothermal killing 
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Figure 5.1: : Schematic representation of the AMP-loaded liposome and gold nanorod system,
to provide bactericidal activity against S. aureus through AMP triggered release at low laser
intensities (bottom left), photothermal killing at higher laser in the absence of AMPs (bottom
right), and a combination treatment of triggered AMP release and photothermal killing at higher
laser intensities (bottom centre).
5.1 Optimising the liposome fabrication protocol
The initial liposome composition, DSPC/cholesterol/DSPE-PEG2000 (65/30/5 mol%), was
based on work described by Ron-Doitch et al. (2016) where the AMPs LL-37 and indoli-
cidin were encapsulated within liposomes that demonstrated no aggregation over a year post
fabrication.119 This lipid formulation is also similar to work by Thet et al. (2013), whereby
vesicles of DSPC/cholesterol/DPPE (68/30/2 mol%) show high resistance to dye leakage in-
duced by S. aureus.362 Phosphatidylcholine lipids are commonly utilised as the most abundant
lipids in these formulations due to their inertness, bio-compatibility and well defined physical
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properties.363 DSPC in particular proved to be popular in drug delivery systems due to its long
(18 carbon) and saturated hydrocarbon tails that decrease liposome permeability by increasing
the bilayer thickness and providing high lipid packing densities, compared to their unsaturated
counterparts.364 Increasing the chain length of hydrocarbons also increases the gel-fluid phase
transition temperature, and reduces leakage of encapsualted materials in the presence of bacte-
ria.365,366 Cholesterol was included within the liposomes to stiffen the lipid bilayers and in turn
reduce premature leakage. Cholesterol sits within the alkyl chains of the lipids, increasing the
ordering and decreasing passive leakage.367–369 The DSPE-PEG2000 provides steric hindrance
between the liposome and foreign objects, increasing their colloidal stability. The inclusion
of hydrophilic chains also has shown to increase in encapsulation efficiency of polar materials
within the liposome lumen.370
The first step in optimising the liposome formulation process was to determine how the ho-
mogenisation step affected the liposome size and dispersity. The liposomes were fabricated
using the conventional thin-lipid film hydration technique, whereby a lipid film was hydrated
with a buffer and mixed for an hour whilst maintained at above the phase transition temper-
ature of the most abundant lipid (DSPC, Tm= 55
◦). This forms a polydisperse suspension of
multilamellar vesicles (MLVs) that require homogenisation, which is primarily achieved through
mechanical agitation using ultrasound waves or by extrusion through a porous membrane. Li-
posomes comprised of DSPC/cholesterol/DSPE-PEG2000 (65/30/5 mol%) were placed into an
ultrasonic bath or tip sonicated for 10 mins and the resulting liposomes had diameters of 150
± 30 nm and 80 ± 20 nm, respectively. Liposomes homogenised using extrusion were passed
through a 0.4 µm polycarbonate membrane 7, 11 or 15 times to investigate whether the number
of extrusion steps influenced the size distribution of the resultant liposomes. The liposomes
were sized using Nanosight.
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Figure 5.2: Liposome size when varying the number of times the solution is passed through a
400 nm extrusion membrane. Results are the average of 3 independent experiments.
Table 5.1: The proportion of liposomes the are below 250 nm, between 250 to 400 nm and
above 400 nm, depending on the number of times the solution was passed through a 400 nm
membrane.
No. of extrusion steps < 250 nm 250 - 400 nm > 400 nm
7 11% 42% 47%
11 18% 60% 22%
15 38% 58% 4%
The Nanosight data, Figure 5.2, depicts three distinct liposome populations with peaks between
100-200 nm, 250-400 nm and 400-600 nm. The proportion of liposomes in each size bracket is
dependent upon the number of extrusion steps, Table 5.1. The largest proportion of liposomes
fall within 250-400 nm for samples that had been extruded 11 or 15 times, 60% and 58% respec-
tively, whereas the sample extruded 7 time had the highest proportion of liposomes between
400-600 nm, 47%. The proportion of liposomes larger than 400 nm was seen to decrease sig-
nificantly with a 43% reduction between 7 and 15 extrusion steps, clearly indicating that the
liposomes larger than the membrane pore size are being disrupted. Conversely, the number
of liposomes smaller than 250 nm was seen to increase with the number of extrusion steps.
These results are in agreement with the extrusion model described by Patty et al. (2003) where
the liposome homogenisation is modelled upon the motion of bubbles blown through a circu-
lar orifice.371 The model claims that MLVs larger than the pore diameter clog the membrane
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until the shear forces acting upon the vesicle cause the surface tension to surpass the rupture
tension. This rupturing causes the outer layers of the vesicle to become detached and reform
into new liposomes, repetition of this process causes the formation of unilamellar vesicles. The
proportion of liposomes beneath the membrane pore size, 400 nm, is seen to increase with the
extrusion steps as the larger liposomes are broken up the lipids reform into vesicles smaller
than the membrane pore size. The proportion of liposomes in the 250-400 nm region does not
however increase going from 11 to 15 extrusion cycles, this is attributed to the majority of the
lipids detached from the largest liposomes reforming into liposomes significantly smaller than
the pore size. As such, all further liposomes were formulated using 11 extrusion steps in order
to provide maximum control over the vesicle size.
5.2 Optimising liposome composition to reduce leakage and in-
crease thermoresponsive release efficacy
In order to ensure that the liposome formulation was optimised such that the cholesterol content
and the ratio of DSPC to DPPC were investigated to determine how this affected the stability,
leakage and size.
5.2.1 The effects of cholesterol on liposome leakage
Cholesterol was investigated first due to it’s ability to regulate the membrane fluidity and
mechanical strength, which in turn affects the membrane permeability.368 Cholesterol increases
the structural integrity of a bilayer by sitting within the hydrocarbon chains. When present in
high concentrations this can introduce conformational ordering of the lipid chains that reduces
the membrane permeability, Figure 5.3. The cholesterol content within the vesicles was varied
between 0-30 mol% to identify whether there is an optimum proportion at which there is little
leakage at physiological temperatures (37◦C), but still provide release of encapsulated materials
when heated to the liposome gel-fluid phase transition temperature. The leakage was assessed
by encapsulating the self-quenching dye calcein within the liposome lumen and determining the
fluorescence increase upon release.
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Figure 5.3: A schematic representation of cholesterol-free and -rich liposomes, loaded with the
self-quenching dye calcein, as well as the effects that cholesterol imparts on the lipids within a
bilayer and how this affects the membrane permeability.
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Figure 5.4: A) Calcein leakage from liposomes containing varying amounts of cholesterol when
incubated at 37◦C in MHB II. B) Calcein leakage of from liposomes when incubated in MHB
II initially containing 1x106 S. aureus CFU ml−1. Results are the average of 6 replicates.
The calcein leakage from liposomes maintained at 37◦C for 4 days showed a dependence upon
the cholesterol content, Figure 5.4A. As the cholesterol content was increased from 0 to 30 mol%
the amount of leakage was seen to decrease from 100% to 2% > leakage after 4 days. An increase
in the cholesterol content also resulted in a decrease in the calcein leakage when incubated with
a S. aureus suspension, however significant leakage was observed in all samples, Figure 5.4B.
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The liposomes containing 30 mol% cholesterol exhibited leakage of 24% and 64% after the first
and second days respectively. Pathogenic bacteria are known to secrete an array of virulence
factors and pore forming toxins that target the lipid membranes of mammalian cells,372–374
and as such are known to induce leakage from liposomes.362,375–377 This induced leakage may
be unavoidable but minimising premature release is important to ensure the system maintains
antimicrobial efficacy, as well as limiting the release of sub-lethal doses that could driving
resistance development, ultimately rendering the treatment futile.
The 30% cholesterol liposome leakage was also assessed in a variety of environments. The vesi-
cles were incubated at 37◦C in PBS, a 5mM IK8 solution in PBS and 5x103 human dermal
fibroblast (HDF) cells in fibroblast growth media, the fluorescence was measured daily. HDFs
were chosen due to there abundance in the wound healing environment, contributing to the reep-
ithelialisation process by forming an extracellular matrix to aid wound closure, and regulating
both inflammatory and proliferative stages of wound healing.378
Figure 5.5: The leakage from calcein-loaded liposomes was determined by measuring the sample
fluorescence when incubated at 37◦C in PBS (squares), 5 mM IK8 (circles), and human dermal
fibroblasts (HDF, triangles). Error bars indicate standard deviation (n=6).
The 30% cholesterol liposomes demonstrated negligible leakage after 4 days in all of the en-
vironments, Figure 5.5. When incubated with 5 mM IK8 in PBS negligible leakage, <1% is
observed indicating that the IK8 does not interact with liposomes, clearly indicating that min-
imal liposomal disruption by IK8 occurred when encapsulated within the liposome lumen. It is
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also important that the HDF cells did not induce leakage, < 5% after 4 days, as this means that
the cells will not cause premature leakage upon implementation of this system into a wound
dressing.
These results indicate that liposomes with higher cholesterol content are preferable due to its
affects on the liposome permeability, both with and without bacteria. The enhancement of the
membrane structural properties can however be detrimental to the lipid thermoresponsivity.
Lipid bilayers can exist in two states; a gel phases, below the Tm, where interactions between
the hydrocarbon chains are dominated by Van der Waals interacting reducing lipid mobility,
and a fluid phase, above the Tm, where lipid molecules have enough kinetic energy to overcome
these interactions and become highly mobile. In the fluid phase the hydrocarbon chains be-
come more disordered leading to a reduction in bilayer thickness and an enhanced membrane
permeability.379,380 However, the highest rate of release is observed at the liposome the phase
transition temperature.346 This is attributed to the increased permeability at the boundaries
between the gel and fluid phase domains. At temperatures slightly below the phase transition
temperature there are a large number of small isolated domains with a large perimeter and as
such maximising the total regions where permeability is highest.347,348
5.2.2 The effect of cholesterol on liposome thermo-responsive release
To obtain thermal release profile of the liposome compositions the vesicles were loaded with
calcein and the fluorescence was measured after 5 mins of incubation at 25◦C before repeating
this process raising the temperature in 5◦C increments up to 60◦C, Figure 5.6B. 1% Triton
X-100 was added to control samples to ascertain the maximum fluorescence value, and to all
test samples to ensure the calcein fluorescence was not affected during the heating.
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Figure 5.6: A) The thermal release profile of calcein encapsulated within liposomes containing
varying concentrations of cholesterol. Liposomes were heated from 25-60◦C in 5◦C increments
measuring the fluorescence after 5 mins at each temperature. Results are the average of 6 repli-
cates. B) The corresponding thermal profile within the wells when increasing the temperature
within the incubator.
Figure 5.6A displays the the cumulative calcein release at each temperature and shows that
regardless of the cholesterol content, little calcein was released at temperatures below 45◦C. The
most dramatic increase in fluorescence was observed after incubation at 55◦C, the transition
temperature of DSPC. A decrease in total calcein released is observed as the cholesterol content
increases from 0-25 mol%, at which point the release profiles of liposomes with cholesterol
above 25 mol% become indistinguishable from one another. In order to attempt to release the
remaining dye the liposomes were heated to 60◦C for up to 2 hours, but showed no substantial
increase in fluorescence after heating for longer than 5 minutes. The liposomes with cholesterol
content greater than 20 mol% were also heated up to 100◦C however they showed no additional
release beyond 60◦C. In both circumstance the sample evaporated rapidly, it is likely that
the liposomes degraded at temperatures higher than 60◦C, however the decrease in sample
volume would have ensured that the calcein remain at self-quenching concentrations even if the
liposomes released the dye.
The significant reduction in thermal release at high cholesterol content is attributed to the
formation of a liquid-ordered phase in which the phase transition temperature is significantly
reduced.379,381 Redondo-Morata et al. observed the diminishing phase transition using the
differential scanning calorimetry where the vesicles with 20% cholesterol content exhibited a
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dramatically reduced phase transition and liposomes containing 30% cholesterol displayed a
broad and small peak such that little phase transition is observed, at contents higher than
this no phase transition can be identified, Figure 5.7.382 This effect has also been shown to





Figure 5.7: Differential scanning calorimetry thermograms of DPPC liposomes containing 0-50
mol% cholesterol, when suspended in 10 mM HEPES, 20 mM MgCl2, and 150 mM NaCl, pH
7.4. Reproduced with permission.382 Copyright 2012, American Chemical Society.
5.2.3 Substituting DSPC for DPPC to increase the thermal release profile
Another attempt at increasing the release profile of the vesicles was performed by substituting
25-75% of the DSPC for Dipalmitoylphosphatidylcholine (DPPC). The acyl chain length of the
phosphatidylcholine lipid directly influences the drug retention capabilities of the vesicles they
form with longer chains providing reduced bilayer permeability, therefore replacing a portion
of the DSPC with DPPC, hydrocarbon chain lengths of 18- and 16-carbons respectively, may
increase the permeability.383 This however proved to be unsuccessful in increasing the quantity
of calcein released, liposomes containing 25, 50 and 75 mol% DPPC released 17 ± 14%, 18 ± 9%
and 17 ± 3% of encapsulated calcein when incubated at 55◦C for 5 mins. This result strongly
suggests that cholesterol is the dominant factor governing the liposome thermal release profile.
Including DPPC within the liposome composition may yet be useful at a later date due to the
lower transition temperature of DPPC (41◦C) making the temperature required for optimum
release more easily obtainable.
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5.2.4 Liposome cargo release when heated to the Tm in the presence of S.
aureus
The lack of success in finding a suitable liposome composition that sufficiently releases the en-
capsulated materials only at the transition temperature led to the investigation of alternative
method to achieve thermoresponsive release. Certain pore forming toxins (such as actinoporins)
exhibit preferential insertion into a lipid bilayer at the boundary between phase domains where
there is a lower interfacial energy, otherwise known as the line tension.384 Upon successful in-
sertion of a toxin molecule into the membrane, additional toxins oligomerise to form secondary
pore structures that allow small molecule leakage.385 As such, it was hypothesised that upon
heating to the liposome Tm, despite the reduction in phase transition properties and conse-
quently the gel-fluid domains, there would be an increase in the pore forming toxin activity
enabling the release of an encapsulated payload. To investigate this calcein loaded liposomes
were incubated with S. aureus for an hour before heating for 5 minutes to observe whether
embracing the bacteria induced liposome disruption can lead to possible thermal release.
Figure 5.8: Calcein release from liposomes containing 20-30 mol% cholesterol, upon heating to
55◦C for 5 mins (diagonal striped), incubation with S. aureus (hashed) and heating to 55◦C
in the presence of the bacteria (solid grey). 100% calcein release was determined through the
addition of 1% Triton X-100 to the liposome samples in each environment on day 0. Results
are the average of two experiments each with three replicates.
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An increased calcein release was observed when heating the liposomes to the Tm in the presence
of S. aureus. All liposomes between 20-30 mol% cholesterol demonstrated a substantial increase
in release compared to those incubated at the Tm or with bacteria individually, Figure 5.8.
The 30% cholesterol liposomes, that exhibit the least premature leakage, exhibited 55 ± 6%
of the dye release, substantially more than from heating or the bacteria individually, 16% and
25% respectively. These results infer that heating the liposome to its Tm increases the the pore
forming capabilities of the bacterial toxins allowing release of the encapsualted materials. As
such, 30 mol% cholesterol liposomes demonstrate high retention of encapsulated materials and
an adequate release profile and were therefore taken forward for testing as AMP reservoirs.
5.3 IK8 antimicrobial efficacy and liposomal encapsulation
5.3.1 Determining the MIC of IK8 against S. aureus and P. aeruginosa
Before determining the best means of liposome fabrication to increase the IK8 encapsulation
efficiency, the MIC of IK8 against the pathogenic bacteria must be determined to ensure en-
capsulation of lethal dosages is possible.
Figure 5.9: The change in the OD600 of S. aureus and P. aeruginosa after an 18 h incubation
with increasing concentrations of IK8. The minimum inhibitory concentration (MIC) is the
concentration at which there is no increase in turbidity indicating no bacteria proliferation.
Black circles indicate the change in OD600 < 0.01. Results are the average of 6 replicates.
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Both S. aureus and P. aeruginosa both exhibit no proliferation when treated with 32 µg ml−1 of
IK8, Figure 5.9. The MIC value against P. aeruginosa is equal to that published by Ong et al.
(2013).15 The MIC value obtained against S. aureus is half the published value, this discrepancy
can be attributed to the different strains of the bacteria upon which the peptide was tested.
Antimicrobial activity is categorised as bactericidal if its mechanism of action directly kills
bacteria, or bacteriostatic if the drug inhibits bacteria proliferation thus leading to bacteria
eradication. A drug is deemed bactericidal if there is a 3-log reduction in the CFU ml−1 of
a bacteria when inoculated with the drug at the MIC. As such, S. aureus and P. aeruginosa
were inoculated with 32 µg ml−1 of IK8 before incubation for 18 hours and spreading onto
agar plates. This produced 5- and 6-log CFU ml−1 reductions in S. aureus and P. aeruginosa
respectively, indicating that the IK8 mechanism of action is bactericidal.
5.3.2 Liposome IK8 encapsulation efficiency
The encapsulation efficiency is defined as the proportion of the initial drug added to the lipid
film that is contained within the final liposome suspension post removal of non-encapsulated
drug. The IK8 encapsulation efficiency was calculated using the following equation,
EE(%) = Dilutionfactor × 100× MFinal
MInitial
(5.1)
where MFinal is the final mass of IK8 after dialysis and MInitial is the mass of IK8 used during
the hydration of the lipid film. The encapsulation efficiency of IK8 by the liposomes was
assessed by varying both the lipid mass used to form the initial thin film and the concentration
of peptide used during the lipid film hydration. Firstly, the dependence of the encapsulation
efficiency upon the mass of the lipid film was investigated by increasing the lipid mass from 1
to 20 mg, whilst maintaining the concentration of the hydrating peptide solution, 1 mg ml−1.
The excess IK8 was then removed through dialysis for 48 hours before the liposomes were lysed
using DMSO and the concentration of peptide was quantified using reverse-phase HPLC, Figure
5.10C. Increasing the mass of the lipid film from 1 to 20 mg in turn increased the encapsulation
efficiency from 6 ± 1 % to 38 ± 13 %, Figure 5.10A. A lipid film mass of 10 mg was deemed
optimal due to the encapsulation of 24 ± 4% of the initial peptide, ∼7.5 times the MIC against S.
aureus and P. aeruginosa. Although lipid films of 15 and 20 mg provided greater encapsulation
efficiencies 32 ± 10 % and 38 ± 13 % respectively, these samples exhibited significantly higher
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sample-to-sample variability (between 4 independent samples) than the 10 mg lipid films. The
greater variability in encapsulation efficiency would make controlling the concentration of IK8
administered to bacteria more difficult.
Figure 5.10: A) The encapsulation efficiency of IK8 as the mass of lipid used to form the
lipid film was increased when hydrated with a 1 mg ml−1 IK8 solution. B) The encapsulation
efficiency (solid circles) and capacity (hollow diamonds) when varying the concentration of IK8
in the solution used to hydrate a 10 mg lipid film. C) An example of a HPLC trace used to
determine the concentration of IK8 encapsulated within a liposome sample diluted 30 times.
Results from both A) and B) are the average of 4 independent experiments.
The next step was to investigate how increasing the IK8 concentration affected the encapsulation
efficiency when hydrating a 10 mg lipid film. An increase in the AMP concentration from 1
to 10 mg ml−1 resulted in a decrease in the encapsulation efficiency from 24 ± 4% to 13 ±
2% (Figure 5.10B), however the total encapsulation capacity was seen to increase, 235 ± 43 to
1290 ± 210 µg ml−1. A 5 mg ml−1 IK8 solution deemed the optimum concentration as this
enabled encapsulation of 770 ± 21 µg ml−1, 15 ± 1% of the initial peptide added, approximately
24 times the MIC against both S. aureus and P. aeruginosa (32 µg ml−1), and demonstrated
significantly less sample-to-sample variability in encapsulation efficiency than using higher IK8
111
Chapter 5. Development of a gold nanorod and antimicrobial peptide loaded liposome system
to provide light-stimulated release to treat S. aureus Section 5.3
concentrations to hydrate the lipid film.
5.3.3 IK8 encapsulation within cationic liposomes
The encapsulation of IK8 within liposomes containing cationic lipids 1,2-dipalmitoyl-3-
trimethylammonium-propane (DPTAP) was next investigated. The intention being that the
cationic lipids would provide electrostatic repulsion to the cationic IK8 to inhibit leakage. This
would allow a reduction in the cholesterol content within the liposome bilayer and hence could
increase the thermal responsivity of the liposome and in turn increase the release efficiency.
The IK8-loaded cationic liposomes were formed through thin lipid film hydration however a
portion of the DSPC was replaced with DPTAP, whilst maintaining constant proportions of
cholesterol and DSPE-PEG2k (30 and 5 mol% respectively). The inclusion of DPTAP provided
the liposomes with a positive zeta-potential, with increasing positivity as the proportion of
DPTAP also increased, Table 5.2. The DPTAP did not appear to affect the IK8-loaded liposome
formation, with all samples having an initial average diameter between 350-400 nm. However,
after one day the cationic liposomes showed a substantial increase in diameter, with those
containing a higher proportion of DPTAP growing more, whereas the liposomes without DPTAP
did not. Control samples of liposomes containing 5% DPTAP that were fabricated without IK8
demonstrated no change in diameter over 24 hours, 372 ± 38 nm to 379 ± 53 nm, meaning that
the increase in liposome size only occurred with samples containing IK8 and indicating that the
AMP is the cause of the structural instability.
Table 5.2: The initial charge and the morphological stability of IK8-loaded cationic liposomes.
DPTAP (%) Zeta-potential (mV) Avg. diameter (nm) Avg. diameter after 1 day (nm)
0 -5.9 ± 3.9 365 ± 36 364 ± 40
5 +24.8 ± 8.2 395 ± 84 416 ± 115
10 +36.3 ± 3.7 393 ± 86 589 ± 220
20 +40.4 ± 6.4 387 ± 76 779 ± 266
Table 5.3: The initial encapsulation capacity of DPTAP containing liposomes and the peptide
leakage after one and two days.
DPTAP (%) Encapsulation efficiency Leakage after 1 day Total leakage after 2 days
0 23.5% 1% 1%
5 20.2% 84.5% 85.8%
10 17.1% 86.6% 91.2%
20 6.0% 84.1% 85.0%
The effect of including DPTAP on the liposome leakage was next investigated. IK8-loaded
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liposomes containing 0-20% DPTAP were fabricated and cleaned of excess peptide by passing
the sample through an Amicon R©Ultra-4 Centrifugal Filter Unit (Mw cutoff = 10 kDa). This
removed half of the supernatant each time which was replaced with fresh buffer, the process was
repeated 10 times. The effects of DPTAP on the liposome leakage were assessed by incubating
the samples at 37◦C for 24 or 48 hours, before cleaning with centrifugal filters, as previously
described, and disrupting the remaining liposomes with DMSO (5% v/v) and using HPLC to
quantify the remaining IK8 concentration. After one day of incubation all liposomes containing
DPTAP encapsulated less than 14% of the IK8 the same liposomes contained immediately post
fabrication, indicating that over 86% of the peptide had leaked out of the vesicles, Table 5.3.
Liposomes without DPTAP exhibited ∼1% leakage under the same conditions. The encap-
sulation efficiency was also seen to decrease as the positive charge on the liposome increased,
from 24% to 6% as the zeta-potential changed from -6 to +40 mV. This indicates that there is
electrostatic repulsion between the liposome and the peptide, that could be affecting both the
encapsulation efficiency and the structural integrity. As such, it was decided that cationic lipids
should not be included within the liposome composition.
5.4 IK8-loaded liposome colloidal stability
The colloidal stability of the IK8-loaded liposomes was tested to ensure that the vesicles did
not agglomerate or distort during storage in a fridge at 4◦C. DLS measurements of liposomes
loaded with 0.8 mg ml−1 were taken over the course of three weeks after fabrication.
Post fabrication, the immediate liposome diameter was 365 ± 36 nm and after three weeks
385 ± 42 nm, Figure 5.11. The polydispersity index (PDI) also showed very little change with
values of 0.12 ± 0.05 and 0.17 ± 0.04, at days 0 and 21 respectively, a homogeneous sample
with a PDI value of ≤ 0.2 is generally considered as monodisperse.386 As such, the IK8-loaded
liposomes showed excellent colloidal stability over the three-week observation period.
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Figure 5.11: The diameter (solid circles) and polydispersity index (hollow diamonds) of IK8-
loaded liposomes held when stored in a fridge at 4◦C. Results are the average of 4 independent
experiments, and lines correspond to linear fits.
5.5 IK8-loaded liposome antimicrobial effects
The antimicrobial properties of the IK8-liposomes was assessed by adding varying amounts of
vesicles (containing 0.5, 1, 2 and 4 times the MIC) that were intact, lysed with 5% v/v DMSO,
or vesicles heated to 55◦C for 5 mins, to a S. aureus suspension. Intact vesicles were added to the
bacteria to ensure that the bacteria induced leakage of IK8 would not inhibit proliferation, such
that the desired thermally induced release is negated. The liposomes lysed using DMSO were
added to the bacteria to determine whether the maximum release of IK8 from the liposomes
would be substantial enough to provide antimicrobial effects. The liposomes heated to 55◦C
(± 1◦C for 5 mins) immediately prior to the addition to the bacteria, determined whether the
thermally induced release of IK8 could reduce bacteria proliferation. After incoulation with the
liposomes the bacteria samples were incubated at 37◦C for 18 hours before they were centrifuged
(200 x g, 5 mins) to pellet the bacteria and leave the liposomes in solution, the supernatant was
then discarded and the bacteria resuspended in MHBII before the OD600 was measured.
114
Section 5.5
Chapter 5. Development of a gold nanorod and antimicrobial peptide loaded liposome system
to provide light-stimulated release to treat S. aureus
Figure 5.12: S. aureus proliferation upon inoculation with IK8-loaded liposomes that have been
lysed using DMSO, heated to 55◦C for 5 minutes an hour after addition to the bacteria, or intact
vesicles, as compared to the proliferation of the bacteria in Mueller-Hinton broth. Results are
the average of 2 independent experiments, each with 6 replicates.
From Figure 5.12 several conclusions can be drawn. Firstly, the lysed liposomes containing
the MIC x 2 of IK8 showed complete inhibition of S. aureus proliferation. Lysed liposomes
containing 1 x MIC showed only partial restriction of growth indicating that the entire content
of the liposomes was not adequately released to perform the antimicrobial activity. As such,
in order to stop any growth of S. aureus the bacteria must be treated with liposomes contain-
ing between 1-2 times the MIC. Secondly, the thermally triggered release of IK8 only showed
increased antimicrobial activity compared to the unlysed liposomes when loaded with 1 and 2
times the MIC. The heated liposomes containing the MIC x 2, showed near total restriction
of proliferation, however insufficient quantities of IK8 were released upon heating of 1 x MIC
115
Chapter 5. Development of a gold nanorod and antimicrobial peptide loaded liposome system
to provide light-stimulated release to treat S. aureus Section 5.6
liposomes to have any significant effect on the bacteria growth. Thirdly, the bacteria induced
leakage of IK8 from the unlysed liposomes containing 2 x MIC gave rise to a significant decrease
in bacteria proliferation, and the leakage from the liposomes containing the MIC x 4 produced
complete restriction of growth. Finally, neither the the addition of liposomes containing no IK8
(MIC x 0) or the heating of the bacteria to 55◦C for 5 mins produced any effects on the bacteria
proliferation. The results from Figure 5.12 demonstrate that the IK8-loaded liposomes are able
to provide thermal sensitive release of AMPs to induce antimicrobial activity whilst restrict
some of the bacteria induced leakage. Moving forward, 2 times the MIC was the optimal con-
centration of liposome encapsulated IK8, enabling complete inhibition of bacteria proliferation
upon liposomal release of AMP and significant bacterial growth without vesicle heating or lysis.
5.6 Liposome protection of IK8 from protease degradation
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Figure 5.13: The proportion of IK8 remaining when free in solution (solid circles) or encap-
sulated within liposomes (hollow diamonds) upon the addition of 0.5 µg ml−1 of the protease
trypsin. Results are the average of three independent experiments. Two-tailed T-testing was
performed between free and encapsulated IK8 quantities remaining at each time point, p-values
indicate; * < 0.05, ** < 0.01, *** < 0.001.
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The final stage of the liposome testing was to assess whether the liposomal encapsulation of IK8
provided protection against enzymatic degradation. AMP are highly susceptible to proteolysis,
meaning the internalisation inside a vehicle could protect the drug molecule to ensure that lethal
concentrations are retained until the treatment is required. IK8-loaded liposomes and IK8 free
in solution were incubated with 0.5 µg ml−1 of the protease trypsin (approximately double the
concentration in the blood of a healthy adult)387 for 5 hours with a sample extracted hourly,
the trypsin was deactivated using a 40% tricholoacetic acid and the concentration of AMP
quantified using HPLC. Figure 5.13 shows that after 5 hours over double the concentration of
IK8 encapsulated within liposomes was intact compared to the free IK8, 80 ± 6 % and 36 ± 2
% respectively. The lipid bilayer encapsulating the IK8 therefore provides a protective barrier
that restricts the access of protease to the AMP, thus allowing treatment infection environments
that are often rich in such proteolytic enzymes, such as an open wound.388
5.7 IK8 and phospholipid-stabilised AuNR toxicity to fibroblast
cells
Considering the cytotoxicity of any medical delivery device is important, however, it is of even
more significance when being used to treat a wound that is susceptible to infection. Hindering
the regenerative process through increasing the toxicity to mammalian cells leaves the wound
vulnerable to infection and increases the risks of a wound becoming chronic.389–391 As such,
the cytocompatibility of both IK8 and the phospholipid-stabilised AuNRs was assessed using
human dermal fibroblast (HDF) cells; which play a critical role in the formation of granulation
tissue.392,393 Briefly, HDF cells were seeded into a 96-well plate, 7 x 104 cells per well, and
incubated for 24 hours. The media was then replaced by media with 10% PBS containing the
IK8 or lipid-coated AuNRs to provide final concentrations between 8-125 µg ml−1. The cells
were agian left to incubate for 24 hours before the HDF viability was determined using a WST-1
assay.
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Figure 5.14: Human dermal fibroblast cell viability after incubation with increasing concen-
trations of IK8 and phospholipid stabilised AuNRs for 24 hours. Results are the average of 6
independent samples.
No cytotoxicity was observed upon incubation of the HDF cells with either the lipid coated
AuNRs or free IK8 in media at concentrations four times greater than those required to com-
pletely inhibit the growth of both S. aureus and P. aeruginosa, Figure 5.14. Ong et al. have
previously demonstrated that IK8 has very weak hemolytic properties requiring 2 g l−1 in order
to induce ∼10% hemolysis.16 The lack of cytotoxicity and hemolytic activity of IK8 at concen-
trations several times the MIC against S. aureus potentially allows for the liposomal loading
of high concentrations of peptide to provide multiple treatment events, with no risk of toxicity
in the event of leakage. There are currently only two studies in the literature investigating the
toxicity of phospholipid-coated AuNRs, both of which provide significantly higher toxicity val-
ues than we present. Early work by Takahasi et al. demonstrated a 20% reduction in HeLa cell
viability at 2.4 µg ml−1 of PC-AuNRs, however it appears likely that residual amounts CTAB
remained in solution.394 A later study demonstrated a decrease in viability of MCF-7 breast
cancer cells, 3T3 fibroblast cells and HMEC-1 dermal microvessel endothelial cells when incu-
bated with 1,2-dimyristoyl-sn-glycero-3-phosphocholine (DMPC) coated AuNRs.395 However,
the maximum Au concentration used in this study was 20 µg ml−1 and all cell lines showed less
than a 20% drop in viability. It is clear that considerably more research is required to gain a
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better understanding of the toxicity profiles of phospholipid-stabilised AuNRs.
5.8 Light-stimulated delivery of IK8 to treat S. aureus
To determine the antimicrobial capabilities of the photothermal triggered release of liposome
encapsualted IK8, different concentrations of liposomes, corresponding to IK8 concentrations
between 0-4 times the MIC against S. aureus, were added to a bacteria suspension (1x106 CFU
ml−1) along with 48 µg ml−1 of lipid-coated AuNRs, allowed to incubate for 1 hour before being
irradiated at 2.1 W cm−2, 860 nm, for 10 mins, heating the sample to 55◦C. After an 18 hour
incubation the bacteria are diluted and spread on MHII agar plates, the number of viable CFUs
was then counted the following day.
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Figure 5.15: The effects upon S. aureus viability when treated with liposomes loaded with 0,
1, 2 and 4 times the MIC and 48µg ml−1 of phospholipid-coated AuNRs, when irradiated at 0
and 2.1 W cm−2 for 10 mins. Control samples containing just NRs are used to determine the
toxicity of the NRs and the photothermal killing in the absence of liposomes. The threshold for
bactericidal activity, a 3-log reduction in CFU ml−1, is denoted as a dashed line. Results are
the average of 2 independent experiments, each containing 6 replicates of treated bacteria and
plated thrice. Two-tailed T-testing was performed against untreated S. aureus in broth unless
otherwise stated with p-values indicating; * < 0.05, *** < 0.001, **** < 0.0001.
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Several results may be drawn from Figure 5.15. Firstly, all samples containing IK8 demonstrate
a significant increase in number of log reductions in CFU ml−1 when irradiated at 2.1 W cm−2,
compared to no irradiation. This clearly indicates that the photothermal heating has triggered
the release of the encapsulated AMP causing the reduction in bacteria viability compared to
the sample without irradiation. Secondly, bactericidal activity, a 3-log reduction in the number
of viable bacteria, was achieved when using only 1 x the MIC of IK8 when irradiated. Thirdly,
samples containing liposomes with 2 and 4 x the MIC both showed 3- and 7-log reductions in
the CFU ml−1 without the application of the laser indicating that the bacteria induced leakage
of IK8 from the liposomes has then produce bacteria killing effects itself. The bacteria treated
with liposomes containing no IK8 showed no bacteria killing both with and without the laser
irradiation, meaning that the liposomes themselves do not affect the bacteria viability and that
the laser irradiation also does not cause any bacteria death. The bacteria treated with the
lipid-coated AuNRs also showed no bacteria killing activity both with and without the laser
irradiation. This demonstrates that not only are the lipid AuNRs non-toxic to the S. aureus but
that the photothermal heating to 55◦C for 10 minutes did not hinder the bacteria proliferation.
5.9 Photothermal enhancement of the IK8 antimicrobial effi-
cacy
Preliminary experiments incubating S. aureus at 60◦C for 10 mins demonstrated a decrease
in viability. As such, it was investigated as to whether the photothermal heating can induce
bacteria death by increasing the concentration of AuNRs which in turn increases the tempera-
ture attained during photothermal heating using a continuous wave laser at 2.1 W cm−2. By
increasing the AuNR concentration to 105 µg ml−1 a maximum temperature of 65◦C could be
reached. The S. aureus were treated with three different conditions; 1) liposomes containing
1 x MIC of IK8 alongside the AuNRs under irradiation, to show triggered release of IK8 and
possible photothermal enhancement of the AMP killing, 2) AuNRs with irradiation, to demon-
strate the potential antimicrobial effects of photothermal heating alone, 3) 1 x MIC IK8-loaded
liposomes and AuNRs, to demonstrate whether the inclusion of higher concentrations of AuNRs
can induce AMP leakage.
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Figure 5.16: The log-reductions in S. aureus when treated with IK8-loaded liposomes and
AuNRs (grey) without irradiation and AuNRs alone (diagonal slashed) and IK8-liposomes with
AuNRs (hashed) both when irradiated at 2.1 W cm−2 for 10 mins. The S. aureus were treated
with 50, 80 and 105 µg ml−1 of AuNRs to heat the samples to 55◦C, 60◦C and 65◦C respectively.
Results are the average of 2 independent experiments, each containing 6 replicates of treated
bacteria and plated thrice. Two-tailed T-tests were performed against untreated S. aureus in
broth unless otherwise stated with p-values indicating; *** < 0.001, **** < 0.0001.
There are three main conclusions that can be drawn from Figure 5.16. Firstly photothermal
triggered release of IK8 is again demonstrated, resulting in a 3-log reduction in S. aureus CFU
ml−1, when IK8-loaded liposomes and AuNRs were heated to 55◦C. Secondly, photothermal
killing of S. aureus is observed at 60◦C. In the absence of AMPs a 4-log reduction in CFU ml−1
was observed under irradiation, clearly indicating that the bacteria death can only be attributed
to the temperature. Further increasing the temperature to 65◦C resulted in complete bacteria
eradication. Thirdly, the use of the AMP-loaded liposomes and the photothermal heating
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provided additive antimicrobial effects. As demonstrated in Figure 5.6A, when heating 30
mol% cholesterol liposomes beyond their gel-fluid phase transition temperature there is little
additional release of materials, meaning that the antimicrobial effects of the IK8-liposomes are
likely to be very similar, independent of whether the sample is heated to 55◦C or 60◦C. The
7-log reduction in viable S. aureus is therefore due to the additive 3-log reduction from the
release of IK8 and the 4-log reduction from the photothermal heating to 60◦C. This figure also
depicts that the antimicrobial activity of the irradiated IK8-liposome and AuNRs at 55◦C is
2-log lower than when the AMP is in solution, implying that some of the peptide is retained
within the liposomes. There was no decrease in the S. aureus viability when the IK8-liposomes
and AuNRs were added to the bacteria without the laser application, meaning that the AuNRs
do not destabilise the liposomes causing release. Again no bacteria decrease was observed when
treated with the maximum concentration of AuNRs, 105 µg ml−1, and when irradiated in the
absence of AuNRs.
Conclusion
In this chapter the optimal lipid composition, DSPC/cholesterol/DSPE-mPEG2k (65/30/5
mol%), was determined to prevent premature leakage of encapsulated materials (< 5% at 37◦C
in all media), but provide release when heated above the gel-fluid lipid phase transition temper-
ature, Tm=55
◦C, in the presence of pathogenic bacteria. The liposome fabrication procedure
was also optimised to encapsulate 770 µg ml−1 of IK8, approximately 24 times the MIC against
both S. aureus and P. aeruginosa. These liposomes are also suitable for storage at 4◦C, demon-
strating no leakage of encapsulated materials or change in diameter after 3 weeks. The liposomal
encapsulation of AMPs also offers significant protection against proteases in solution with 80%
of liposome encapsulated AMP remaining after incubation with trypsin, as opposed to 36% of
free IK8 in solution remaining, potentially providing a viable route to toward clinical translation.
Utilising the IK8-loaded liposomes in combination with phospholipid stabilised AuNRs the first
instance of the triggered delivery of AMPs was demonstrated, enabling antibacterial treatment
against S. aureus. Using liposomes containing the MIC of IK8 no antimicrobial effects were
observed until the system was heated to 55◦C, the gel-fluid phase transition temperature of
the liposomes, at which point there was a 3.1-log reduction in CFU ml−1. The bacteria killing
effects of photothermal heating alone were also investigated; S. aureus viability was unaffected
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until the sample was heated to 60◦C leading to a 4.1-log reduction in CFU ml−1. When used
in combination with the IK8-liposomes the system produced a 6.9-log reduction in CFU ml−1,
depicting an additive antimicrobial effect from the AMP and photothermal treatments. This is
the first demonstration of the photothermal enhancement of AMPS. Moving forward this thesis
will be discussing the incorporation of this AuNR - IK8-liposome system into a hydrogel to form
the basis of a therapeutic wound dressing.
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Some of the content within this chapter can be found within the following the following publica-
tions: S. C. T. Moorcroft et al. Nanoparticle-Loaded Hydrogel for the Light-Activated Release
and Photothermal Enhancement of Antimicrobial Peptides. ACS Appl. Mater. Interfaces 2020,
12(22), 24544–24554.350
Motivation:
In this chapter we will be investigating the incorporation of the IK8-loaded liposome and
phospholipid-stabilised AuNR system, described in Chapter 5, into a hydrogel to create a thera-
peutic wound dressing, see Figure 6.1. The incorporation of AMP-loaded liposomes and AuNRs
into a hydrogel as a scaffold that could be placed in contact with a wound would provide a drug
depot that releases the antimicrobial content only upon exposure to specific stimuli. Hydrogels
are excellent materials to provide the structural basis for the dressing due their fundamental bio-
compatibility owed to their high levels of water content and high permeability for oxygen.396,397
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The moist environment that hydrogels maintain aids the epidermal regeneration and reduces
scarring by accelerating the angiogenesis process, preventing cell dehydration and increasing
the rate at which dead cells and fibrin are broken down.19,398 The wide range of materials
from which to form a hydrogel provides an array of fabrication options and tunable mechanical
properties.399
Here the fabrication of a 4-arm PEG-maleimide hydrogel (4APM) crosslinked with PEG dithiol
was investigated, before studying how the properties of the gels are affected by the inclusion of
AuNRs and liposomes. The photothermal properties of the nanoparticle loaded gel were char-
acterised to determine whether antimicrobial triggered release and photothermal enhancement
of antimicrobial activity are possible from within the gel dressing. Furthermore, this chapter
discusses the possibility of finely tuning the AMP release properties such that an individual gel
could provide multiple rounds of treatment.
Untreated hydrogel 
Live bacteria Dead bacteria 




4arm PEG maleimide 













Figure 6.1: A schematic representation of the PEG-based hydrogel containing gold nanorods
and antimicrobial peptide (IK8) loaded liposomes, demonstrating the mechanism for NIR light-
triggered release of AMPs.
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6.1 Hydrogel fabrication and characterisation
The properties of the IK8-liposome and AuNR system placed very stringent restrictions on the
type of hydrogel that would be suitable for use. Commonly hydrogel gelation is initiated with
heating, uv-irradiation or the use of toxic chemicals, however, these methods are unsuitable for
the liposomal delivery of AMPS; heating could prematurely trigger the release of the encapsu-
lated materials, peptide bonds absorb UV light meaning they are susceptible to UV irradiation
that can alter the primary and secondary structures they form,400 and it is highly preferential
not to include any toxic components within a medical device.401,402 As such, a hydrogel con-
sisting of 4-arm poly(ethylene) glycol-maleimide (4APM) cross linked with PEG dithiol was
deemed appropriate as the two components of the gel need only be mixed in the correct buffer-
ing environment to initiate and control the gelation time.403 Both of the components have been
confirmed as non-toxic and there is a large amount of literature describing the cytocompatibility
of PEG-based hydrogels.404–409 The PEG hydrogel was also chosen due to its high permeability
by small hydrophilic molecules and largely neutral network, which means that the gel should
provide minimal interference with the AMP release kinetics.410
6.1.1 Optimising the gel fabrication to control gelation time
Figure 6.2: Thiol-maleimide michael addition reaction. Initially the thiolate anion will attack
the π-bond within the maleimide group to form an enolate intermediate before the negatively
charged oxygen deprotonates an additional thiol group, forming a thiolate anion that can react
with another maleimide group.
The formation of the gel occurs through a thiol-michael addition ’click’ reaction between the
maleimide group of the 4APM (R) and the thiol groups of the PEG dithiol (R’) as depicted
by Figure 6.2. In this reaction the thiol-michael addition occurs through the deprotonation of
the thiol to form a thiolate-anion, a strong nucleophile that can attack the π-bond within the
maleimide group, binding the two PEG molecules together.411 A basic enolate intermediate is
formed which in turn deprotonates another thiol group causing a chain reaction. As demon-
strated by Table 6.1, the weight percentage of the gel, the buffer, the buffering concentration
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and the pH all affect the rate of the thiol-maleimide reaction which in turn affects the gelation
time. In order to fabricate the gel a 40 µl droplet of the 4APM was placed onto a parafilm
coated glass slide and 10 µl of the PEG dithiol solution was injected directly into the droplet.
The solution was then retracted and expelled from a pipette until this was no longer possible,
the duration of this mixing was defined as the gelation time. The samples were also inverted in
order to ensure that the liquid does not flow.
Table 6.1: The effects of changing the gel wt%, the buffer, the buffering concentration and the
pH on the gelation time and the characteristics of the gel post gelation. Each bordered row
represents a different set of experimental results to compare, for ease of reading. The first bor-
dered row demonstrates the effects of fabricating gels of decreasing wt% and salt concentration
using PBS buffer, the second row to determine the effects of pH using sodium citrate buffer,
the third row was to observe how the salt concentration affects the gel formation and both the
fourth and fifth rows display the effects of the wt% on gels formed using different pH values.
Gel wt% Buffer (conc.) pH Gelation time Hydrogel description
10 PBS (1 X PBS) 7.4 0 s Instant gelation
5 PBS (1 x PBS) 7.4 0 s Instant gelation
2.5 PBS (1 X PBS) 7.4 0 s Instant gelation
1 PBS (1 x PBS) 7.4 0 s Instant gelation
5 PBS (0.1 X PBS) 7.4 0 s Instant gelation
5 PBS (0.01 X PBS) 7.4 0 s Instant gelation
5 Sod. cit. (10 µM) 4 > 30 mins A gel was not formed in 30 mins
5 Sod. cit. (10 µM) 5 7.5 mins A sticky and ductile gel
5 Sod. cit. (10 µM) 6 20 s A solid, smooth and homogenous gel
5 Sod. cit. (10 µM) 7 0 s Instant gelation
5 Sod. cit. (100 µM) 6 0 s Instant gelation
5 Sod. cit. (1 µM) 6 90 s A sticky and ductile gel
10 Sod. cit. (10 µM) 5 2 mins A solid, smooth and homogenous gel
2.5 Sod. cit. (10 µM) 5 15 mins A sticky and ductile gel
1 Sod. cit. (10 µM) 5 > 30 mins A gel was not formed in 30 mins
10 Sod. cit. (10 µM) 6 0 s Instant gelation
2.5 Sod. cit. (10 µM) 6 2.5 mins A sticky and ductile gel
1 Sod. cit. (10 µM) 6 20 mins A very sticky and ductile gel
When the two components of the gel were initially dissolved in PBS, regardless of the final weight
percentage of the gel and the PBS concentration, all gels exhibited instantaneous gelation, Table
6.1. The gelation occurred so rapidly that the pipette tip containing the PEG dithiol pierced
the 4APM droplet a gel formed in the pipette tip meaning the majority of the PEG dithiol
solution could not be injected. As such, in order to slow the reaction down it was decided to
move to a more acidic buffer.403 Sodium citrate buffer (10 µM) was chosen as the pH could
be tuned between pH 2-8 and allowed simple control over the salt concentration. 5 wt% gels
were then fabricated using buffers ranging from pH 4-7. It was found that increasing the buffer
acidity increased the gelation time, such that a gel that formed instantly using the pH 7 buffer
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took > 30 mins at pH 4. This is expected as a more basic the buffer can deprotonate the thiol
groups faster causing a more rapid gelation, whereas at the most acidic condition (pH 4) no
deprotonation occurs and as such no gel was formed. The effects of salt concentration were then
observed by fabricating 5 wt% gels using pH 6 citrate buffers at 1 and 100 µM. The highest salt
concentration (100 µM) resulted in instant gel formation, and the lowest salt concentration (1
µM) increased the gelation time. The effects of varying the wt% of the gel were then observed
with gels fabricated from 1-10 wt% using 10 µM citrate buffers of pH 5 and 6. Gels made at
both pH values demonstrated an a decrease in gelation time with an increasing wt%. This is
due to the higher wt% gel having an increased concentration of reactive groups meaning that
the first reactions will occur more rapidly. Using the pH 6 buffer to fabricate a 10 wt% gel
resulted in an instantaneous gelation directly at the tip of the pipette leaving the majority of
the 4APM solution as a liquid surrounding a solid sphere, demonstrating the heterogeneity that
occurs when the reaction occurs too quickly. All of gels formed at pH 5 took longer to gelate
than the gels of equal mass at pH 6, reiterating the effects of pH on the gelation process. The 5
wt% gel fabricated at pH 6 was deemed the most desirable, allowing for a reasonable degree of
mixing before gelation at 20 seconds producing a stiff and smooth gel that was not drawn out
by removing the pipette tip.
6.1.2 Hydrogel viscoelastic properties
A) B) 
Figure 6.3: The storage moduli, G’, (solid lines) and loss moduli, G”, (dashed lines) of PEG
gels of 10 wt% (black), 5 wt% (red), 2.5 wt% (blue) and 1 wt% (green), under A) a constant
1% strain for 5 minutes and B) under an oscillating strain of up to 1% of increasing frequency
up to 10 Hz.
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The mechanical properties of the gels are important, it is vital that the dressing will form a
solid gel, not a fluid that could flow into a wound, and is flexible to withstand skin stretching.
Rheometry was used to gain a better understanding of the viscoelastic properties. Gels were
fabricated on the base plate of the rheometer, allowed to gelate and were then subjected to either
a constant 1% strain force or to 1% strain from an oscillating top plate of increasing frequencies
up to 10 Hz. This provided storage and loss moduli (G’ and G” respectively), which describe the
energy stored within the network and the energy lost when under strain. For the 5 and 10 wt%
gels the concentrations of each component were sufficiently high to allow extensive chemical
crosslinking that resulted in significantly higher storage moduli than loss moduli, indicating
that the material is solid, Figure 6.3A.412,413 The 2.5 and 1 wt% gels show very little difference
between G’ and G” indicating that they exhibit viscous properties. These results correlate
with the gelation times and characteristics observed from the gels as displayed in Table 6.1.
The frequency sweep data also shows the elastic properties of the 5 and 10 wt% gels, with
substantially higher G’ values than G” at all frequencies, Figure 6.3B. At 5.75 and 9.11 Hz the
G’ and G” values for the 1 and 2.5 wt% gels cross such that the loss modulus is dominant. This
means that under these strain forces more energy is lost than is stored within the material, this
behaviour is indicative of a fluid rather than a gel.414 These rheological measurements show
the ability to tune the mechanical properties of the gel by simply changing the concentration
of the gel components, with fluidic properties at low concentrations (≤ 2.5 wt%), and a solid
of increasing stiffness (G’ is increasingly larger than G”), at higher concentrations (≥ 5 wt%).
This demonstrates the potential for the gel to be applied in a variety of ways, for example a
stiff high wt% gel that does not flow would be useful as a prefabricated dressing placed inside
a sterilised packaging that could simply be opened and applied, whereas the viscous properties
of the low wt% gels would allow the gel to be spread directly on the skin/wound.
6.1.3 Hydrogel swelling ratio
The swelling ratio of the hydrogel is defined as the fractional increase in the weight of the
hydrogel due to the absorption of water. Hydrogel swelling occurs when a compatible solvent
penetrates the dehydrated polymer network causing an increase in the volume within the gel
and as such providing an outward osmotic force. The crosslinks between the polymers resist the
deformation and as such provide an elastic force that opposed the outward osmotic pressure.415
The solvent sorption ceases when the osmotic and elastic forces are equal. The maximum
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hydrogel masses therefore correlate with the results of the rheology testing, the higher the
elasticity of the gel the larger the volume of water that the gel can absorb.
To determine the swelling ratio, gels of 1-10 wt% were fabricated to 50 µl in eppendorfs and
freeze-dried. The dehydrated gels were then weighed before 1 ml of Milli-Q was added and the
gel was left to rehydrate. The Milli-Q was removed at 10, 30, 60, 120, 180 and 240 mins and
the gels dabbed with lint free tissue paper, to remove all excess water, before reweighing the
gels and adding 1 ml of fresh Milli-Q to the eppendorf.
Figure 6.4: The A) swelling ratio and B) the hydrogel mass as freeze-dried gels of 10 wt% (black
squares, solid line), 5 wt % (dark grey circles, dashed line) and 2.5 wt% (hollow diamonds, dotted
line) were added to 1 ml of Milli-Q. Errors bars indicate the standard deviation (n=5).
The swelling ratio of the 1 wt% gel was unobtainable due to the complete solublisation of the
gel components after 10 minutes of hydration, all other samples provided a defined gel. The
swelling ratio of the gels was found to decrease as the wt% increased, after 4 hours the 2.5, 5
and 10 wt% gels displayed ratios of 30.4 ± 5.6 (absorbing 41 ± 1 mg of Milli-Q), 22.4 ± 1.8
(59 ± 2 mg of Milli-Q) and 19.0 ± 1.8 (87 ± 6 mg of Milli-Q) respectively, Figure 6.4A and
B. A swelling decrease with the gel wt% has been identified in similar 4 arm PEG hydrogels
with comparable swelling ratios.416 All gels appeared to saturate after an hour in the hydrating
medium. The hydrogel mass displays the opposite effect to the swelling ratio, an increase in the
wt% increases the mass of water that can be absorbed. After rehydration the gels of 2.5, 5 and
10 wt% had final masses of 43 ± 1 mg, 62 ± 2 mg and 92 ± 6 mg respectively. In terms of the
experimental procedures it is beneficial that the 5 wt% gel absorption saturation mass was 59
mg, or 59 µl of Milli-Q, as the gels used for experimentation were initially 50 µl meaning they
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would only swell by 9 µl upon the addition of excess fluids.
6.2 AuNR-liposome loaded hydrogel characterisation
The loading of liposomes and Au nanoparticles was achieved by the addition of the particles to
the 4APM dissolved in sodium citrate buffer, to a final volume of 40 µl. The inclusion of the
liposomes/AuNPs appeared to have little affect on the gelation time. The 5 wt% gel remained
solid upon inversion, Figure 6.5A, after 20 seconds of mixing and had a slight uniform brown
coloration indicating a homogenous distribution of the NRs. The gel was however predominantly
transparent, particularly when placed next to the skin, Figure 6.5B. A prototype dressing was
comprised of a 5 mm thick layer of the PEG hydrogel loaded with AuNRs and IK8-liposomes
and covered in a TegadermTMtransparent film dressing, Figure 6.5B. The details on the skin
below are clearly visible, such as the freckle at the center of the gel, offering the additional
benefit of being able visually assess the wound. The gel was formed in the bottom of a petri
dish mould to provide the circular shape with a distinct edge. Such was the ease of fabrication,
a wide variety of particles may be loaded into the gel simply through addition to the 4APM
solution prior to gelation. This was demonstrated through the inclusion of gold nanoseaweed
into the gel at varying concentrations, Figure 6.5C. This image also shows the different visual
characteristics of gels of different wt% PEG, after being allowed to dry at room temperature
for 30 mins. The left most and central gels, 10 and 5 wt% PEG respectively, can be identified
as being solid due to the fact that they have dried from a droplet into amorphous shapes, if
they had remained liquid they would have maintained their droplet shape due to presence of
surface tension. The different colours are due to the concentrations of AuNSW, 240 and 24 µg
ml−1 left and center gels respectively. The right hand gel, 2.5 wt%, is being drawn away from
the slide using a pipette tip demonstrating the viscous and highly ductile properties of the gel
when at low PEG concentrations.
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Figure 6.5: Images of the 5 wt% PEG hydrogels: A) loaded with liposomes and AuNRs, provid-
ing the brown colouration, B) as a prototype dressing loaded with AuNRs and IK8-liposomes,
placed against the skin and covered with a TegadermTMtransparent film dressing, C) gels of 10,
5 and 2.5 wt % (left, centre, right) containing 240, 24 and 0 µg ml−1 of gold nanoseaweed,417
after drying at room temperature for 30 mins.
6.2.1 Viscoelastic properties
To determine whether the inclusion of liposomes and AuNRs had any effect on the mechan-
ical properties of the PEG-hydrogel, rheology was performed on separate gels containing 48
µg ml−1 of AuNRs, liposomes containing 1 x the MIC against S. aureus and both particles
simultaneously, and compared against a 5 wt% with no particles.
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A) B) 
Figure 6.6: The storage moduli (solid lines) and loss moduli (dashed lines) of 5 wt% gel (black)
and 5 wt% gels containing AuNRs (red), liposomes (blue) and AuNRs with liposomes (green).
The inclusion of both AuNRs and liposomes imparted a decrease in the storage modulus com-
pared to the blank 5 wt% PEG gel, 114 and 94 Pa reductions respectively, Figure 6.6A. The
addition of both particles to the gel offers a further reduction in G’ of 186 Pa, almost an additive
reduction from the AuNRs and liposomes independently. This is attributed to the inclusion of
the particles producing a disruption in the hydrogel network, leaving a zone surrounding the
particles with unbound 4APM and PEG dithiol molecules that affects the bulk mechanical
properties.418 The same decrease in elasticity was observed during the frequency sweep, with
reductions in G’ of 158 Pa, 178 Pa and 279 Pa upon including liposomes, AuNRs and both
types of particle into the hydrogel, Figure 6.6B.
6.2.2 AuNR and liposome retention within the gel
The next step in the AuNR-liposome loaded gel characterisation was to determine the AuNR
and liposome retention. High retention rates are vitally important, the leakage of substantial
amounts of liposomes could lead to the premature leakage of non-lethal doses of AMP into a
bacteria infected wound, thus promoting resistance, or it could leave the gel with an insufficient
drug payload to kill bacteria upon triggered release. Similarly if the AuNRs show significant
leakage, the photothermal heating profile may not be adequate to trigger the release of the
AMPs. The gel retention was measured by including AuNRs and Texas-red labelled liposomes
within a 50 µl gel along with 150 µl of sodium citrate buffer (pH6, 10mM). The maximum
fluorescence (EX/EM, 596/615 nm) and the absorbance (860 nm) were obtained by measuring
the gels directly, and each day the supernatant was moved to an empty well of a clear bottom
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well plate before the fluorescence and absorbance were measured to determine the amount of
liposomes and AuNRs that had leaked from the gel.
Figure 6.7: The release of lipid-coated AuNRs (black circles) and Texas-red labeled liposomes
(grey diamonds) from a 50 µl 5 wt% PEG hydrogel into 150 µl of citrate buffer over a 7-day
observation. Results are the average of four independent experiments.
The PEG gel demonstrated high retention of both particles with 10 ± 2% of AuNRs and 9 ± 2%
liposomes released after 3 days, after which no further particles were lost, Figure 6.7. The high
retention of the particles means that this system would be viable for use as a wound dressing
that could be last for several days with little effect on the antimicrobial viability. These results
also confirm the high liposome loading efficiency into the gel. Given the gel was fabricated in
situ and only ∼5% of the liposomes were observed in the supernatant after 24 hours indicates
that a minimum of ∼95% of the liposomes are within the gel immediately after fabrication.
6.2.3 Characterisation of AuNR-loaded gel photothermal properties
The photothermal response of the AuNR-loaded gels was characterized in order to control the
thermally induced liposome release of AMPs. It is important that the inclusion of the AuNRs
into the gel did not cause aggregation that could affect the photothermal heating profile. As
such, 50 µl gels were fabricated in 96-well plates before the addition of 150 µl of MHB II and a
thermocouple. The wells were then irradiated with a continuous wave laser, 860 nm, at 1.8 – 2.8
W cm−2 for 10 min. This gave control of the maximum temperature achieved within the wells to
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be between 50 and 65◦C (±1◦C), which was reached in 5 mins and maintained for a further 5 min,
Figure 6.8A. The photothermal efficiency was maintained through repeated irradiation cycles,
Figure 6.8B, demonstrating the ability to achieve dose-dependent temperature increases with
the NR-loaded hydrogels and provide reproducible levels of heating (with the same temperature
attained) over several irradiation cycles. The reproducibility of the heating profiles indicates
that there is no change in optical properties and therefore no reshaping or aggregation of the
AuNRs under irradiation, at these laser intensities. This is be beneficial within a wound dressing
as it would allow a single gel to be provide multiple rounds of photothermal treatment that could
achieve multi-stage delivery of antimicrobial agents.
Figure 6.8: A) Photothermal heating profiles of the AuNR loaded 5 wt% hydrogel under varying
laser intensities for 10 minutes, starting from a base temperature of 35◦C. B) The photothermal
heating profile of the NR loaded gel over repeated irradiation cycle at 2.4 W cm−2 laser intensity
(λ = 860 nm) for 10 minutes.
6.2.4 Photothermal triggered released from liposome loaded hydrogels
The final step in the characterisation of the gel was to determine whether the photothermal
release of liposome encapsulated materials was affected by the inclusion into the gel matrix.
Gels of 2.5, 5 and 10 wt% were fabricated containing AuNRs and calcein-loaded liposomes,
incubated with an S. aureus suspension for one hour before irradiation at 0 or 2.1 W cm−2 (λ
= 860 nm) for 10 mins. A control sample without the gel was included for comparison.
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Figure 6.9: A) Bacterial and photothermal induced release of calcein (diagonal lines and hashed
columns respectively) from liposomes in PEG gels of different wt% when incubated in a S.
aureus suspension. All gels contained 48 µg ml−1 AuNRs and a laser power of 2.1 W cm−2 was
used to irradiate the samples to heat them to 55◦C for 5 mins. 1% Triton-X100 was added to
samples (grey columns) to ensure that the maximum fluorescent response was the same across
all gels. Results are the average from 6 replicates. B) AuNR and calcein liposomes loaded into
the 5 wt% PEG hydrogel, irradiated for 10 mins with intensities between 0 - 2.8 W cm−2 (λ =
860 nm) and placed under a UV-lamp.
The incorporation of AuNRs and liposomes into the PEG matrix was found to increase the
delivery profile from all of the gels with 71 ± 11%, 64 ± 6% and 64 ± 2% calcein release
from gels of 2.5, 5 and 10 wt% respectively, compared to 56 ± 2% release from liposomes
free in suspension, Figure 6.9A. This increase may be due to the confinement of the liposomes
and AuNRs within the 50 µl volume of the gel, rather than when they are free in solution
and are able to diffuse throughout the 200 µl total volume of liquid. This would increase the
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likelihood of the liposomes and thermally radiating AuNRs being in a close proximity to one
another making the liposomes more susceptible to thermal destabilization. The inclusion of the
liposomes within a gel also exhibited reduced bacteria induced release leakage. This may be due
to the PEG matrix restricting access of the bacteria to the liposomes and hence limiting their
direct interaction, meaning any induced leakage most likely arises due to the bacteria producing
toxins that target the membrane.
The triggered release of calcein was also visually demonstrated by fabricating 5 wt% gels with
AuNRs and calcein-loaded liposomes. The gels systems were incubated with S. aureus for an
hour and then irradiating between 0 - 2.8 W cm−2 for 10 mins, before the supernatant containing
the planktonic bacteria was removed. Under a UV-lamp an obvious fluorescent response can
be observed upon irradiation at 2.1 W cmcm−2 and above (heating to 55◦C and and above),
Figure 6.9B.
6.2.5 Hydrogel toxicity to fibroblast cells
The cytotoxicity of the 5 wt% hydrogel and the gel containing both IK8-liposomes and lipid-
coated AuNRs was assessed against human dermal fibroblasts (HDFs), cells that are integral
to the reepithelialisation process. 10 µl gels were fabricated within the sterile biohood on top
of a glass slide coated in parafilm. The hydrophobicity of the parafilm allowed the hydrogels
to slide across the surface of the slide, and easily be placed into wells containing seeded HDFs
and 90µl of fibroblast growth media. The cells were then incubated for 24 hours utilising the
WST-1 assay to obtain the cell viability.
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Figure 6.10: Cytotoxicity of the PEG hydrogel and the therapeutic IK8 liposomes-NR loaded
PEG hydrogel when incubated with HDFs for 24 h. Results are the average from two indepen-
dent experiments, each with 4 replicates.
Figure 6.10 demonstrates that the incubation of the HDF cells with the AuNR and IK8-liposome
loaded 5 wt% PEG gel showed no detrimental effects on cell viability; with > 97% cell viability
observed in the formulation used. Taken together with the results from 5.14, each component
within the therapeutic gel demonstrates excellent biocompatibility indicating that the gel would
be suitable for treatment of infections in a vulnerable wound environment. The lack of cyto-
toxicity of IK8 at concentrations several times the MIC against S. aureus potentially allows for
the liposomal loading of high concentrations of peptide to provide multiple treatment events,
with no risk of toxicity in the event of premature leakage.
6.3 Treatment of pathogenic bacteria
The antimicrobial efficacy of the dressing was assessed against both S. aureus and P. aeruginosa.
Both bacteria are part of the ESKAPE pathogens, a list of bacteria that are the leading cause
of nosocomial infections due to multidrug resistance,419 and have been highlighted by the world
health organisation as part of the ’priority pathogens’ that pose the greatest threat to human
health.420 S. aureus and P. aeruginosa were chosen in particular to analyse the therapeutic
loaded gel and photothermal antimicrobial effects against a Gram-positive and Gram-negative
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bacterium, respectively. To demonstrate the antibacterial capabilities of the AuNR and IK8-
liposome loaded PEG gel system, planktonic bacteria were treated with one of three variations
on the gel; the IK8-liposome and AuNR loaded gel to demonstrate potential triggered release
of AMPs, an AuNR loaded gel to determine the photothermal induced antimicrobial activity,
and a gel containing free IK8 and AuNRs to demonstrate the photothermal enhancement of the
AMP.
The antimicrobial properties of the AuNR and IK8-liposome loaded gel were assessed through
the treatment of Gram-positive S. aureus and Gram-negative P. aeruginosa. By controlling
the applied laser irradiation intensity between 1.8 and 2.8 W cm−2, we were able to provide
photothermal heating profiles between 50◦C and 65◦C and demonstrate the first instance of
triggered release of AMPs from liposomes. The triggered release of IK8 was observed to occur
for an irradiation of 2.1 W cm−2 for 10 minutes and heating the sample to 55◦C. This produced
6- and 7-log reductions in the number of CFU ml−1 when treating S. aureus and P. aeruginosa
respectively, Figure 6.11. No decrease in bacteria viability was observed when treating either
bacteria with a laser intensity of 1.8 W cm−2, 50◦C. This clearly indicates that the sample
must be heated to the lipid gel-fluid phase transition temperature of DSPC (55◦C) in order
to trigger release of encapsulated materials.235,236,383,421–423 The thermally induced release is
highest close to the phase transition temperature, Tm, due to the coexistence of both gel and
fluid domains, producing grain boundaries that have an increased permeability of hydrophilic
molecules.424–427 The liposomal release of the MIC of IK8 showed a similar level of bactericidal
activity as the gel containing the MIC of free IK8 against both bacterial types, 5.5- and 6.7-
log reductions in CFU ml−1 against S. aureus and P. aeruginosa respectively. This indicates
that the liposomal encapsulation and subsequent triggered release did not affect the peptide’s
antimicrobial efficacy. When taken together with the liposomal protease protection, these results
indicate that this therapeutic gel offers a potential means of maintaining AMPs in a protease
rich wound environment until required, with no decrease in bactericidal efficacy upon triggered
release. By utilizing a photothermal trigger, we are also able to enhance the bactericidal activity
of the therapeutic gel by heating the bacteria to higher temperatures. Enhanced bacterial kill
was observed when treating both bacteria with IK8 and laser irradiation at 2.4 W cm−2 (60◦C)
for 10 min, leading to a 7.8-log reduction in CFU ml−1 of S. aureus and complete bacteria killing
of P. aeruginosa. This is similar to previous observations demonstrating thermal enhancement
of antibiotics against planktonic S. aureus and P. aeruginosa.249,265,428 Furthermore, there have
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been several in vivo studies investigating the antibacterial properties of photothermal heating
from nanoparticle loaded-hydrogels, that heat infected wounds up to 50-60◦C for up to 10
minutes.6–9,261,267,297,428 In all cases the heating demonstrated no thermally induced damage
to peripheral tissues or detrimental effects upon reepithelialization. Through the fabrication of
gels containing AuNRs only, we also evaluated the antimicrobial effects of photothermal heating
alone. Neither bacterial species displayed any decrease in bacteria viability until irradiation at
2.4 W cm−2 (heating to 60◦C), at which point there was a 2.6-log decrease in S. aureus and a 4.4-
log decrease in P. aeruginosa. This correlates with previous studies that have demonstrated that
Gram-negative bacteria are more susceptible to thermal killing than Gram-positive.297 Further
increasing the laser intensity to 2.8 W cm−2 (heating to 65◦C) showed complete antimicrobial
killing of both bacterial species in all samples containing the NRs. All bactericidal activity was
attributed to the photothermal heating, with no bacteria death observed under irradiation at 2.8
W cm−2 in the absence of AuNRs. These results show that the IK8 liposome and AuNR loaded
hydrogel has the potential for use as a broad-spectrum antimicrobial treatment that, through
the regulation of the applied laser intensity, can not only trigger the release of AMPs, but
amplify their antimicrobial effects. By harnessing the photothermal enhancement, the chances
of providing non-lethal treatment are reduced, as such this treatment should provide a decreased
likelihood of bacterial AMP resistance.
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Figure 6.11: The reduction in the number of viable A) S. aureus and B) P. aeruginosa, CFU
following treatment with gels containing AuNRs, AuNRs and free IK8, and AuNRs with IK8-
loaded liposomes, irradiated with an 860 nm laser, at intensities between 1.8 - 2.8 W cm−2
for 10 mins. The bactericidal threshold is noted with a dashed line. Results are the average
over three independent experiments. Two-tailed T-tests were were used to obtain statistical
significance, p-values indicate; *** < 0.001, **** < 0.0001.
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6.4 Repeated treatment of S. aureus from the hydrogel forma-
tion
The ability to utilize the hydrogel as a drug depot to provide repeated triggered release of an-
timicrobial agents at lethal dosages, and in combination with photothermal ablation of bacteria
would provide significant advantages in wound management. Whenever a wound is exposed to
the environment there is a chance of infection occurring.429 As such, it would be beneficial for a
single dressing to be able to provide multiple rounds of treatment, thus decreasing the frequency
with which the dressing needs to be replaced. Being able to use a single dressing for repeated
treatments also makes the dressing financially more viable, as a new gel would not need to be
purchased each time treatment is required, potentially increasing the chances of use in clinic.
In order to determine whether multiple rounds of triggered delivery of AMPs is possible from
the IK8-liposome/AuNR loaded gel, the number of liposomes must be increased such that they
contain enough AMP to provide multiple rounds of bactericidal activity. As such, gels were
fabricated containing different numbers of IK8-liposomes correlating to 0-4 times the MIC and
incubated with a suspension of S. aureus for 18 hours to determine the antimicrobial activity
of IK8 that has been released through the bacteria induced liposome disruption.
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Figure 6.12: A) The reduction in S. aureus viability when different numbers of IK8-liposomes
are incorporated into a 5 wt% gel and incubated with the bacteria suspension for 18 hours.
The dashed line indicates the bactericidal threshold. The CFU ml−1 values are the average
across six replicates of bacteria that are combined before being spread onto three agar plates.
B) Triggered release of calcein from liposomes loaded into 5 wt% gels after incubation in a S.
aureus suspension for 1 h before laser irradiation at 860 nm for 5-10 min, with a laser intensity
of 2.1 W cm−2. Fluorescence measurements (EX/EM, 496/515 nm) were taken immediately
after addition to the bacteria suspension and after an 18 h incubation at 37◦C. 1% Triton-X100
was added to the control wells to find the maximum fluorescence. Results are the average of six
replicates.
Figure 6.12A shows that there was no affect on the bacteria viability until liposomes containing
2 x the MIC of IK8 were incorporated into the gel at which point there was a 0.7-log reduction
in bacteria. Increasing the concentration of IK8 to 3 and 4 x the MIC showed significantly more
bacterial activity with 2.8- and 5.2-log reductions respectively. These values are substantially
lower than the bacteria death observed when performing the equivalent experiment without the
gel (Figure 5.12), liposomes containing 2 and 4 x the MIC showed 3- and 6.5-log reductions.
This decrease in bacteria killing from IK8-liposomes loaded into a gel indicates that the gel
offers a protective effect against direct interaction with bacteria.
The liposome release with laser irradiation time was then investigated to determine whether
the amount of AMP released could be reduced to ensure that a lethal dose of the drug can
be maintained within the liposome reservoirs after the first stimulated release event. Calcein-
loaded liposomes were incorporated into gels, incubated with a 1x106 suspension of S. aureus
for an hour before being irradiated at 2.1 W cm−2 for 5 to 10 mins. As shown in Figure 6.12B,
irradiating the samples for 5 mins resulted in 44 ± 4% release, which increased with irradiation
time up to 7 mins, 66 ± 6%, after which there was no change in the release profile up to the
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maximum irradiation time of 10 mins, 67 ± 3%. This means that using an irradiation time of 5
mins as opposed to 10 mins, would allow the retention of 23% more drug for use in the second
round of treatment. This also means that by increasing the irradiation time to 7 mins or above
in the second round of treatment we would be able to provide a release of a larger proportion
of the IK8 that remained encapsulated.
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Figure 6.13: The log reductions in S. aureus CFUs over two treatment cycles when treated
with the the PEG hydrogel containing 48 µg mL−1 of AuNRs irradiated with a laser intensity
of 2.4 W cm−2 (grey), and gels containing AuNRs and liposomes encapsulating 2.5 times the
MIC of IK8 irradiated at 0 W cm−2 (hashed), 2.1 W cm−2 (diagonal slashed) and 2.4 W cm−2
(horizontal lined). Gels were irradiated for a period of 5 mins during the first treatment event
and left to incubate for 18 h before being replaced with fresh bacteria and irradiated for 10 mins
during the second treatment. Results are averaged across four replicates of bacteria combined
and spread onto three agar plates. Two-tailed T-tests were were used to obtain statistical
significance p-values indicate: * < 0.05, **** < 0.0001.
To demonstrate the antimicrobial capabilities of the AuNR and IK8-liposome loaded gel over
multiple rounds of treatment, gels were fabricated with AuNRs and an increased number of
liposomes such that they contained 2.5 times the MIC of IK8. The gels were inoculated with
the first round of S. aureus before irradiation at 2.1 or 2.4 W cm−2 for 5 mins. The bacteria
were then incubated with the gel for 18 h, before removal and quantification of CFU ml−1. The
gel was then inoculated with a fresh S. aureus suspension and subjected to irradiation at 2.1
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or 2.4 W cm−2 for 10 minutes, before incubation for 18 h. The second round of bacteria was
then removed for CFU quantification. Under irradiation at 2.1 W cm−2 (heating to 55◦C), the
triggered release of IK8 resulted in bactericidal activity over both treatment cycles, with 7.1-
and 3.8-log reductions in S. aureus after the first and second cycles respectively, Figure 6.13.
The decrease in antimicrobial efficacy is attributed to the diminishing number of intact IK8-
liposomes remaining after each release event. The photothermal enhancement of IK8 can also
be observed over both treatments, under irradiation at 2.4 W cm−2 (60◦C). The photothermal
heating produced further 1.1- and 2.5-log reductions in CFUs, in the first and second cycles
respectively, compared to systems providing bacteria killing through only AMP delivery. Using
a gel containing only AuNRs the difference in photothermal killing was confirmed to be due
to the alterations in irradiation time, with the 5 min irradiation in treatment one resulting in
a 0.5-log decrease in CFU ml−1 and the 10 min irradiation during treatment two producing a
2.6-log reduction in CFU ml−1. The bactericidal activity of the gel, both with and without the
photothermal enhancement, demonstrates the potential for multiple therapeutic events and can
be optimized for a variety of treatments. Furthermore, this indicates that the main limitation
in the number of treatments that can be performed is the concentration of antimicrobial agents
encapsulated within the system.
Conclusion
This chapter has demonstrated the fabrication of an AuNR and IK8-liposome loaded hydro-
gel, that can effectively treat pathogenic bacteria through the photothermal stimulated release
of AMPs, which is the first example of an exogenous stimuli-responsive release of AMPs. The
chapter started with the optimisation of the PEG hydrogel formulation protocol. It was demon-
strated that the wt% of the gel, the buffer pH, and the salt concentration of the gel can be used
to control the gelation time and mechanical properties of the gel. A 5 wt% gel fabricated using a
10 mM citrate buffer at pH 6 was desirable due to the reasonable gelation time, 20 seconds, and
the production of a smooth and homogeneous gel. The incorporation of AuNRs and IK8-loaded
liposomes did not affect the liposome integrity nor did it cause any AuNR aggregation. Through
irradiation of the AuNR loaded gel between 1.8-2.8 W cm−2 the photothermal heating could be
regulated to control the temperature of a bulk 200 µl solution between 50-65◦C to within 1◦C
of a target temperature. As such, the photothermal triggered release of calcein from liposomes
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within the gel was demonstrated, and subsequently the incorporation of the AuNR-liposome
system into a 5 wt% PEG matrix increased the release efficiency by 8%.
The antimicrobial properties of the AuNR and IK8-loaded gel system were then investigated.
Irradiation at 2.1 W cm−2 for a period of 10 min heated the sample to 55◦C, triggered the release
of IK8, and resulting in ∼6- and ∼7-log reductions in the number of Gram-positive S. aureus and
Gram-negative P. aeruginosa CFU ml−1 respectively. Increasing the laser intensity to 2.4 W
cm−2, heating to 60◦C, enhanced the antimicrobial activity of the system with additional 2- and
5-log reductions in viable S. aureus and P. aeruginosa respectively. Through the optimization
of the irradiation time and increasing the number of AMP-loaded liposomes, such that the
final concentration of IK8 was 2.5 times the MIC against S. aureus, the gel was shown to
release bactericidal dosages of IK8 to treat two sequential bacterial suspensions, resulting in
7- and 4-log reductions in CFU ml−1 from the first and second treatment cycles respectively.
Furthermore, irradiation at 2.4 W cm−2 demonstrated enhanced antimicrobial activity over
both treatment cycles. This study demonstrates the capability to perform multiple treatment
events using an individual gel, offering a reduced cost per treatment. Other studies have also
demonstrated the photothermal destruction of biofilms using nanorod loaded hydrogels,10,298
and given the innate antibiofilm properties of IK815 results from this chapter indicate that the
photothermal enhancement of these properties will be able to continue into the treatment of
mature biofilms, which are more representative of infections than treating planktonic bacteria.
These results indicate that the facile integration of AMP-loaded liposomes and AuNRs into a
PEG hydrogel network offers protection of encapsulated materials and tunable release profiles
showing potential for the treatment of infections.
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Motivation:
Chapters 5 and 6 of this thesis describe the development of a wound dressing that offers trig-
gered release of AMPs in response to bulk heating mediated by AuNR photothermal agents
dispersed through a gel. Whilst there are many advantages to this, it is hypothesised that
the conjugation of gold nanoparticles to AMP-loaded liposomes would provide a higher release
efficiency, when using a pulsed laser system. The application of a pulsed laser system allows the
deposition of large quantities of energy over timescales equivalent to the thermalisation time of
the particle with the surrounding media; meaning the particle is able to generate large ther-
mal gradients without providing a bulk heating effect. The high temperature in the immediate
vicinity to the particle is able to cause membrane disintegration, whilst the thermal gradients
are capable of vapourising the surrounding liquid creating cavitation bubbles that produce in-
tense pressure waves that can also disrupt a lipid membrane.180,181 Wu et al., demonstrated as
such by tethering hollow gold nanoshells (HGNs) to lipid vesicles (1,2-dipalmitoyl-sn-glycero-
3-phosphocholine, DPPC); the HGN-liposome complex provided substantially higher release of
encapsulated calcein (93%) than HGNs mixed freely in suspension (35%), when irradiated at
16.1 W cm−2 at 800nm with a pulse width of 130 fs and a repetition rate of 1 kHz.180 Not only
would the liposome-AuNP conjugation increase the release efficiency but would remove the re-
liance upon the bacterial toxins for AMP delivery. Furthermore, triggering release without bulk
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heating would minimise any toxicities that could arise from heating of tissues.
In recent years several studies describe the use of liposomes as a soft template for AuNP syn-
thesis, utilising the lipid bilayer as a nucleation site onto which Au is deposited and at high
enough concentrations a coating of AuNPs can be formed. This was first observed by Troutman
et al. using 63 nm DPPC liposomes as a soft template for the adsorption of gold clusters to
form a shell-shaped array.223 They demonstrated that the absorption peak of the particles could
be tuned by altering the quantity of gold used during the synthesis, with higher concentrations
of Au resulting in a higher density of liposome coverage causing the extinction spectra to be
red-shifted displaying shell-like optical properties. Au-coated liposomes were first applied to
medicine by Rengan et al. using the particles to demonstrate phothotermal ablation of MDA
MB 231 cancer cells.213 This study identified that increasing the ratio of ascorbic acid (AA) to
Au ions caused a red shift in the absorption peak, allowing finer control of the peak position
between 550-900 nm. Since this study the AuNP coated liposomes have been used in vivo to
demonstrate the photothermal treatment of HT1080-fluc2 -tuboFP tumour xenografts in murine
models leading to an 80% survival rate after 60 days with treatment and 0% survival after 35
days without. Interestingly, this study also demonstrated that the laser induced degradation
of the Au complex to particles ≤ 5-8 nm enables removal through the renal system. The anti-
cancerous capabilities of the Au-nanocontainers have also been enhanced through loading with
chemotherapeutics that are release upon laser induced degradation.430 The triggered release of
curcumin loaded into the liposome lumen resulted in an additional 2-fold decrease in B16F10
cells, on top of the initial photothermal ablative effects. Despite the advantages of using Au
coated liposomes these systems have not been applied to the field of infectious therapies. As
such, it is hypothesised that the synthesis of AuNP-coated AMP-loaded liposomes will provide
pulse laser triggered release of peptides to treat pathogenic bacteria, Figure 7.1.
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S. aureus (dead) 






Figure 7.1: Schematic representation of gold nanoparticles adsorbed to AMP-loaded liposomes
to provide pulse laser irradiation triggered release of peptides to incite bactericidal activity
against S. aureus. Liposomes and gold nanoparticles have been scaled up for ease of viewing.
7.1 Synthesis of gold nanoparticles in the presence of IK8-loaded
liposomes
This section will cover the attempted gold coating of liposomes by synthesising AuNPs in the
presence of the vesicles. This will involve exploring the ratios between the gold precursor
(chloroauric acid, HAuCl4), the reducing agent (AA) and the liposome concentrations, as well
as identifying the effects of using PEGylated and thiolated lipids.
In the absence of a template, mixing a gold salt with a reducing agent synthesises isotropic
spherical colloidal AuNPs, with a transverse plasmon peak at 550 nm. However, in the presence
of liposomes gold ions can be adsorbed onto the lipid bilayer creating nucleation points for
crystal growth, Figure 7.2A. Upon addition of a reducing agent the charge on the Au ions is
lost causing aggregation onto the nucleation sites on the liposome surface, Figure 7.2B, leading
to the formation of AuNPs, Figure 7.2C. At low AuNP densities on the liposome surface the
plasmonic properties of the AuNPs remain the same as those free in suspension with a transverse
absorption peak at 550 nm. As the density of AuNPs on the liposome surface increases the
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coating can be modelled as a continuous gold shell, and the plasmonic resonance wavelength is
red shifted with increasing packing density, Figure 7.2D.
Figure 7.2: Schematic representation of the gold nanoparticle synthesis on the surface of a
phospholipid liposome. A) Au+3 ions in solution adsorb onto the surface of the liposome, B)
addition of a reducing agent causes the reduced ions to aggregate on the nucleation points on
the liposome surface, C) gold nanoparticles on the liposome surface continue to grow until the
gold is expended. D) As the surface density (Φ) of gold nanoparticles increases the plasmonic
absorbance peak increases in amplitude and is shifted to longer wavelengths. Φ = 0.7 (red), 0.8
(yellow), 0.9 (green), 0.95 (blue), and 1 (black). Edited with permission.223 Copyright 2008,
Wiley.
The liposome gold coating was synthesised through the reduction of HAuCl4 using AA in the
presence of liposomes. Briefly, AMP-loaded liposomes, cleaned using dialysis for 48 hours, were
diluted to 2 mg ml−1 in PBS. 200 µl of the liposomes was then mixed with 100 µl of HAuCl4
before the rapid injection of 400 µl of AA (AA:Au ratios of 1-4:1).
7.1.1 Liposomes containing PEGylated lipids
The Au coating of PEGylated liposomes has been demonstrated by Orsinger et al. to provide
triggered release of carboxyfluorescein.431 As such, during this study initial attempts at Au
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coating were performed on the PEGylated liposomes developed in Chapter 5. These liposomes
were thoroughly characterised and produced efficient encapsulation of IK8 with low sample-to-
sample variability. The Au coating of these liposomes was performed by varying the ratio of AA
to Au ions (1:1 to 4:1) added to the peptide loaded vesicles. The UV-vis spectra of the particles
was initially used to determine the nanoparticle coating, increasing the AA:Au ratio should
cause a red shift in the plamonic peak position if the AuNPs are adsorbed onto the liposome
surface, if the AuNPs are not on adsorbed onto the liposome the plasmonic peak should remain
around 550-600 nm, independent of the AA:Au ratio.213,214
The UV-vis spectra for the attempted Au coating using 2.5 mM and 5 mM HAuCl4 predomi-
nantly displayed absorbance peaks at 600 nm, with little change upon varying the AA:Au ratio,
Figure 7.3A. However, upon increasing the Au concentration to 7.5 and 10 mM HAuCl4 the
liposome-AuNP complexes exhibited absorption peaks that can be red-shift from 600 nm to
850 nm by increasing the AA:Au from 1:1 to 4:1, Figures 7.3B and C. At 10 mM HAuCl4 the
absorption peaks were more defined with a heightened extinction coefficient as the AA:Au ratio
was increased. TEM Images of samples containing AuNPs synthesised using 10 mM HAuCl4
with 10 and 40 mM AA, Figures 7.3E and F respectively, showed that the liposomes are not
being coated in AuNPs. Figure 7.3E, displays the synthesis of a large number of small (< 50
nm) spherical particles, that are not adhered to the liposomes. The particles shown in Figure
7.3E, are much larger, mostly between 100-200 nm, and the surfaces appear rough with many
protrusions. Rather than the Au coating causing the red-shift as the AA:Au ratio is increased,
it appears that the increase in the peak absorbance wavelength is caused by the synthesis of
larger and more anisotropic particles, both factors have been shown to provide a red shift in
the optical absorbance.432–434
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Figure 7.3: The UV-vis spectra of gold nanoparticles synthesised in the presence of PEGylated
liposomes using A) 2.5 mM and 5 mM HAuCl4, B) 7.5 mM HAuCl4 and C) 10 mM HAuCl4,
with 1:1 (solid), 2:1 (dashed), 3:1 (dotted) and 4:1 (dashed and dotted) ratio of AA:Au ions.
D) The absorbance spectra of 10 mM HAuCl4 and 30 mM AA synthesised in the presence of
different concentrations of liposomes. E) TEM images of AuNPs synthesised with liposomes,
using 10 mM HAuCl4 and 10 mM AA. F) TEM images of AuNPs synthesised with liposomes,
using 10 mM HAuCl4 and 40 mM AA.
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Both the TEM and absorbance results indicate that instead of coating the liposomes the gold was
forming branched gold nanoparticles, often termed as nanostar (AuNS)435–439, nanourchin440–443
or nanoflower444,445 structures. Gold branched AuNPs have a solid metallic core that provides
an absorbance peak similar to that of a nanosphere, between 500-600 nm, and protrusions from
the particle surface that absorb light at longer wavelengths. Barbosa et. al demonstrated that
using a seeded synthesis of AuNSs the peak position and amplitude may be controlled by varying
the size of the Au seed and the ratio of Au seeds to the concentration of HAuCl4 used during
the synthesis.435 Figure 7.3B, depicts that the protruding tips produce a shoulder at higher
wavelengths than the absorption peak defined by the particle core (550-600 nm), however as
the protrusions increase in length and the particles become more anistropic, the absorption at
higher wavelengths becomes dominant resulting in the core absorbance becoming a shoulder at
500-600 nm. At the lowest AA:Au ratio (1:1) the peak at 600 nm had a broad slope at longer
wavelengths, however upon increasing the AA:Au ratio to 3:1 the peak at 710 nm is the larger
than that at 600 nm. Further increasing the ratio to 4:1, the 600 nm peak is almost completely
enveloped by the larger peak at 800 nm and syntheses performed using 10 mM HAuCl4 at 3:1
and 4:1 AA:Au ratios show no visible peak at 600 nm (Figure 7.3C).
In the absence of liposomes, the synthesis produces spherical particles with an absorbance at
500-600 nm, at all AA:Au ratios and independent of the HAuCl4 concentration. It is therefore
evident that the synthesis is affected by the presence of the liposomes that induce the anisotropic
growth. This effect has been utilised to synthesise AuNS particles through the deposition of
gold onto liposomes (DPPC/1-palmitoyl-2-hydroxy-sn-glycero-3 phosphocholine (MPPC)/1,2-
distearoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-2000] (DSPE-
mPEG2k)), producing particles with an absorbance peak at 700 nm and a shoulder at 500
nm.446 Sivasubramanian et al. did not demonstrate control over the absorbance properties, nor
did they clarify the synthesis mechanisms beyond stating that the addition of zero valence metal
atoms to a liposome solution has been shown to produce deposition onto the vesicle bilayer.447
This reinforces that the gold deposited onto the bilayer acts as a nucleation point, or seed, onto
which further gold is adsorbed to form the AuNS structure.
The effects of the liposome concentration on particle synthesis were also investigated. The lipid
concentration was varied between 10 and 0.7 mg ml−1 and particles were synthesised using 10
mM HAuCl4 and 30 mM AA. Increasing the liposome concentration above 2 mg ml
−1 caused
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a slight red-shift in the absorbance peak position, ∼80 nm from 2 to 10 mg ml−1, but had
little effect on the peak extinction coefficient, Figure 7.3D. However, upon decreasing the lipid
concentration to 1 mg ml−1 there was a significant decrease in the peak extinction coefficient.
7.1.1.1 Laser irradiation of gold nanostars
 Before irradiation
 After irradiation











































Figure 7.4: A) The UV-vis spectra and B) DLS sizing data of AuNPs synthesised in the presence
of PEGylated liposomes before and after irradiation at 4,500 µJ cm−2 (10 Hz) at 700 nm for
1 min. Inset is an image of the solutions before and after irradiation. TEM images of the
AuNP-liposome complex C) with and D) without laser irradiation.
The study by Sivasubramanian et al. demonstrated that the AuNSs synthesised using calcein-
loaded liposomes could be used to trigger release under pulse laser irradiation, fluence of 10
mJ cm−2 at 690 nm and a frequency of 10 Hz.446 As such, the laser irradiation of AuNSs
synthesised with the IK8-loaded PEGylated liposomes was investigated. The IK8 release from
the liposome-AuNS (3:1 AA:Au, 10 mM HAuCl4) system under pulse laser irradiation at 4,500
µJ cm−2, frequency 10 Hz at 700 nm for 1 minute, was assessed. This resulted in rapid melting
and reshaping of the of the AuNSs into AuNPs, causing a visible colour change from a deep
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blue to the distinctive red of AuNPs, and can be clearly seen in the blue shift in the absorbance
spectrum, Figure 7.4A. TEM images of the AuNSs before and after irradiation, Figures 7.4C
and D respectively, show the morphological change from anisotropic spiky to smooth spherical
particles that produced the change in the absorbance spectrum. Despite the AuNS melting,
no liposome destruction was observed using dynamic light scattering (DLS), Figure 7.4B. After
irradiation there was a prominent peak at 100 nm attributed to the AuNS melting, however
there was little change in the liposome distribution at 350-400 nm. Samples containing calcein-
loaded liposomes were also irradiated however there was no change in fluorescence, indicating
that there was no release of encapsulated materials.
7.1.2 Non-PEGylated liposomes
The presence of a PEG periliposomal layer may have sterically or electrostatically hindered the
gold ion adsorption onto the lipid membrane. As such, the AuNP synthesis was repeated using
non-PEGylated liposomes containing only 1,2-distearoyl-sn-glycero-3-phosphocholine (DSPC)
and cholesterol (70/30 mol%).
Using 2.5 mM HAuCl4 the UV-vis spectra of the synthesised AuNPs show a very broad peak
at 680 nm with a 1:1 AA:Au ratio, Figure 7.5A. At AA:Au ratios of 2:1 and higher the peak
increases and is red-shifted to 900 nm. At 5 mM HAuCl4 all samples exhibit similar absorbance
profiles with a peak at 850-900 nm, however as the AA:Au is increased a shoulder at 670
nm starts to form, Figure 7.5B. This shoulder becomes more prominent upon increasing the
HAuCl4 concentration to 10 mM, Figure 7.5C. TEM images were taken of samples containing
2.5 and 5 mM HAuCl4 at 4:1 ratios of AA:Au. Both samples display the formation of frac-
tal like gold nanoparticles that resemble snowflakes, with a dense centre and seemingly thin
fractal growths forming a flake like structure. It is also apparent that the particles are free in
solution, not adhered to liposomes; meaning such a system would be unable to provide trig-
gered release in response to the pulsed laser irradiation. In order to increase the chances of
AuNP synthesis occurring directly on the liposome surface the thiolated lipid 1,2-dipalmitoyl-
sn-Glycero-3-Phosphothioethanol (DPPE-Ptd) was added to the vesicle composition. Thiols
contain sulphur ions that have a high affinity to Au, meaning that the Au ions should bind to
the thiol groups providing initial nucleation sites onto which the reduced Au+ ions will adhere.
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Section 7.1 Chapter 7. Pulsed laser triggered release of AMPs without bulk heating
7.1.3 Liposomes containing thiol-functionalised lipids
DPPE-Ptd thioethanol was introduced into the liposome composition with the idea that the re-
duced gold ions will bind to the thiol group creating a nucleation site for further gold deposition,
thus increasing the likelihood of AuNPs being bound to the liposome surface. Functionalising
the liposome surface to facilitate Au adhesion has been demonstrated by Jin et al., who utilised
liposomes containing poly-L-histidine, a polymer capable of chelating metal ions, to initiate and
control the growth of a gold shell around the lipid vesicle.222. As such, the initial step was to
optimise the fabrication of the thiolated liposomes. Experiments were performed using lipo-
somes of DSPC/cholesterol/DPPE-Ptd (69/30/1 mol%), however all samples exhibited rapid
vesicle aggregation. As such, 2% DSPE-mPEG2K was introduced into the liposome structure
to improve the colloidal stability. After 48 hours of dialysis the IK8-loaded PEGylated and
thiolated liposomes (DSPC/chol/DSPE-mPEG2K/DPPE-Ptd, 67/30/2/1 mol%) were 330 ±
96 nm in diameter (Figure 7.6A), demonstrating that the inclusion of DPPE-Ptd did not affect
the liposome formation and that the introduction of the PEG prevented aggregation. These
liposomes also exhibited the encapsulation of 681 ± 60 µg ml−1, over 20 times the MIC of IK8
against S. aureus, when using a 10 mg lipid film and a 5 mg ml−1 IK8 solution in PBS.
The AuNP synthesis was performed using liposomes containing 5%, 3% and 1% DPPE-Pdt, the
UV-vis spectra can be seen in Figures 7.6 B, C and D respectively. The absorption spectra of the
samples using 5% and 3% DPPE-Pdt liposomes depict AuNP formation using 2.5 mM of HAuCl4
at a 1:1 AA:Au ratio, but using a higher AA:Au ratios and higher HAuCl4 concentrations,
the particles either aggregated or had very broad spectra that peaked above 900 nm. Using
liposomes containing 1% DPPE-Ptd more control was afforded using 5 mM HAuCl4. At an
AA:Au ratio of 1:1 the AuNPs produced a broad spectrum with a peak at 780 nm. The TEM
images of this sample (Figure 7.6E) show that the AuNPs were anisotropic structures, providing
the red-shift in the absorbance peak. The TEM images also show that the AuNPs have a high
affinity to the thiolated liposomes, over 99% of the particles are adjacent to liposomes. This
indicates that the thiol group can be used to adhere AuNPs to the liposome structure, even
if it does not encourage the synthesis of a Au coating. As such, it was decided that it would
be preferential to bind thoroughly characterised and monodispersed AuNPs to the liposomes,
rather than the amorphous structures displayed in Figure 7.6E.
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Section 7.2 Chapter 7. Pulsed laser triggered release of AMPs without bulk heating
7.2 Gold nanoparticle conjugation to thiolated-liposomes
The facile conjugation of AuNPs to thiolated liposomes indicated that rather than synthesise
an Au coating for the liposomes, simply binding particles to the bilayer may prove an equally
viable means of providing pulsed laser triggered AMP delivery. Given their exceptionally high
absorption cross-section and simplicity of functionalisation, AuNRs were chosen as the ideal
photothermal agent to bind to the liposome surface, see Figure 7.7.
S. aureus (dead) 








Figure 7.7: Schematic representation of AuNR-conjugated IK8-loaded liposomes providing
pulsed laser stimulated release of IK8 to treat a S. aureus suspension.
7.2.1 Citrate capped gold nanospheres
Initially to test whether prefabricated gold nanoparticles can be conjugated to the liposomes,
AA-stabilised AuNPs were mixed with liposomes both with and without 1% DPPE-Ptd. The
AuNPs were synthesised by mixing 5 mM HAuCl4 with 5 mM AA, turning the solution a
deep red. Equal volumes of the AuNP solution and liposome suspensions were allowed to mix
overnight. The sample containing liposomes without DPPE-Ptd displayed large amounts of
precipitation on the surfaces of the vial, whereas the sample with thiolated-liposomes remained
a deep red coloration. The 5 µl sample for TEM imaging was extracted from the centre of the
vial without mixing.
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Figure 7.8: TEM images of citrate-stabilised AuNPs mixed with liposomes A) without and B)
with thiolated lipids. AuNPs can be seen as small dark spots, liposomes are indicated with
red arrows. Inset bar charts display the percentage of the total AuNPs than are immediately
adjacent to a liposome. n = 2961 & 1616 for liposomes without and with thiolated lipids
respectively.
TEM images of the samples displayed a significant difference in the AuNP distribution. The
sample containing liposomes without the thiolated lipids displayed a random distribution of
AuNPs, with 64% not adjacent to a liposome (n=2961), Figure 7.8A. Images of the equivalent
sample with liposomes containing DPPE-Ptd showed 96% of AuNPs associated with liposomes
(n=1616), Figure 7.8B. The significant difference in the particle positioning indicates that the
DPPE-Ptd does provide AuNP-liposome adhesion.
7.2.2 PEG-maleimide functionalised phospholipid stabilised AuNRs
Conjugation of thiolated molecules to AuNP can be performed by simply mixing the two compo-
nents and utilising the high affinity of sulphur ions to gold to replace the original coating. This
procedure however relies on the thiol gaining direct access to the AuNP surface, meaning the
steric stabilisation afforded to PEGylated AuNPs can obstruct the binding process. As such,
binding between the thiolated liposomes and the PEGylated phospholipid coated AuNRs, as de-
scribed in chapter 4, was hindered. Given the significant reduction in toxicity of the phospholipid
stabilised AuNRs against S. aureus compared to alternate coatings (Figure 4.5), functionalising
the phospholipid coating to enable binding to the thiolated liposomes was deemed the best
way forward. As such, a portion of the DSPE-mPEG2k in the phospholipid bilayer coating
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the AuNR, was substituted with DSPE-mPEG2k-maleimide to enable a maleimide-thiol ”click”
reaction (as described in Section 6.1.1) to conjugate the AuNR to the liposome surface. The
inclusion of the maleimide functionalised phospholipids was achieved through the lipid coating
procedure as described in section 4.2, however the final batch of liposomes to be sonicated
with the AuNRs, was fabricated using DSPC/DSPE-mPEG/DSPE-mPEG-maleimide (95/4/1
mol%). Maleimide-functionalised lipids were only included in the final round of the CTAB +
NaOL replacement as inclusion in earlier stages made the dispersion of the pellet significantly
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Figure 7.9: A) The absorbance spectra of binary surfactant (solid black line) and maleimide-
functinalised phospholipid stabilised (grey dashed line) AuNRs. B) TEM images of maleimide-
functionalised phospholipid stabilised AuNRs. C) The length (left) and width (right) distribu-
tions of the maleimide-functionalised phospholipid stabilised AuNRs (n=311).
Initially liposomes containing 1, 3 and 5% DPSE-mPEG2k-maleimide (DSPC/DPSE-mPEG2k
/DPSE-mPEG2k-maleimide molar ratios of 95/4/1, 95/2/3 and 95/0/5 respectively), were soni-
cated with AuNRs, however after the lipid replacement with 3 and 5% maleimide-functionalised
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lipids the resultant AuNR pellets could not be dispersed. AuNRs coated with 1% DSPE-
mPEG2k-maleimide were easily dispersed and the lipid coating process had little effect on the
AuNR optical properties, Figure 7.9A. The TEM images show a tight size distribution of AuNRs
(63 x 25 nm, Figure 7.9C) and a high shape yield (>99%, Figure 7.9B).
7.2.3 Maleimide-functionalised phospholipid coated AuNR conjugation to
thiolated liposomes
2 µm  2 µm  



























Figure 7.10: TEM images of the supernatant and dispersed pellets of maleimide-functionalised
AuNRs mixed with liposomes both with and without DPPE-Ptd. These effects were observed
in two independent samples.
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To determine whether the maleimide-thiol ”click” reaction was possible, equal volumes of
maleimide-functionalised AuNRs (200 µg ml−1 of Au) were mixed with liposomes both with and
without DPPE-Ptd (10 mg ml−1 lipid) and left overnight. The following morning the samples
were centrifuged (9,000 x g, 30 mins), the supernatant was removed and the pellet was dispersed
in Milli-Q. The supernatant and dispersed particles of both samples were then imaged using
TEM.
Figure 7.10 displays clear differences in the AuNR and liposome distribution between the two
samples. The supernatant of the sample containing liposomes without DPPE-Ptd was found to
contain the majority of the liposomes, as they do not have the density to be pelleted at 9,000 x
g, with no AuNRs. Conversely, the dispersed pellet displays predominantly the dense AuNRs,
with very few liposomes. The distinct separation between the liposomes in the supernatant
and the AuNRs within the pellet, clearly indicating that there was no binding between the
liposomes and the AuNRs. The sample containing the thiolated liposomes however, displayed a
larger proportion of the liposomes within the pellet than in the supernatant. These liposomes
also all have AuNRs adjacent to them, indicating that the AuNRs had bound to the vesicles
making complexes dense enough to be pelleted at 9,000 g. The liposomes in the supernatant do
not have associated AuNRs, meaning they would not be pelleted. These results demonstrate the
successful conjugation of phospholipid AuNRs to thiolated liposomes using ”click” chemistry.
7.3 Pulse laser irradiation of maleimide-functionalised phopholipid
stabilised AuNRs and triggered liposomal release
The photothermal response of the AuNRs under pulsed laser irradiation was next investigated.
AuNRs were added to a quartz curvette and placed directly in the beam path, the power was
regulated by inserting filters of neutral density (ND) 1 and 2, reducing the pulse power by 90
and 99% respectively. The AuNRs were then irradiated with a fluence of 4,500 µJ cm−2, with
a pulsewidth of 5 ns and a repetition rate of 10 Hz at 738 nm, before the optical properties of
the AuNRs were then analysed using the UV-vis to identify any morphological changes.
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Figure 7.11: The AuNR absorbance spectra when irradiated for up to 10 mins at 738 nm using
a 10 Hz pulse laser at A) 4,500 µJ cm−2, B) 450 µJ cm−2 and C) 45 µJ cm−2. D) The change in
bulk temperature within a quartz curvette containing 200 µl of 200 µg ml−1 AuNRs in Milli-Q,
starting from a base temperature of 22◦C, upon irradiation for 10 mins with a fluence of 450
µJ cm−2 at 10 HZ at 738 nm.
Significant changes in the AuNR absorbance properties can be observed within 5 seconds of
irradiation with a 4,500 µJ cm−2 fluence. The AuNRs exhibited an almost complete reduction
in the longitudinal plasmonic peak at 738 nm and a substantial increase in the transverse
plasmonic peak at 520 nm, Figure 7.11A. The change in the absorbance is attributed to the
plasmonic absorbance of the light causing electron-phonon relaxation within the gold matrix
providing enough kinetic energy to allow gold atom migration.182 The AuNR surface atoms at
the highest energy move from the areas of highest curvature, at the ends of AuNR, to the lower
energy edges, and has been confirmed in the literature.159,182–187 As such, this migration causes
a reduction in the aspect ratio until a sphere is formed. The same transformational effects are
observed upon irradiation at a fluence of 450 µJ cm−2, however the change in the morphology
164
Section 7.3 Chapter 7. Pulsed laser triggered release of AMPs without bulk heating
takes significantly longer, Figure 7.11B, with the peak absorbance value decreasing exponentially
over time. The 10-fold decrease in the laser fluence decreases the energy available to be absorbed
by the electrons, which in turn reduces the temperature achieved through electron-phonon
scattering and kinetic energy of the surface atoms, ultimately slowing the migration process.189
It is apparent however that from this slower process there is a red shift in the longitudinal
absorption peak. Over the course of the 10 minute irradiation the longitudinal peak position
decreases by ∼70 nm, in agreement with the literature that the irradiation does cause a decrease
in the aspect ratio as the atoms migrate toward the formation of a sphere. This also affects
the rate of transformation. As the absorbance efficiency at 738 nm decreases, less energy is
transferred to the gold lattice meaning that the migration process slows with the irradiation
time. The ∼1◦C increase after 10 mins of irradiation at 450 µJ cm−2 also demonstrates low bulk
heating that is desired from this AMP delivery system, Figure 7.11D. Upon further reducing
the laser fluence to 45 µJ cm−2, after a 10 minute irradiation only 16% reduction in the AuNR
longitudinal peak was observed, Figure 7.11C.
7.3.1 Photothermal triggered release from AuNR adsorbed liposome com-
plexes
The next stage of development was to ascertain whether the liposome-AuNR system can provide
triggered release under pulsed laser irradiation. IK8-loaded liposomes were fabricated both
with and without thiolated lipids and mixed with an equal volume of maleimide-functionalised
phospholipid coated AuNRs (200 µg ml−1). The following day the samples were irradiated for
10 mins with a fluence of 45 or 45 µJ cm−2 (10 Hz at 738 nm), before centrifuging at 17,000 x g
for 30 mins to pellet the AuNRs and liposomes. The particle-free supernatant was then added
to the colorimetric Bicinchoninic acid (BCA) assay that utilises the absorbance at 562 nm to
quantify the peptide concentration.
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Figure 7.12: The IK8 release profile from liposomes with and without DPPE-Ptd, when mixed
with maleimide-functionalised AuNRs and irradiated with a fluence of 45 (dark grey column)
or 450 (diagonal slashed column) µJ cm−2 for 10 mins. Error bars indicate the standard
deviation (n=4) and Two-tailed T-testing was performed to identify statistical significance,
p-values indicate: ** < 0.01.
The main conclusion that can be drawn from Figure 7.12 is that triggered delivery of IK8 was
only achieved when utilising the maleimide-AuNRs in combination with thiolated liposomes
and irradiated at a fluence of 450 µJ cm−2, releasing 67 ± 5% of encapsulated AMP. The same
system using a fluence of 45 µJ cm−2 resulted in release of 7 ± 1%, a statistically significant
decrease, indicating that a higher laser energy is required to cause liposome disruption. In both
circumstances where the liposomes did not contain DPPE-Ptd there was little release under
laser irradiation, < 10% in both samples. In this system the maleimide-functionalised AuNRs
cannot bind to the liposomes meaning they are free in suspension, and as such upon irradiation
at 450 µJ cm−2 displayed a 58% reduction in AMP release compared to their counterpart
with AuNR-liposome binding. The importance of the proximity of a photothermal source
to the liposome is dependent on the means of liposome disruption. As opposed to the use
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of a CW laser, the liposome disruption from a pulse laser does not utilise the photothermal
heating directly but instead exploits mechanical disruption of drug carriers through micro- or
nano-bubble cavitation.194,222,241 Wu et al. (2008) suggested that the high thermal gradients
produced AuNPs upon pulsed laser irradiation, are capable of vaporising water molecules in
the immediate vicinity to the particle.180 This vaporised pocket of water expands rapidly before
imploding and releasing a shock wave that can disrupt a lipid bilayer. These effects are so
highly localised that tethering HGNs to the liposome surface increased the cargo release profile
by 58% compared to HGNs free in suspension.
A) B) 





















Figure 7.13: The calcein release profiles from maleimide-functionalised AuNRs bound to thio-
lated liposomes when A) varying AuNR concentration between 0 - 100 µg ml−1 under irradiation
for 10 mins, and B) varying the irradiation time, 1 - 10 mins, using 100 µg ml−1 of AuNRs. All
samples were irradiated at 738 nm with a fluence of 450 µJ cm−2 at 10 Hz.
The effects of the AuNR concentration and the irradiation time were next investigated to
optimise the release profiles from the AuNR-liposome complex. As the AuNRs free in suspension
produced a 58% reduction in release compared to AuNRs conjugated to the liposomes, there
no further optimisation of the free AuNR system. A linear relationship was displayed when
increasing the concentration of AuNR bound to the liposome, with a maximum release of 64
± 6% with 100 µg ml−1 of Au, Figure 7.13A. The rate of increase of calcein release was found
to exponentially decrease with time. After 1 minute 44 ± 6% of the calcein was released, after
which there was a rapid decrease in release rate resulting in 61 ± 7% after 5 mins and 64 ± 6%
after 10 mins. This exponential decrease in release correlates with the exponential decrease in
absorbance at 738 nm as the AuNRs reshape with irradiation time, Figure 7.11B. This indicates
that if the AuNR were able to retain its absorbance at 738 nm it would be possible to enhance
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the liposome release profile.










































































Figure 7.14: The reductions in S. aureus when treated with AuNR conjugated IK8-liposomes
(ANCIL) with and without pulse laser irradiation at 450 µJ cm−2 at 738 nm for 5 mins, as
well as CFU reductions from IK8-liposomes and AuNRs independently. The ANCIL complex
was formed between liposomes functionalised with thiolated lipid DPPE-PtD, encapsulating
the MIC of IK8, and 100 µg ml−1 of maleimide-functionalised phospholipid stabilised AuNRs.
Results are the average of six replicates. Two-tailed T-testing was used to determine statistical
significance, against S. aureus samples grown in MHB II, unless otherwise indicated. p-values
indicate: ** < 0.01 and *** < 0.001.
The antimicrobial capabilities of this system were next assessed. Briefly, equal volumes of IK8
loaded thiolated-liposomes (10 mg ml−1 of lipid) and maleimide-functionalised AuNRs (200
µg ml−1 of Au) were mixed overnight. The following day the AuNR-liposome complexes were
irradiated at 450 µJ cm−2, at 738 nm for 5 minutes. The sample was then diluted in MHB
II to 2 x the MIC before 100 µl was combined with 100 µl of S. aureus (1 x 105 CFU ml−1).
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The suspension was then incubated for 18 hours before microdilution and spreading onto agar
plates. IK8-liposomes containing DPPE-Ptd (encapsulating 1 x the MIC of IK8) and maleimide-
functionalised phospholipid coated AuNRs (100 µg ml−1) were incubated with the bacteria as
controls.
Upon irradiation, the AuNR conjugated IK8-liposome (ANCIL) complexes exhibited triggered
release of IK8 resulting in bactericidal activity with a 4.4-log reduction in CFU ml−1, Figure
7.14. This represents an additional 3.1-log reduction increase in antimicrobial activity compared
to the equivalent system without laser irradiation. To our knowledge, this is the first instance
of pulsed laser induced phothermally triggered delivery of AMPs to treat pathogenic bacteria.
The second conclusion that can be drawn is that the IK8-loaded liposomes exhibited leakage
that resulted in a 1.5-log reduction in CFU ml−1. This decrease in S. aureus viability is greater
than that exhibited by the DSPC/cholesterol/DSPE-mPEG2k (65/30/5 mol%) liposomes used
in previous chapters (Figure 5.16). The increase in bacteria induced leakage may be due to the
decrease in DSPE-mPEG2k in the liposomes containing DPPE-Ptd, in order to allow access of
the maleimide groups of the AuNRs. DSPE-mPEG2k has been shown to provide steric hinder-
ance between liposomes and bacteria448, as such reducing the concentration of DSPE-mPEG2k
may have increased the bacterial interactions, inducing a greater degree of IK8 leakage that
produced more prominent antimicrobial effects. Finally the maleimide functionalised AuNRs
had little affect on the S. aureus viability, but appeared to slightly decrease the degree of leakage
from bound IK8-liposomes, however this difference is not statistically significant.
Conclusion:
This chapter has demonstrated the fabrication of a liposome-AuNR conjugate to provide bac-
tericidal activity, using the first instance of pulsed laser induced photothermal triggered release
of AMPs from liposomes. Initial attempts to conjugate AuNPs onto the liposome surface were
performed by synthesising the particles in the presence of the AMP-loaded liposomes char-
acterised in Chapter 5. However, these syntheses were unsuccessful in producing an AuNP
coating instead producing a controllable growth of gold nanostars using the liposomes as a soft
template. Through the regulation of the concentration of HAuCl4, the AA to Au ion ratio
and the liposome concentration the AuNS size and morphology could be altered such that the
absorption peak could be tuned between between 550-800 nm. The system was then irradiated
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for 1 minute using a nanosecond pulse laser with a fluence of 4,500 µJ cm−2 at 700 nm with a
pules rate of 10 Hz, to determine the effects on the AuNS-liposome system and to see whether
this triggered release from the liposomes. The irradiation caused rapid melting of the nanostars
resulting in the transformation into nanospheres, with a characterisitic peak at 550 nm and
caused a colour change from blue to red. This failed to induce liposome disruption or release
of encapsualted materials, as such the Au coating was attempted on non-PEGylated liposomes
to allow increased access of Au ions onto the lipid bilayer. This resulted in the formation of
anisotropic gold fractal structures that were free in suspension alongside the liposomes. In an
attempt to conjugate the AuNPs to the liposome, 1 mol% of the thiolated lipid DPPE-Ptd
was included in the lipid composition. Synthesis of the AuNPs in the presence of the thio-
lated liposomes resulted in the fabrication of amorphous AuNPs, that exhibited highly efficient
binding to the liposomes, > 99% of particles had formed complexes with liposomes. It was
then decided to conjugate AuNRs to the thiolated liposomes through the functionalisation of
the AuNR phospholipid bilayer with maleimide groups that enable ”click” reactions with the
thiols groups. Through simply mixing the two components overnight > 99% of the AuNRs
were tethered to liposomes. The resultant AuNR-liposome complex provided triggered release
of 67% of encapsualted AMP under irradiation at 450 µJ cm−2 (10 Hz, 738 nm) for 10 mins,
a substantial increase in the 9% released using AuNRs free in the liposome suspension. This
system was then used to demonstrate the triggered release of AMPs in order to treat plank-
tonic S. aureus, resulting in a 4.4-log reduction in CFU ml−1. Further characterisation of the
AuNR-liposome systems is required in order to ensure long-term stability, biocompatibility and
increased release efficacy, however this proof of concept study demonstrates pulsed laser trig-
gered release, with no bulk heating effects, exhibiting huge potential for the stimuli-responsive
delivery of antimicrobial agents.
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Conclusions and Future Work
The aim of this work was to develop drug delivery systems that provide light-responsive release
of AMPs. Despite the high antimicrobial efficacy and reduced chances of resistance development
AMP clinical translation has been hindered by low biostability, potential systemic toxicity, and
susceptibility to protease degradation. As such, the delivery systems aim to address these issues
to forward the implementation of AMPs as a part of the antimicrobial arsenal.
The development of the AMP delivery system started with the synthesis and characterisation
of AuNRs that provided the light-responsive capabilities of the systems. Chapter 4 described
how varying the centrimmonium bromide (CTAB) and sodium oleate (NaOL) ratios controlled
the synthesis of AuNRs. Further we also showed that phospholipid replacement of the binary
surfactants stabilising the AuNR provided both improved colloidal stability and cytocompati-
bility.
Through varying the concentrations of CTAB and NaOL in the AuNR growth solution, the
longitudinal plasmonic absorption peak was be tuned between 650-1,000 nm, producing a high
AuNR yield (>98%), reproducibility and scalable up to 5 litres.208 The binary surfactant sta-
bilised AuNRs demonstrated an innate colloidal instability, requiring a critical concentration of
CTAB in solution to inhibit aggregation. In order to avoid potential toxicity effects associated
with high CTAB concentrations, a surface replacement was performed coating the AuNRs with a
phospholipid bilayer (DSPC/DSPE-mPEG2k, 95/1 mol%) containing PEG-functionalised lipids
to provide steric stability. The replacement procedure had little effect on the AuNR optical prop-
erties, with the rods displaying no aggregation from UV-vis spectroscopy and TEM imaging.
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The phospholipid stabilised AuNRs demonstrated colloidal stability in Mueller-Hinton broth II
for 24 hours with little change in optical properties, as opposed to the binary surfactant coated
AuNRs, which show significant aggregation nearly eliminating the longitudinal absorption peak.
Furthermore, the phospholipid stabilised AuNRs exhibit increased cytocompatibility against S.
aureus, with no significant decrease in viability upon inoculation at 250 µg ml−1 of Au, as
opposed to the binary surfactant AuNRs which completely inhibited S. aureus proliferation
at 63 µg ml−1. The photothermal capabilities of the phospholipid stabilised AuNRs was next
assessed, attaining heating up to 70◦C using a 2.1 W cm−2 continuous wave laser at 860 nm for
10 mins.
In chapter 5 the viability of an AMP-loaded liposome and AuNR delivery system was investi-
gated. The system development started by optimising the liposome composition and encapsula-
tion efficiency. Depending on the concentration cholesterol can provide a stiffening effect within
a lipid bilayer influencing the small-molecule permeability and lipid phase transition properties,
as such its effect on the liposome leakage and thermo-responsive release were first assessed.
Vesicles composed of DSPC/DSPE-mPEG2k with varying cholesterol content (0-30 mol%) en-
capsulating calcein at self-quenching concentrations (0.1 M) incubated at 37◦C, showed that
increasing cholesterol concentrations decreased calcein leakage such that at 30 mol% cholesterol
negligible leakage was observed 4 days post fabrication. Increasing the cholesterol content also
decreased both the bacteria induced leakage and the liposomal thermo-responsive release at the
lipid gel-fluid phase transition temperature (Tm). However, incubating the liposomes with a
bacterial suspension for one hour before heating to the Tm released 55 ± 6% of encapsulated
dye. Using the conventional thin lipid film hydration liposome fabrication technique, with 10
mg lipid films hydrated with 5 mg ml−1 IK8 solutions, the vesicles encapsulated approximately
24 times the MIC of IK8 against both S. aureus and P. aeruginosa, 32 µg ml−1. Liposomal
encapsulation provided a protective effect against proteases, with over double the amount of
liposome encapsulated IK8 remaining compared with free IK8 in solution, when incubated in a
trypsin solution for 5 hours. As such, these liposomes demonstrate negligible premature leakage,
an adequate thermal release profile, encapsulation of bactericidal concentrations of AMP and a
protection of cargo from protease degradation.
To demonstrate the antimicrobial capabilities of IK8-loaded liposomes a mixture of vesicles
and phospholipid stabilised AuNRs, described in Chapter 4, was used to inoculate a S. aureus
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suspension before continuous wave laser irradiation at 860 nm. S. aureus suspensions treated
with AuNRs and liposomes containing 1, 2 and 4 times the MIC of IK8 resulted in additional
3-, 4- and 5-log reductions in CFU ml−1 respectively, when irradiated at 2.1 W cm−2 (860 nm,
for 10 mins) compared to non-irradiated controls. This clearly demonstrated the first instance
of light stimulated release of AMPs. Furthermore, irradiating samples at 2.4 W cm−2 (heating
to 60◦C) demonstrated a photothermal induced killing effect, that enhanced the IK8 efficacy
with an additional 4-log reduction in viable bacteria.
Chapter 6 built upon the AuNR and IK8-loaded liposome system developed in chapter 5, by
incorporating the particles into a PEG-based hydrogel wound dressing. The hydrogel network
was formed by mixing 4-arm PEG maleimide (4APM) with PEG dithiol at a 1:1 thiol to
maleimide ratio. A 5 wt% gel fabricated using citrate buffer (pH 6) formed a homogeneous
and stiff gel in 20 s. Rheological analysis of the gels using both constant strain (1%) and
frequency sweep techniques demonstrated that at 5 wt% the network formed an elastic gel that
did not break even at the highest frequencies, meaning it is an ideal material for topical use
where it would be frequently be under strain due to the stretching of the skin. AuNR and
liposome loading into the hydrogel network was achieved by adding the particles to the 4APM
solution prior to gelation, offering a facile means of integration at ∼100% loading efficiency. The
resultant gel displayed a slight decrease in elasticity, and was able to retain over 90% of AuNRs
and liposomes after incubation in buffer for a week. Additionally, a 5 mm thick prototype
dressing allowed clear visibility of underlying features when placed next to the skin, meaning a
visible assessment of a wound would not require the removal of the dressing.
Loading the AuNRs into the PEG matrix did not affect the gel optical properties, allowing
controlled heating up to 65◦C and demonstrating no decrease in photothermal efficiency after
several irradiation cycles. The incorporation of the AuNR-liposome system into the gel did
not decrease the photothermal release efficiency, providing 64% release under irradiation at 2.1
W cm−2 for 10 mins. The light-stimulated release of the MIC of IK8 from the gel dressing
provided 5- and 7-log reductions in the CFU ml−1 against S. aureus and P. aeruginosa respec-
tively, whilst the photothermal enhancement of the AMP efficacy was maintained when the gel
was irradiated at 2.4 W cm−2 (60◦C) for 10 mins, killing an additional 3-log CFU ml−1 of S.
aureus and eradicating P. aeruginosa. Individual gels then demonstrated the potential for mul-
tiple treatment rounds. Loading gels with 2.5 times the MIC of liposomal IK8 and decreasing
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the irradiation time of the first treatment cycle to 6 mins enabled the delivery of bactericidal
concentrations of IK8 more than once. The dressing displayed 7- and 4-log reductions in S.
aureus after the first and second irradiation cycles at 2.1 W cm−2 respectively. The photother-
mal antibacterial effects were also displayed over both cycles producing further 1.1- and 2.5-log
reductions in the first and second treatments.
Taken together, the results from chapters 5 and 6 describe the development of a AuNR and
AMP-loaded wound dressing that provides the first examples of both light stimulated delivery
of AMPs and the photothermal enhancement of AMPs.350 The liposome encapsulation of AMPs
demonstrated a protective effect against protease degradation, whilst the light sensitivity al-
lowed spatial and temporal delivery of the AMPs. The delivery of AMPs transdermally from a
wound dressing directly to an infection site increases the pharmacodynamic profile and in turn
decreases the required drug dose compared to alternative routes of administration; reducing
both the chances of systemic toxicity and the cost of treatment.449 As such, this wound dressing
addressed some of the main factors hindering AMP clinical translation; proteolytic degrada-
tion, low toxicity, and cost-efficient treatment. The IK8-liposome fabrication using the tradi-
tional thin-lipid film technique allows the facile encapsulation of most hydrophilic molecules, as
demonstrated by the loading of both calcein and IK8, meaning this system could be adapted
for delivery of a range of therapeutics.
Chapter 7 described the development of an alternative AMP delivery system that is responsive
to pulsed laser irradiation, providing AMP release without bulk heating effects. Initially, at-
tempts were made to coat IK8-loaded liposomes with AuNPs by utilising the vesicles as a soft
template when performing the particle synthesis. The synthesis using PEGylated liposomes
produced anisotropic gold nanostars (AuNSs) with a tunable plamonic absorption peak, how-
ever the AuNSs did not induce liposomal release of encapsualted cargoes under the pulsed laser
irradiation (4.5 mJ cm−2 for 10 mins at 738 nm). Using TEM imaging the AuNSs did not
appear to be conjugated to the liposome templates, hypothesising that this was due to the PEG
steric hinderance of Au atoms reaching the liposome surface the Au coating was attempted
using non-PEGylated liposomes. This produced fractal snowflake-like gold nanoparticles that
again did not appear conjugated to the liposome template. As such, the thiol containing lipid
DPPE-Ptd (DSPC/cholesterol/DSPE-mPEG2k/DPPE-Ptd, 67/30/2/1 mol%) was included in
the liposome composition to provide initial binding sites for the Au ions. The synthesis in
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the presence of the thiolated liposomes resulted in particles with poor absorbance efficiency
and little control over the peak position, however 96% of the AuNPs were conjugated to the
liposomes. Instead of binding AuNPs to the liposome template during synthesis it was deemed
preferential to conjugate AuNRs to the lipid bilayer due to their monodisperse structures,
high photothermal efficiency and tunable plasmonic absorption wavelength. DPSE-mPEG2k-
maleimide was included into the phospholipid bilayer (DSPC/DSPE-mPEG2k/DSPE-mPEG2k-
maleimide, 95/4/1 mol%) stabilising the AuNRs and provided conjugation to the liposome bi-
layer using a ”click” reaction with the DPPE-Ptd. After mixing the particles overnight AuNR
conjugated IK8-liposomes (ANCIL) complexes were formed, demonstrating release of 67% of
encapsulated IK8 when irradiated at 450 µJ cm−2 for 10 mins at 738 nm. Mixing maleimide-
functionalised AuNRs with liposomes without DPPE-Ptd (DSPC/cholesterol/DSPE-mPEG2k,
69/30/1 mol%), showed no binding and released only 9% of encapsulated IK8, demonstrating
the necessity of the conjugation between the photothermal agent and the liposome when using
a pulsed laser source. The laser irradiation of the ANCIL complexes containing the MIC of IK8
displayed a 4.4-log reduction in S. aureus CFUs ml−1, a 3.1-log increase in bactericidal activity
compared to S. aureus inoculation with non-irradiated ANCILs. This provided proof-of-concept
that AuNP conjugated liposome complexes can be utilised to provide light-stimulated delivery
of therapeutics with only a 1◦C increase in sample temperature.
8.1 Future work
8.1.1 Further testing of the AuNR and IK8-liposome hydrogel dressing
The next step in the testing of the AuNR and IK8-liposome loaded wound dressing would be in
vivo testing on a murine model. Based off the study by Tao et al. who treated infected wounds
in vivo using a copper nanoparticle loaded hydrogel6, this would involve using a skin biopsy
punch to remove a 5 mm radius circle of dermal tissue from the back of a Sprague Dawley rat
and inoculation with 10 µl of S. aureus or P. aeruginosa at 1 x 107 CFU ml−1. A prefabricated
gel would then be administered and irradiation of the the wound dressing for 10 mins, heating
the dressing and wound to induce delivery of the AMP and to provide photothermal bacteria
killing. The wound would then be imaged daily to determine whether the therapeutic dressing
can increase the healing rate compared to models with control dressings and no dressings. The
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where A0 and At are the initial area and area after time t. Quantification of the viable bacteria
would be obtained by removing the wounded tissue, post euthanisation of the model, and
homogenising the sample in PBS before spreading onto agar plates for bacteria counting the
following day. This would not only test the efficacy of treatment but would determine whether
the photothermal enhancement of the AMP efficacy is also maintained in vivo. Histological
analysis of the infected tissue could also be performed to determine the whether the dressing
and the heat affect the inflammatory response and angiogenesis. Furthermore, the major organs
could be harvested to determine the toxicity of the AMP.
The IK8-liposome and AuNR loaded wound dressing could also be tested against biofilms,
both IK8 and photothermal heating have both demonstrated antibiofilm effects, but never in
conjunction with one another. Initial testing would be performed on mature biofilms grown in
well plates, before the fabrication of the gel in situ. The samples would then be irradiated and
left to incubate for 18 hours before using a live/dead assay to determine the bacteria viability.
If the wound dressing effectively kills the biofilm bacteria then the treatment would be assessed
on mature biofilms grown on murine models.
8.1.2 Decreased AMP resistance when used in conjunction with thermal
killing
Despite the reduced chances of bacteria developing resistance to AMPs, resistance still a con-
cern.450 Given that in chapters 5 and 6 the AMP efficacy has been shown to increase when used
in conjunction with heating it would be worthwhile investigating whether using both effects
simultaneously can reduce the acquired AMP resistance. This could be ascertained by inocu-
lating bacteria with an AMP and heating the sample to 60◦C for 10 mins, the bacteria that
survive the treatment would then be quantified and cultured. This process would be repeated
until the treatment becomes ineffective. This would then be compared to bacteria treated with
equal amounts of AMP without the additional heating. If the bacteria treated with the heating
as well as the AMP took more treatment rounds to becoming ineffective then the heating can
be stated to decrease the chances of resistance acquisition. If this were to be proven the impli-
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cations could be incredibly significant, given that heating a wound to bactericidal temperatures
for short periods of time has been demonstrated not to affect wound healing, this could become
an integral part of future infection treatments to decrease likelihood of resistance.
8.1.3 Further characterisation of the ANCIL system
Chapter 7 provides proof-of-concept for the ANCIL system treating Gram-positive S. aureus,
however more characterisation is required before the complex could be taken forward as a
medical device. Firstly, the cytotoxicity of the liposomes containing DPPE-Ptd, the maleimide-
funcationalised phospholipid stabilised AuNRs and the ANCIL complex, needs to be assessed
against a cell type associated with wound healing, such as the dermal fibroblast. The leakage
from the ANCIL complex must also be assessed to ensure that the inclusion of DPPE-Ptd or the
AuNR conjugation does not affect the membrane integrity promoting premature drug leakage.
Finally, the ANCIL system should be use to demonstrate efficacy against a Gram-negative
bacteria to show broad-spectrum activity.
8.1.4 Further investigation of AuNP synthesis using liposomal soft templates
Nanoparticle synthesis is a burgeoning field, with particular focus on the discovery of novel
surfactants that control the particle morphology. Many surfactants have an inherent cytotoxi-
city, meaning they have to be replaced by biocompatible stabilising molecules post fabrication,
increasing the time and cost of manufacture. The unique nanostar and fractal flake-like mor-
phologies of the AuNPs synthesised in the presence of biocompatible liposomes, as described in
chapter 7, offer tunable plasmonic properties that are desirable in photothermal agents. The
AuNS and flake-like particle morphologies are completely different however the only difference
between the syntheses was the inclusion of DSPE-mPEG2k in the liposome, as such it would
be a good idea to expand this parameter space using alternative lipids to determine what ef-
fects they have on the crystal growth. Furthermore, the liposomes appeared to increase the
gold nanoparticle colloidal stability demonstrating no precipitation even after several weeks. As
such, the AuNP synthesis utilising liposomes as soft templates requires further investigation
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[435] S. Barbosa, A. Agrawal, L. Rodŕıguez-Lorenzo, I. Pastoriza-Santos, R. A. Alvarez-Puebla,
A. Kornowski, H. Weller, and L. M. Liz-Marzán. Tuning size and sensing properties in
colloidal gold nanostars. Langmuir, 26(18):14943–14950, 2010.
[436] M. Wang, X. Cao, W. Lu, L. Tao, H. Zhao, Y. Wang, M. Guo, J. Dong, and W. Qian.
Surface-enhanced Raman spectroscopic detection and differentiation of lung cancer cell
lines (A549, H1229) and normal cell line (AT II) based on gold nanostar substrates. RSC
Advances, 4(109):64225–64234, 2014.
[437] M. M. Phiri, D. W. Mulder, and B. C. Vorster. Seedless gold nanostars with seed-like
advantages for biosensing applications. Royal Society Open Science, 6(2), 2019.
[438] C. G. Khoury and T. Vo-Dinh. Gold Nanostars For Surface-Enhanced Raman Scattering:
Synthesis, Characterization and Optimization. Phys. Chem. C Nanomater. Interfaces,
2008(112):18849–18859, 2008.
[439] F. Liebig, R. Henning, R. M. Sarhan, C. Prietzel, C. N. Schmitt, M. Bargheer, and J.
Koetz. A simple one-step procedure to synthesise gold nanostars in concentrated aqueous
surfactant solutions. RSC Advances, 9(41):23633–23641, 2019.
[440] D. Maysinger, A. Moquin, J. Choi, M. Kodiha, and U. Stochaj. Gold nanourchins
and celastrol reorganize the nucleo- and cytoskeleton of glioblastoma cells. Nanoscale,
10(4):1716–1726, 2018.
[441] O. M. Bakr, B. H. Wunsch, and F. Stellacci. High-yield synthesis of multi-branched
urchin-like gold nanoparticles. Chemistry of Materials, 18(14):3297–3301, 2006.
[442] K. T. Kim, S. A. Meeuwissen, R. J. Nolte, and J. C. Van Hest. Smart nanocontainers
and nanoreactors. Nanoscale, 2(6):844–858, 2010.
[443] G. W. Kim and J. W. Ha. Effect of adsorbate electrophilicity and spiky uneven surfaces
on single gold nanourchin-based localized surface plasmon resonance sensors. Chemical
Physics Letters, 697:38–42, 2018.
[444] L. Wang, G. Wei, C. Guo, L. Sun, Y. Sun, Y. Song, T. Yang, and Z. Li. Photochemical
synthesis and self-assembly of gold nanoparticles. Colloids and Surfaces A: Physicochem-
ical and Engineering Aspects, 312(2-3):148–153, 2008.
[445] F. Liebig, R. Henning, R. M. Sarhan, C. Prietzel, M. Bargheer, and J. Koetz. A new
route to gold nanoflowers. Nanotechnology, 29(18), 2018.
221
BIBLIOGRAPHY BIBLIOGRAPHY
[446] K. Sivasubramanian, M. Mathiyazhakan, C. Wiraja, P. K. Upputuri, C. Xu, and M. Pra-
manik. Near-infrared light-responsive liposomal contrast agent for photoacoustic imaging
and drug release applications. Journal of Biomedical Optics, 22(4):041007, 2016.
[447] W. T. Ferrar, D. F. O’Brien, A. Warshawsky, and C. L. Voycheck. Metalization of Lipid
Vesicles via Electroless Plating. J. Am. Chem. Soc., 110:288–289, 1988.
[448] K. Ahmed, P. W. Muiruri, G. H. Jones, M. J. Scott, and M. N. Jones. The effect of
grafted poly(ethylene glycol) on the electrophoretic properties of phospholipid liposomes
and their adsorption to bacterial biofilms. Colloid Surface A, 194(3):287–296, 2001.
[449] R. Bajracharya, J. G. Song, S. Y. Back, and H.-K. Han. Recent Advancements in Non-
Invasive Formulations for Protein Drug Delivery. Computational and Structural Biotech-
nology Journal, 17:1290–1308, 2019.
[450] H.-S. Joo, C.-I. Fu, and M. Otto. Bacterial strategies of resistance to antimicrobial pep-
tides. Philosophical Transactions of the Royal Society B: Biological Sciences, 371(1695):2
0150292, 2016.
222
